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1 Introduction 
1.1 Occurrence of Chiral Saturated Heterocycles 
Chiral substituted tetrahydrofuran and dihydrobenzofuran scaffolds are present in 
numerous biologically active compounds.[1] Prominent examples of such tetrahydro-
furans include capecitabine (1), an oral chemotherapy agent marketed by Roche under 
the trade name Xeloda®, which is used in the treatment of colorectal and breast cancer 
(Figure 1.1).[2] Another example is represented by the naturally occurring dia-
stereomeric pair of calyxolanes A and B (2a, 2b) that were isolated from the Caribbean 
marine sponge Calyx podatypa.[3] 
 
Figure 1.1 Structures of natural and man-made chiral tetrahydrofurans. 
Chiral substituted 2,3-dihydrobenzofurans can also be found in natural products such 
as conocarpan (3) and thespesone (4) (Figure 1.2). Isolated from the wood of Conocarpus 
erectus, conocarpan (3) exhibits insecticidal, antifungal and antitrypanosomal 
activities.[4] Thespesone (4), first isolated in 1983 from the heartwood of the tree 
Thespesia populnea, is a para-naphtoquinone connected to the dihydrofuran moiety.[5] 
The first total synthesis of thespesone (4) and its non-natural enantiomer was reported 
by SCHOBERT et al., along with its cytotoxic activity against a small panel of human 
cancer cell lines.[6] 
 
Figure 1.2 Structures of biologically active benzodihydrofurans. 
2,3-Dihydrobenzofuran-2-carboxylic acid 5 and its derivatives are potent hypo-
lipidemic agents and subtype-selective PPARα agonists, and therefore were selected 
as candidates for further preclinical evaluations.[7] 
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The widespread occurrence of tetrahydrothiophene core structures in natural as well 
as non-natural products makes them important compounds for the pharmaceutical 
industry.[8] The essential coenzyme biotin (6), a water-soluble vitamin which is 
responsible for important transformations in the human body, contains such a motif 
(Figure 1.3).[9] The 4’-thioadenosine derivative 7 for example, is a highly potent and 
selective A3 adenosine receptor antagonist, whereas sulopenem (8), exhibits anti-
bacterial properties. Substituted tetrahydrothiophene 1,1-dioxides are also interesting 
targets for pharmaceutical research as shown by two examples in Figure 1.3. 
Mono-substituted tetrahydrothiophene 1,1-dioxide 9 is a Hepatitis C virus protease 
inhibitor, whilst the disubstituted analog 10 possesses high HIV-1 protease inhibition 
activity.[10] 
 
Figure 1.3 Structures of chiral tetrahydrothiophenes and oxidized analogs. 
The medicinal importance of chiral saturated heterocyclic compounds calls for 
straightforward and high yielding stereoselective methods for their synthesis. Many 
different approaches are known to produce such scaffolds;[8, 11] some stereoselective 
variants to synthesize substituted tetrahydrofurans, 2,3-dihydrobenzofurans and 
tetrahydrothiophene 1,1-dioxides are shown in the following section.  
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1.2 Asymmetric Synthesis of Saturated Heterocycles 
The hydroformylation reaction, discovered by ROELEN in 1938, emerged as an 
important industrial process for the synthesis of aldehydes from olefins.[12] An 
asymmetric version of this reaction involving a homogeneous catalyst was recently 
applied to the synthesis of 2- and 3-substituted tetrahydrofuran carbaldehydes 12 and 
13 (Scheme 1.1).[13] 
 
Scheme 1.1 Synthesis of 2- and 3-substituted carbaldehydes. 
The chiral C2-symmetric bis-diazaphospholane ligand 15 promotes the asymmetric 
hydroformylation of 2,5-dihydrofuran (11) to give selectively the β-regioisomer 13 and 
2,3-dihydrofuran (14) as the by-product (4%), while the same reaction with 
2,3-dihydrofuran (14) yields α-carbaldehyde 12. Both reactions proceed with high 
conversion and enantioselectivity. However, the limited substrate scope of this 
method reduces its applicability. 
A more broadly applicable transformation is shown in Scheme 1.2. The 
consecutive ring-expansion reaction of epoxides with dimethylsulfonium methylide, 
gives access to both 2-aryl and 2-alkyl substituted tetrahydrofurans depending on the 
substitution of the epoxide.[14] 
 
Scheme 1.2 Synthesis of 2-substituted tetrahydrofurans. 
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Starting with optically pure epoxides, which are readily synthesized by SHARPLESS[15] 
or SHI[16] epoxidation, the nucleophilic ring expansion proceeds with retention of 
stereochemistry providing 2-substituted tetrahydrofurans in good yield and unaltered 
enantiomeric excess. 
The preparation of 2,4-disubstituted tetrahydrofurans from enantioenriched 
intermediates can be accomplished by a reduction-cyclization sequence in one step, as 
shown in the application of enatiopure γ-nitro-aldehydes 20 described by MACMILLAN 
in the context of the organocatalyzed carbo-oxidation of styrene derivatives 
(Scheme 1.3).[17] 
Scheme 1.3 Carbo-oxidation of styrene and subsequent ring formation. 
Various substituents are tolerated on both the aldehyde 18 and the styrene 19. 
However, the ring closure was performed with only one nitro-aldehyde 20, affording 
the product 21 in quantitative yield with moderate diastereo- and high 
enantioselectivity. The synthesis of other derivatives with different substituents on the 
heterocycle should be possible by this route. 
Starting from racemic compounds, as in the kinetic resolution of homoaldols via 
catalytic asymmetric transacetalization, enantioenriched 2,5-disubstituted tetrahydro-
furans 23 can be obtained (Scheme 1.4).[18] 
Scheme 1.4 Synthesis of 2,5-disubstituted tetrahydrofurans 23 via acetalization. 
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This transformation tolerates not only a broad substrate range, but also delivers the 
products 23 with high enantiomeric excess and moderate to excellent diastereo-
selectivity. The only limitation is the maximum theoretical yield of 50% and the 
predefined ether substituent at the 2-position. 
A chemoenzymatic strategy was applied to the asymmetric synthesis of 
2,3-dihydrobenzofurans (Scheme 1.5).[19] Protection of commercially available 
phenols 25 followed by reaction with nBuLi and 2-methyloxirane resulted in racemic 
alcohols 27. The alcohols were enzymatically resolved to deliver suitable enantiopure 
precursors 28, which in turn cyclized after deprotection to the desired 
2,3-dihydrobenzofurans 30. 
Scheme 1.5 Synthesis of 2,3-dihydrobenzofurans 30 in five steps. 
Product 30 was obtained in enantiomerically pure fashion, but with the limitation of a 
maximum yield of 50% and the drawback of a lengthy synthesis. 
Asymmetric cyclization cross-coupling sequence with alkyl electrophiles was 
pursued by FU et al. to selectively obtain 2,3-dihydrobenzofurans substituted at the C3 
(Scheme 1.6).[20] Transmetallation of the organometallic reagent 31 containing a 
proximal olefin, followed by cyclization and subsequent cross-coupling with an 
alkylbromide, leads to two newly formed carbon-carbon bonds and a stereogenic 
center. Remarkably, almost no direct cross-coupled or endo cyclized by-products were 
formed (<5%). 
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Scheme 1.6 Synthesis of 2,3-dihydrobenzofurans 33 via a cyclization cross-coupling sequence. 
Domino reactions have also been successfully utilized in the asymmetric synthesis of 
tetrahydrothiophene derivatives, such as the Michael-aldol reaction sequence.[21] 
Depending on the use of acidic or basic additives in the organocatalytic system, 
tetrahydrothiophene carbaldehydes 37 or (tetrahydrothiophen-2-yl)phenyl methan-
ones 38 are obtained in moderate to good yield. As an example, reaction of thiol 34 and 
aldehyde 35 in the presence of L-proline derived catalyst 36 and benzoic acid gives 
tetrahydrothiophene carbaldehyde 37 as a single isomer (Scheme 1.7). In contrast, 
addition of basic NaHCO3 promotes the domino process to afford a 98:2 mixture of 
both isomers 37 and 38; the major product could be isolated in 56% yield and 94% ee. 
Scheme 1.7 Synthesis of tetrahydrothiophenes 37 and 38 via Michael-aldol reaction. 
To access the corresponding dioxides one additional step is necessary to oxidize the 
preformed thioethers.[22] 
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A direct and very attractive route to enantioenriched reduced heterocycles from 
aromatic precursors is provided by transition-metal-catalyzed asymmetric hydro-
genation (Scheme 1.8). 
 
Scheme 1.8 Synthesis of chiral heterocycles via asymmetric hydrogenation. 
Despite extensive efforts in the field of asymmetric hydrogenation of heteroaromatic 
compounds over the last two decades, enantioselective hydrogenation of furans, 
benzofurans and thiophenes is still limited in scope,[23] whereas for substituted 
thiophene 1,1-dioxides to date no hydrogenation protocol exists. 
1.3 Aim of This Work 
The main focus of the research presented in this dissertation was to further broaden 
the substrate scope of the iridium-catalyzed hydrogenation of heterocyclic 
compounds. The synthesis of various substituted furans and benzofurans is shown in 
Chapter 2, while their asymmetric iridium-catalyzed hydrogenation is the subject of 
Chapter 3. Furthermore, the preparation of disubstituted thiophene 1,1-dioxides and 
their stereoselective reduction using iridium-catalysts are described in the following 
two chapters (Chapter 4, Chapter 5). 
Finally, investigations on the iridium-catalyzed hydrogenation of oxazoles and 
thiazoles are reported in Chapter 6. 
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2 Synthesis of Furans and Benzofurans as Substrates for 
Iridium-Catalyzed Asymmetric Hydrogenation 
2.1 Introduction 
Furan and benzofuran core structures are common subunits in pharmaceuticals, 
natural products and other biologically important molecules.[24] To access substituted 
furans and benzofurans two main approaches can be applied. The first strategy is 
based on the construction of the heterocycle, whereas the second takes advantage of 
various kinds of ring functionalization methods. 
A simple and effective method to synthesize 3-substituted furans, relies on the ring 
construction in one step via a tandem DIELS–ALDER/retro DIELS–ALDER reaction 
sequence as depicted in Scheme 2.1.[25] 
 
Scheme 2.1 Synthesis of 3-substituted furans via tandem DIELS–ALDER/ 
retro DIELS–ALDER sequence. 
4-Phenyloxazole (39), as diene and substituted acetylenes 40, as dienophiles react 
under thermal conditions to provide both 3-aryl- and 3-alkylfurans 41 in moderate to 
good yield. Albeit starting materials are broadly accessible and many functional 
groups are tolerated, high temperature and long reaction times render this sequence 
unattractive. Another method to access 3-substituted furans in one step, is the 
nickel-catalyzed KUMADA cross-coupling reaction.[26] This synthetic route has been 
chosen for the synthesis of some substrates for iridium-catalyzed asymmetric 
hydrogenation and will be further discussed in Section 2.2. 
Preparation of 2-substituted furans can be achieved either by electrophilic 
aromatic substitution or metallation. The latter approach takes advantage of the 
inductive effect of the oxygen atom, allowing functionalization at the C2/C5 position. 
The commercially, readily available and relatively cheap furan 42, a precursor of the 
widely used solvent tetrahydrofuran (THF) and therefore produced on industrial 
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scale, is a perfect starting material for the synthesis of 2-substituted furans as shown 
in Scheme 2.2.[27] 
 
Scheme 2.2 Synthesis of 2-phenylfuran (44a) via NEGISHI cross-coupling. 
Deprotonation of furan (42) with one equivalent of nBuLi results in 2-lithiofuran, 
which is transmetallated with zinc chloride to give the heteroaryl zinc compound 43. 
Subsequent palladium-catalyzed cross-coupling with aryl iodides or bromides (the 
latter must be activated by an electron-withdrawing group) affords 2-phenyl-
furan (44a) in good yield. Alternatively, the 2-lithiofuran can be trapped with various 
electrophiles, providing an entry to 2-alkyl substituted furans in moderate to good 
yield (Scheme 2.3).[28] 
 
Scheme 2.3 Synthesis of 2-substituted and 2,5-disubstituted furans. 
Second lithiation of the 2-substituted product 45 provides 2,5-disubstituted 
heterocycles with similar chemical yield. Another classical approach to synthesize 
disubstituted furan rings is represented by the synthesis developed by PAAL and 
KNORR in 1884.[29] Both groups reported almost simultaneously the cyclizing 
dehydration of 1,4-diketones 47 upon treatment with strong mineral acids (Scheme 2.4). 
 
Scheme 2.4 Synthesis of substituted furans via PAAL–KNORR furan synthesis. 
This approach results in either 2,5-disubstituted or 3,4-disubstituted furans depending 
on the substitution pattern of the starting 1,4-dicarbonyl compound 47. However, it 
has two major drawbacks. First, the limited availability of 1,4-dicarbonyl compounds 
and secondly, the restricted functional group tolerance under strongly acidic 
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conditions. The synthesis of 2,4-disubstituted furans can be achieved from acyclic, 
readily available starting materials in a multi-step synthesis. As such synthetic 
protocols were applied to the synthesis of some substrates, their discussion will follow 
in Section 2.4. 
3-Substituted benzofurans can be accessed by lithium-halogen exchange using 
3-bromobenzofuran (50) at low temperature to avoid ring-opening of 3-lithiobenzo-
furan (49) to give 2-hydroxyphenylacetylene (52) (Scheme 2.5).[30] 
 
Scheme 2.5 Generation of 3-lithiobenzofuran (49). 
More often though ring construction represents a more practical alternative to 
metallation. An example of how 3-substituted benzofurans can easily be generated by 
ring formation is shown in Scheme 2.6.[31] One possible reaction pathway involves initial 
formation of the hydroxy-epoxide 54 via COREY–CHAYKOVSKY reaction followed by 
intramolecular ring opening to give the 3-hydroxydihydrobenzofuran 55, that finally 
undergoes water elimination promoted by elevated temperature or acid to furnish the 
desired 3-methylbenzofuran 56. Although this series of steps appears to be likely, the 
hydroxy-epoxide intermediate 54 was not detected in this reaction. 
 
Scheme 2.6 Synthesis of 3-substituted benzofurans 56 via COREY–CHAYKOVSKY reaction. 
Benzofurans with substitution at C2 can be prepared either by direct metallation, 
analogous to 2-substituted furans, or by application of cross-coupling reactions, such 
as SUZUKI[32] or NEGISHI[33] coupling (Section 2.6). Platinum-catalyzed intramolecular 
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carboalkoxylation provides 2-aryl-substituted as well as 2-alkyl substituted 
benzofurans in a single step (Scheme 2.7).[34] 
 
Scheme 2.7 Synthesis of 2-substituted benzofurans 55. 
Catalytic amounts of PtCl2 activate the alkyne towards nucleophilic attack. Hence, 
phenol derivative 57 bearing an alkyne at the ortho-position smoothly cyclizes to 
benzofuran 58. 
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2.2 Synthesis of 3-Substituted Furans 
2.2.1 Aromatic Substituents 
The synthesis of 3-substituted furans can be achieved in many different ways. A cross-
coupling reaction was chosen to substitute the furan with both aryl and alkyl 
substituents at the C3 position in one step. Thus starting from the commercially 
available 3-bromofuran (59) the corresponding alkyl or aryl substituent could be 
introduced via a nickel-catalyzed KUMADA coupling[26] with the appropriate Grignard 
reagent (Scheme 2.8). 
 
Scheme 2.8 Synthesis of 3-aryl-substituted furans. 
To investigate the electronic effects of the substituents on the iridium-catalyzed 
hydrogenation of furans, three different aromatic substituents bearing electron 
neutral 41a, electron donating 41b and electron withdrawing 41c groups were 
successfully attached to the heterocycle using the above mentioned cross-coupling 
(Figure 2.1). 
 
Figure 2.1 Structures of aryl 3-substituted furans with corresponding yields. 
A first attempt to synthesize furan 41a from commercially available 3-bromofuran (59) 
succeeded in moderate yield overnight (37%) (Table 2.1, entry 1). While nickel salts 
could be removed by distillation, the homocoupling product which was formed 
during the reaction had to be separated by flash chromatography. 
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Table 2.1 Influence of the reaction parameters on the yield of 3-phenylfuran (41a). 
entry time (h) PhMgBr (eq.) scale (mmol) yield (%)[a] 
1 16 1.20 3.35 37 
2 2 1.05 4.21 37 
3 3 1.10 7.52 60 
[a] Yield after distillation and flash chromatography. 
To reduce the amount of the undesired by-product a smaller excess of the Grignard 
compound was used in the second run (Table 2.1, entry 2). After a reaction time of two 
hours 3-bromofuran (59) was completely consumed. However, this modification did 
not improve the yield. Only after the reaction was performed on a twice bigger scale 
with the same concentration, the yield increased to 60% (Table 2.1, entry 3). 
3-(4-Methoxyphenyl)furan (41b) was synthesized in the same manner as 
furan 41a using commercially available 4-methoxyphenylmagnesium bromide and 
was obtained 77% yield. The synthesis of 3-((4-trifluoromethyl)phenyl)furan (41c) was 
achieved by using freshly prepared Grignard compound from 4-bromobenzo-
trifluoride (60) and 3-bromofuran (59) through metal-catalyzed cross-coupling 
reaction (Scheme 2.9). 
 
Scheme 2.9 Synthesis of 3-(4-(trifluoromethyl)phenyl)furan (41c) via Grignard reaction  
and subsequent KUMADA coupling. 
The yield of the 3-aryl-substituted furans varied with the electronic properties of the 
substituents. While the highest yield was obtained for the substrate with an electron 
donating methoxy group (77%), the yield was lower when an electron withdrawing 
moiety (CF3) was introduced. It should be noticed that also in the case of compounds 
41b and 41c the undesired homocoupling by-products had to be removed by flash 
chromatography.  
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2.2.2 Aliphatic Substituents 
To broaden the scope and to investigate the different influences of alkyl and aryl 
substituents on the iridium-catalyzed hydrogenation of furans, linear and branched 
alkyl chains were also considered. 
The sequence of a Grignard reaction and KUMADA coupling described above 
was applied to prepare 3-alkyl substituted furans. However, 3-propylfuran (62) could 
not be isolated. This can be attributed to the volatility of furans with short alkyl chains, 
as in case of 3-propylfuran (62) and 3-(4-methylpent-3-en-1-yl)furan (63) (Figure 2.2). 
 
Figure 2.2 Structures of alkyl 3-substituted furans with corresponding yields. 
Compound 63, also called perillen, was found to be the characteristic flowery odor in 
many essential oils.[35] Perillen (63) was synthesized from the freshly prepared 
Grignard compound from 5-bromo-2-methyl-2-pentene and 3-bromofuran (59). The 
product was detected by GC-MS in the crude reaction mixture and by proton NMR 
analysis after flash chromatography together with npentane. After letting the 
combined fractions standing over night the product 63 evaporated almost completely. 
When longer alkyl chains were introduced, like in 3-octylfuran (64), the desired furan 
could be prepared through the aforementioned nickel-catalyzed cross-coupling 
reaction in 14% yield. Substitution of the furan at the 3-position was also possible with 
branched alkyl moieties as for 3-cyclohexylfuran (65) although with moderate yield 
(40%). The low yield was not optimized and is a result of tedious product purification 
to remove the homocoupling by-product by flash chromatography and metal traces 
by distillation. 
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2.3 Synthesis of 2-Substituted Furans 
The synthesis of 2-substituted furans is even more straightforward. Because of the 
inductive effect of the oxygen atom direct α-lithiation is possible.[30] After 
deprotonation of furan (39), the lithiated intermediate can be either transmetallated or 
directly reacted with electrophiles. 
Aryl substituted furans were successfully synthesized by initial lithiation 
followed by transmetallation with zinc, since the heteroaryl zinc compounds are 
usually compatible with many functional groups.[27] The zinc derivative was then 
subjected to NEGISHI cross-coupling reaction conditions (Scheme 2.10). 
 
Scheme 2.10 Synthesis of 2-substituted aryl furans by cross-coupling. 
The electronic properties of the aryl halides used as cross-coupling partners had a great 
influence on the yield of the products. When an electron withdrawing group was 
present, the product was obtained in higher yield than with aryl halides bearing an 
electron donating substituent. Since the main emphasis of the research presented in 
this thesis was the investigation of the asymmetric hydrogenation of furans, the 
synthesis of the substrates was not extensively optimized. 
Both cyclic and acyclic alkyl substituted furans were investigated. The method 
of choice to prepare 2-cyclohexylfuran (66) was the KUMADA cross-coupling.[36] After 
chromatographic separation of the homocoupling by-product, the pure product 66 
was obtained in good yield (Scheme 2.11). 
 
Scheme 2.11 Synthesis of 2-cyclohexylfuran (66) by KUMADA coupling. 
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Direct lithiation in THF, followed by electrophilic substitution was chosen to prepare 
2-octylfuran (71) (Scheme 2.12). Even though furan is readily deprotonated, the reaction 
proceeded only slowly. After 24 hours, starting material 70 was still detected together 
with the desired product 71 and the disubstituted by-product 72. 
 
Scheme 2.12 Synthesis of 2-octylfuran (71). 
Separation of the three components by flash chromatography with pure npentane was 
not possible. However, the desired product 71 and the 2,5-disubstituted furan 72 were 
separated by “Kugelrohr” distillation. The low yield is a direct consequence of the 
difficult separation from the starting material. Therefore several methods were tried 
to convert the unreacted starting material into a compound that is easier to remove. 
Fractions from the distillation were used for these investigations. One possibility was 
to transform 1-bromooctane (70) into the corresponding Grignard compound with 
subsequent hydrolysis to give highly volatile alkane 73, which can be simply removed 
by evaporation (Scheme 2.13). 
 
Scheme 2.13 Formation of a Grignard compound from 1-bromooctane (70)  
with subsequent hydrolysis. 
After formation of the alkyl Grignard reagent from a mixture of product 71 and 
starting material 70 (1:0.7, 1H-NMR), the reaction mixture was quenched. But instead 
of the expected octane, the dimer 73 was detected by 1H-NMR and GC-MS. The 
separation of hexadecane 73 from product 71 was performed by flash chromatography 
to deliver the latter in quantitative recovery. Another fraction with a lower content of 
bromo alkane 70 (9%, by 1H-NMR) was converted using silver tosylate into the 
corresponding tosylated compound 74, via SN2 reaction (Scheme 2.14). 
 
Scheme 2.14 Transformation of 1-bromooctane (70) into the corresponding tosylate 74. 
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By-product 74 has not only a different retention factor on the thin layer 
chromatography, but is also UV active and therefore even easier to be removed by 
flash chromatography. Indeed separation was straightforward with an almost 
quantitative product recovery from the mixture (96%).  
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2.4 Synthesis of 2,4-Disubstituted Furans 
The preparation of 2,4-disubstituted furans required a different strategy. A multi-step 
synthesis starting from commercially available propargyl alcohol was chosen, which 
gives direct access to 4-bromo-2-phenylfuran (75) (Scheme 2.15).[37] 
Scheme 2.15 Synthesis of 4-bromo-2-phenylfuran (75) in five steps. 
The relatively cheap propargyl alcohol (76) was protected as a THP ether 77 and, after 
lithiation, the chain was elongated by reaction with benzaldehyde. Oxidation to the 
ketone with manganese dioxide and acid catalyzed deprotection afforded the 
alcohol 78. These three reactions were performed in a stepwise manner, although a one 
pot procedure was also reported with lower yield (68%).[37] Alcohol 78 reacted in the 
presence of hydrobromic acid to give product 75. As for the mono-substituted furans, 
the brominated precursor 75 was subjected to the KUMADA cross-coupling conditions 
(Scheme 2.16). 
 
Scheme 2.16 Synthesis of 2,4-disubstituted furans. 
After successful introduction of a phenyl substituent to yield 2,4-diphenylfuran (79), 
aliphatic moieties were attached. Therefore, furan 75 was reacted with the Grignard 
reagent, obtained from 1-bromopropane, in the cross-coupling. In this case, not only 
conversion was incomplete, but additional dehalogenation of the starting material 75 
hampered the isolation of 2-phenyl-4-propylfuran (80). Thus another procedure was 
considered for the preparation of mixed aryl-alkyl and purely alkyl substituted 
2,4-disubstituted furans, that required only two steps to obtain two different 
substituted furans with moderate yield (Scheme 2.17).[38] 
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Scheme 2.17 Two-step synthesis of 4-methyl-2-phenylfuran (85) and 2-hexyl-4-methylfuran (86). 
Starting with either phenyl acetylene (81) or 1-octyne (82), lithiation and addition of 
chloroacetone resulted in the corresponding epoxides 83 and 84. In the second step the 
epoxide underwent an acid-catalyzed rearrangement in the presence of methanol. The 
synthesis of 2-hexyl-4-methylfuran (86) was accomplished with a moderate overall 
yield (30%) after flash chromatography and distillation. In the case of 4-methyl-
2-phenylfuran (85) both reaction steps proceeded very well, but purification was 
challenging. According to the literature,[39] the compound should form colorless 
needles with a melting point of 37–39 °C. However, it was not possible to crystallize it, 
because it readily dissolves in npentane at room temperature. After purification with 
flash chromatography and distillation furan 85 was either obtained as pale yellow 
hygroscopic crystals or as colorless oil. 
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2.5 Synthesis of 2,5-Disubstituted Furans 
Previous investigations on the iridium-catalyzed hydrogenation of symmetrical 
2,5-disubstituted furans showed mainly the formation of the achiral meso form,[40] 
therefore this substitution pattern was not further studied. However, unsymmetrical 
2,5-disubstituted furans were investigated, since their hydrogenation could not lead 
to the formation of meso species. The 2,5-dialkyl and 2-aryl-5-alkyl substituted furans 
were prepared from the 2-substituted furans already synthesized as described in 
Section 2.3. After deprotonation of 2-octylfuran (71) with nBuLi and transmetallation 
with zinc, the organozinc compound 87 was reacted with iodobenzene in a 
palladium-catalyzed NEGISHI coupling (Scheme 2.18). 
 
Scheme 2.18 Synthesis of 2-phenyl-5-octylfuran (88) via NEGISHI cross-coupling. 
Because of incomplete conversion (80%, by GC-MS) and several purifications needed 
(flash chromatography twice and a distillation) the product was isolated in low yield 
(14%). The pure 2,5-alkyl substituted furan 89 was also obtained in a one-step 
procedure starting from the same precursor 71 (Scheme 2.19). 
 
Scheme 2.19 Synthesis of (2-(2-methoxyethyl)-5-octylfuran) (89) by direct metallation. 
Although the starting furan 71 was not completely consumed (77%, by GC-MS), the 
purification of the crude mixture was straightforward because of the different 
polarities of the product and the starting material 71. As a result the product 
2-(2-methoxyethyl)-5-octylfuran (89) was obtained in good yield (66%). 
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2.6 Synthesis of 3-Substituted and 2-Substituted Benzofurans 
Substituted benzofurans can be obtained either by cyclization reaction of acyclic 
precursors or by substitution of a prefunctionalized or a simple benzofuran. For the 
synthesis of the 3-substituted benzofurans shown in this work, a cyclization reaction 
was chosen (Scheme 2.20).[41] 
 
Scheme 2.20 Synthesis of 3-substituted benzofurans by COREY–CHAYKOVSKY reaction. 
The commercially available acetophenone derivatives 53a and 53b were transformed 
to the corresponding benzofurans 56a and 56b via COREY–CHAYKOVSKY reaction. To 
prevent O-methylation, the epoxidation reaction had to be performed at 40 °C. After 
consumption of the starting material the temperature could be increased to obtain full 
conversion of the tertiary alcohols into benzofurans 56a and 56b.[42] 
Benzofurans substituted with an alkyl moiety at the 2-position were prepared 
by direct metallation with subsequent nucleophilic substitution (Scheme 2.21).[33] 
 
Scheme 2.21 Synthesis of 2-alkyl substituted benzofurans. 
For both substrates it was necessary to purify the corresponding product by flash 
chromatography with subsequent bulb to bulb distillation. In this way the starting 
material, bromo alkane and/or benzofuran, could be removed. When the reaction was 
performed with tBuLi and isopropyl iodide, only 5% of the product was detected by 
proton NMR with the rest being benzofuran. Even a second treatment of this mixture 
with tBuLi and phenantroline, as indicator for lithiation of the heterocycle, did not 
improve the yield. Nevertheless, a similar substituted 2-alkenyl benzofuran 93 was 
synthesized by electrophilic addition of acetone to the lithiated benzofuran followed 
by water elimination (Scheme 2.22). 
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Scheme 2.22 Synthesis of 2-(prop-1-en-2-yl)benzofuran (93). 
In addition to alkyl substituted benzofuran substrates several aryl substituted analogs 
were prepared. To this end, SUZUKI cross-coupling was selected as the reaction of 
choice (Scheme 2.23).[33] 
 
Scheme 2.23 Synthesis of 2-substituted aryl benzofurans via SUZUKI coupling. 
The reaction of 2-benzofuranboronic acid (94) with iodobenzene and 4-iodobenzo-
trifluoride proceeded with high yield. Only the benzofuran substituted with an 
electron-donating group 95b was obtained in lower yield. The benzyl substituted 
analog was synthesized from a brominated precursor in a multiple-step synthesis 
(Scheme 2.24).[33, 43]  
 
Scheme 2.24 Synthesis of 2-benzylbenzofuran (99). 
Without the need for protecting groups the aldehyde 96 was converted into 
gem-dibromoolefin 97 via RAMIREZ–COREY–FUCHS olefination reaction. To the pre-
formed PPh3=CBr2 ylide NEt3 was added followed by salicyladehyde 96 to provide the 
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gem-dibromoolefin 97 in quantitative yield. The latter was then converted into 
2-bromobenzofuran (98) in high yield through an intramolecular cyclization in the 
presence of copper iodide and potassium phosphate. NEGISHI cross-coupling of 
2-bromobenzofuran (98) with benzylbromide resulted in 2-benzylbenzofuran (99) in 
good yield. 
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3 Iridium-Catalyzed Asymmetric Hydrogenation of Furans and 
Benzofurans 
3.1 Introduction 
Stereoselective hydrogenation of heterocycles is a promising method to prepare chiral 
heterocyclic compounds, which are abundant in biological active molecules (see 
Chapter 1). Although optically active tetrahydrofuran and dihydrofuran units are 
present in numerous pharmaceutically relevant molecules, general methods for their 
asymmetric synthesis are rather scarce. After the pioneering work of the TAKAYA 
group in 1995 reporting an enantiomeric excess of 50% for the asymmetric 
hydrogenation of 2-methylfuran with a Ru(binap) catalyst (Scheme 3.1, example a),[23k] 
further progress was rather slow. In 2003 two heterogeneous catalytic systems were 
reported that gave 77% ee in the hydrogenation of 2-methylfuran (rhodium on wool, 
Scheme 3.1, example b)[23j] and 98% ee in the hydrogenation of furfural (using a Pt-
biopolymer complex, Scheme 3.1, example c).[23g] However, these systems are not well 
defined and the scope of the hydrogenation was not investigated. 
 
Scheme 3.1 Progress in the asymmetric hydrogenation of substituted furans. 
In 2006, SPINDLER and co-workers published a rhodium(diphosphine)-catalyzed 
hydrogenation of a 2,5-disubstituted furan leading to the corresponding enantio-
merically enriched tetrahydrofuran with perfect cis selectivity and 72% ee (Scheme 3.1, 
example d).[23f] Recently after completion of the experimental work for this thesis, 
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GLORIUS and co-workers reported a ruthenium catalyst based on a chiral N-hetero-
cyclic carbene ligand for the reduction of an array of 2,5- and 2,4-disubstituted furans 
(Scheme 3.1, example e).[23l] Electron-donating groups on the phenyl ring gave 
2,5-tetrahydrobenzofurans with lower conversion, but higher ee, whereas no general 
trend was observed for the diastereomeric ratio. The 2,4-disubstituted cis products 
were selectively obtained with moderate yield, but excellent enantiomeric excess. Also 
2-substituted benzofurans were investigated using the same catalytic system 
(Scheme 3.2). While benzofuran substrates carrying alkyl substituents were reported to 
give inferior results, high enantiomeric excess was reported for heterocycles bearing 
an aryl moiety.[23b] The authors demonstrated the applicability of their protocol to 
aryl-substituted benzofurans in the enantioselective total synthesis of corsifuran A.[23c] 
 
Scheme 3.2 Recent progress in the asymmetric hydrogenation of substituted benzofurans. 
A systematic study of the asymmetric hydrogenation of heteroaryl-aryl alkenes, 
carried out in the group of PFALTZ, showed that certain N,P ligand-based iridium 
catalysts reduce not only the olefinic C=C bond, but also the adjacent furyl 
substituent.[23h] In a subsequent catalyst screening for the asymmetric hydrogenation 
of furan and benzofuran derivatives, bicyclic pyridine-phosphinite complexes such as 
L1 and L2 (see Figure 3.1) with bulky electron-rich (tBu)2P groups showed superior 
activity and enantioselectivity (Scheme 3.3). 
 
Scheme 3.3 Results of initial studies performed in the PFALTZ group. 
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In view of the fact that a widely applicable hydrogenation system for the reduction of 
structurally diverse furans and benzofurans is still not available, a more thorough 
investigation of the iridium-catalyzed hydrogenation of furan and benzofuran 
derivatives was carried out. The results of this study are described in this chapter. 
3.2 Iridium Complexes Used for the Hydrogenation of Furans and 
Benzofurans 
The substituted furans synthesized during this work (see Chapter 2) were investigated 
as substrates for the iridium-catalyzed asymmetric hydrogenation, using a range of 
catalysts based on the N,P ligands shown in Figure 3.1. 
 
Figure 3.1 Ligand structures of [Ir(L)COD]BArF complexes used in this work. 
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3.3 Enantioselective Hydrogenation of 3-Substituted Furans 
Hydrogenation experiments were first performed with 3-phenylfuran (41a). For the 
initial investigation four different catalytic systems were chosen (Table 3.1). 
Table 3.1 Iridium-catalyzed hydrogenation of 3-phenylfuran (41a). 
 
entry catalyst structure ligand t (h) conv. (%)[a] ee (%)[a] 
1 
 
(S)-L1d 4 3    9 (−) 
2 (S)-L1d 24 5   17 (−) 
3 (S)-L1d 24 1    n.d.[b] 
4 
 
(S)-L2c 4 36 >98 (−) 
5 (S)-L2c 24 74 >99 (−) 
6 (S)-L2c 24 86      99 (−)[b] 
7 
 
L8b 4 3   46 (−) 
8 L8b 24 21   51 (−) 
9 L8b 24 30      63 (−)[b] 
10 
 
L12 4 <1 n.d. 
11 L12 24 <1 n.d. 
12 L12 24 <1    n.d.[b] 
[a] Determined by GC analysis on a chiral stationary phase. [b] Reaction carried out at 40 °C. 
With the cyclohexane-annulated bicyclic pyridine-phosphinite ligand L1d 
substrate 41a was reduced with very low conversion and low enantiomeric excess 
(entries 1-3). The five-membered ring analog of ligand, L2c, afforded after four hours 
3-phenyltetrahydrofuran (100) with good ee although with low conversion (entry 4). 
Prolonged reaction time combined with higher temperature resulted in increased 
conversion without affecting the excellent enantioselectivity (entries 5 and 6). The low 
conversion obtained with the phosphino-methyl-oxazoline ligand L8b could be 
improved together with the enantiomeric excess by increasing both the temperature 
and the reaction time (entries 8 and 9). In contrast, for the hydrogenation of furan 41a 
with the complex based on ligand L12 an increase in temperature and reaction time 
did not improve the performance of the catalyst, which failed to provide the desired 
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tetrahydrofuran 100 in detectable amount (entries 10-12). To further increase the 
conversion the reaction parameters of the enantioselective hydrogenation with ligand 
L2c were scrutinized (Table 3.2). 
Table 3.2 Optimization of the reaction parameters for the hydrogenation of furan 41a. 
 
entry catalyst structure cat. load. (mol%) solvent conv. (%)[a] ee (%)[a] 
1 
 
1 CH2Cl2 94 99 (−) 
2 2 CH2Cl2 96 99 (−) 
3 0.5 PhCl 77 98 (−) 
4 1 PhCl 94 98 (−) 
5 2 PhCl 99 98 (−) 
6 1 PhCl 99    98 (+)[b] 
[a] Determined by GC analysis on a chiral stationary phase. [b] Reaction carried out with 
(R)-enantiomer of L2c. 
The increased reaction temperature of 60 °C had the most noticeable influence on the 
conversion (94% vs. 74% and 86% at 25 °C and 40 °C, respectively). Higher catalyst 
loading resulted in slightly higher conversion (entry 2). When the solvent was changed 
to chlorobenzene the hydrogenation reaction gave with similar results (entry 4). With 
2 mol% catalyst loading the yield was almost quantitative (entry 5). High 
enantioselectivity was also obtained with lower catalyst loading, but at the expense of 
conversion (entry 3). With the (R)-enantiomer of the pyridine-phosphinite ligand L2c 
using 1 mol% catalyst loading, tetrahydrofuran 100 was obtained with excellent 
conversion and enantiomeric excess (entry 6). 
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With optimized reaction conditions in hand, other available iridium-complexes 
previously developed in our group were tested. The results of the hydrogenation of 
3-phenylfuran (41a) with different bicyclic pyridine-phosphinite ligand complexes 
containing five or six-membered carbocyclic rings are presented in Table 3.3. 
Table 3.3 Iridium-catalyzed hydrogenation of furan 41a using ligands L1 and L2. 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[a] 
1 
 
Cy CH3 (S)-L1a 18 19 (−) 
2 Cy Ph (R)-L1b <1 n.d. 
3 tBu Ph (S)-L1e 33 79 (−) 
4 Ph CH3 (R)-L1f <1 n.d. 
5 Ph Ph (R)-L1g –[b] – 
6 oTol H (S)-L1h 6 7 (+) 
7 oTol CH3 (R)-L1i 2 n.d. 
8 
 
Cy H (R)-L2a <1 n.d. 
9 Cy Ph (R)-L2b 61 73 (+) 
10 Ph H (R)-L2d <1 n.d. 
11 oTol H (R)-L2f <1 n.d. 
12 oTol Ph (S)-L2g 20 51 (−) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Starting material was recovered. 
Among the cyclohexane-annulated bicyclic pyridine-phosphinite ligands L1, L1e 
having the same substituents as L2c, gave the highest enantioselectivity with 79% ee 
(entry 3). This combination of an alkyl group at the phosphorus atom and a phenyl 
substituent on the pyridine ring also gave the best results for the five-membered ring 
analogs (entry 9). However, the enantioselectivities were significantly lower than those 
induced by ligand L2c (see Table 3.2). 
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Chiral phosphino-oxazoline ligands L3, L4 and L6 were also investigated in the 
hydrogenation of 3-phenylfuran (41a) (Table 3.4). 
Table 3.4 Iridium-catalyzed hydrogenation of substrate 41a with phosphino-oxazoline ligands. 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[a] 
1 
 
Cy iPr L3a 15 38 (+) 
2 Cy tBu L3b 31 30 (+) 
3 Ph iPr L3d –[b] – 
4 Ph tBu L3e –[b] – 
5 oTol tBu L3f 74   7 (−) 
6 o(OMe)C6H4 tBu L3g <1 n.d. 
7 
 
Et Et L4a 45   7 (+) 
8 Cy Cy L4b <1 n.d. 
9 oTol oTol L4c 56 28 (−) 
10 3,5-Dmp[c] 3,5-Dmp[c] L4d 91 56 (+) 
11 
 
iPr Ph (S,S)-L6a 60   6 (+) 
12 iPr Ph (R,S)-L6b 80   8 (−) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Starting material was recovered.  
[c] Dmp: Dimethylphenyl. 
The hydrogenation of 3-phenylfuran (41a) using chiral phosphino-oxazoline ligand L3 
under the optimized reaction conditions gave no or only low enantiomeric excess 
(entries 1-6). The decrease of the ee correlates with increasing steric bulk on the ligand. 
Moreover, the conversion varied strongly (0-74%). With ligand L4 higher 
enantioselectivity (56% ee) was obtained with moderate to good conversion 
(entries 7-10). On the other hand, ligand class L6 emerged to be less selective in the 
hydrogenation of furan 41a. Even though 3-phenyltetrahydrofuran (100) could be 
obtained with moderate conversion, the enantiomeric excess turned out to be very low 
(entries 11 and 12). Other classes of iridium-catalysts were investigated with 
3-phenylfuran (41a) (Table 3.5). 
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Table 3.5 Iridium-catalyzed hydrogenation of furan 41a with selected ligand classes. 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[a] 
1 
 
Ph tBu (R)-L5a <1 n.d. 
2 oTol tBu (R)-L5b 22    8 (+) 
3 
 
Ph iPr L7a 2 n.d. 
4 Ph tBu L7b 3 n.d. 
5 oTol tBu L7c –b) – 
6 
 
tBu Np L8a 47 77 (+) 
7 Ph iPr L8c <1 n.d. 
8 Xyl iPr L8d <1 n.d. 
9 
 
Ph H L9 6 18 (+) 
10 
 
Ph H L10 22 42 (−) 
11 
 
Ph tBu L11 30 rac 
[a] Determined by GC analysis on a chiral stationary phase. [b] Starting material was recovered. 
The iridium catalyst based on Neo-PHOX ligand L5 suffered from low conversion and 
very low ee (entries 1 and 2). Higher enantiomeric excess, but lower conversion was 
induced by Simple-PHOX ligands L7a-b (entries 3 and 4). Phosphino-methyl-
oxazoline ligand L8a gave the highest enantioselectivity (77% ee) among the ligand 
classes shown in Table 3.5. Also here the alkyl substituent on the phosphorus atom was 
crucial for the activity of the catalytic system, since replacement of the alkyl by a 
phenyl or xylyl group resulted in almost no conversion (entry 6 vs. entries 7 and 8). 
Some of the ligands that had been already tested for the hydrogenation of furan 41a, 
were also investigated for the reduction of 3-(4-methoxyphenyl)furan (41b) (Table 3.6). 
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Table 3.6 Selected iridium catalysts in the hydrogenation of furan 41b. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 
 
(S)-L1e 4   65 (−)[e] 
2 
 
(S)-L2c 
77   93 (−)[c] 
3 83 95 (−) 
4 97   94 (−)[d] 
5 98   91 (−)[e] 
6 
(R)-L2c 
85 95 (+) 
7 96   94 (+)[d] 
8 99   92 (+)[e] 
9 
 
L3a 40 21 (+) 
10 
 
(R)-L5a 9 20 (−) 
11 
 
L7a 23 34 (−) 
12 
 
L8a 47 71 (+) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Determined by HPLC analysis on a 
chiral stationary phase. [c] Reaction carried out at 40 °C in CH2Cl2. [d] Reaction time 63 h. [e] 2 mol% 
catalyst loading. 
This substrate was also reduced with high enantioselectivity up to 95% ee when using 
the bicyclic pyridine-phosphinite ligand L2c. The conversion could be enhanced by 
increasing the catalyst loading to 2 mol% at the expense of the enantiomeric excess 
(entry 3 vs. entry 5). However, longer reaction times resulted in high conversion while 
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retaining the enantioselectivity (entries 4 and 7). With the phosphino-methyl-
oxazoline ligand L8a similar results were obtained as for 3-phenylfuran (41a) (see 
Table 3.5) (47%, 71% ee vs. 47%, 77% ee). Furthermore, the hydrogenation of 3-(4-(tri-
fluoromethyl)phenyl)furan (41c) was studied (Table 3.7). 
Table 3.7 Selected iridium catalysts in the hydrogenation of furan 41c. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[a] 
1 
 
(S)-L1e 17   88 (−)[d] 
2 
 
(S)-L2c 
81 97 (−)[b] 
3 64        97 (−) 
4 70 97 (−)[c] 
5 88  97 (−)[d] 
6 
(R)-L2c 
69   96 (+) 
7 64   96 (+)[c] 
8 89   96 (+)[d] 
9 
 
L3a 1 n.d. 
10 
 
(R)-L5a <1 n.d. 
11 
 
L7a <1 n.d. 
12 
 
L8a 13 53 (+) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Reaction carried out at 40 °C in CH2Cl2. 
[c] Reaction time 63 h. [d] 2 mol% catalyst loading. 
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The hydrogenation of furan 41c with the complex based on ligand L2c proceeded with 
higher enantioselectivity (97% ee), however with lower conversion compared to 
reaction of 3-(4-methoxyphenyl)furan (41b). Surprisingly, a decrease of the reaction 
temperature had a positive effect on the conversion (entry 2). Increased catalyst 
loading led to higher conversion using both enantiomers of ligand L2 (entries 5 and 8). 
Table 3.8 Selected iridium catalysts in the hydrogenation of 3-cyclohexylfuran (65). 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[a] 
1 
 
(S)-L1e 28   75 (−)[d] 
2 
 
(S)-L2c 
31 >98 (−)[b] 
3 76 98 (−) 
4 71   98 (−)[c] 
5 >99   98 (−)[d] 
6 
(R)-L2c 
49 98 (+) 
7 57   97 (+)[c] 
8 77   98 (+)[d] 
9 
 
L3a 41 54 (+) 
10 
 
(R)-L5a 2 n.d. 
11 
 
L7a 29  2 (+) 
12 
 
L8a 29 50 (+) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Reaction carried out at 40 °C in CH2Cl2. 
[c] Reaction time 63 h. [d] 2 mol% catalyst loading. 
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In order to directly compare the hydrogenation results for 3-aryl substituted furans 
with those for alkyl substituted ones, the hydrogenation of 3-cyclohexylfuran (65) was 
performed with the same ligands (Table 3.8). A similar level of enantioselectivity as for 
the hydrogenation of 3-phenylfuran (41a) was obtained for 3-cyclohexylfuran (65) with 
the iridium complex based on the cyclopentane-annulated bicyclic pyridine-
phosphinite ligand L2c, but with lower conversion (entry 3). Paralleling what observed 
for 3-phenylfuran (41a), an increased catalyst loading gave higher conversion with no 
erosion of the enantiomeric excess (entry 5). Prolonged reaction time did not drive the 
reaction to completion (entries 4 and 7). 
A substrate bearing a linear alkyl chain, 3-octylfuran (64), was also tested under 
the optimized reaction conditions (Table 3.9). 
Table 3.9 Iridium-catalyzed hydrogenation of furan 64 with selected complexes. 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[a] 
1 
 
tBu Ph (S)-L1e 4 81 (−) 
2 tBu Ph (S)-L1e –[b] – 
3 
 
tBu Ph (S)-L2c 13 94 (−) 
4 tBu Ph (S)-L2c –[b] – 
5 Ph Ph (S)-L2e 1 n.d. 
6 Ph Ph (S)-L2e –[b] – 
7 
 
Ph tBu L3e 1 n.d. 
8 Ph tBu L3e –[b] – 
[a] Determined by GC analysis on a chiral stationary phase. [b] Reaction carried out at 110 bar H2 
pressure and 100 °C, starting material was recovered. 
Although 3-octylfuran (64) was hydrogenated with low conversion in the presence of 
the highly active catalyst complex based on L2c, it was reduced with high enantio-
selectivity (entry 3). Forcing hydrogenation conditions, such as increased reaction 
temperature and hydrogen pressure, resulted in no conversion at all (entries 2, 4, 6, 8). 
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To increase the conversion different solvents were tested using the iridium catalyst 
based on the cyclopentane-annulated bicyclic pyridine-phosphinite ligand L2c 
(Table 3.10). 
Table 3.10 Solvent screening for the hydrogenation of 3-octylfuran (64). 
 
entry catalyst structure solvent conv. (%)[a] ee (%)[a] 
1 
 
toluene –[b] – 
2 benzene –[b] – 
3 iPrOH –[b] – 
4 EtOAc –[b] – 
5 MeOH –[b] – 
6 EtOH –[b] – 
7 CH2Cl2 20 95 (−) 
[a] Determined by GC analysis on a chiral stationary phase. [b] Starting material was recovered. 
The only medium in which the hydrogenation gave product 104 was CH2Cl2, the 
standard solvent used in iridium-catalyzed hydrogenation.[44] 
Apart from the loss of aromaticity during hydrogenation, one explanation for 
the observed low reactivity of furan 64 might be the coordination of the oxygen atom 
to the metal center of the catalyst. Lewis acids could facilitate the hydrogenation by 
coordination to the oxygen atom of the substrate. In addition, complexation of the 
O-atom of the furan by the Lewis acid could prevent catalyst deactivation by 
coordination of the substrate or the hydrogenated product to the iridium atom. In this 
case stoichiometric amounts of the Lewis acid should be used. Both strong and weak 
Lewis acids were tested in the iridium-catalyzed asymmetric hydrogenation of 
3-octylfuran (64) with the four ligands shown in Table 3.9. In this study the catalyst 
based on L2c behaved as well as the most active and selective one, so in the further 
investigation only this catalytic system was tested. The results obtained upon addition 
of additives are summarized in Table 3.11. 
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Table 3.11 Hydrogenation of 3-octylfuran (64) with additives. 
 
entry catalyst structure additive amount (eq.) conv. (%)[a] ee (%)[a] 
1 
 
none – 20 95 (−) 
2 B(OCH3)3 1.74 21 95 (−) 
3 BF3·O(C2H5)2 1.01 >99 59 (+) 
4 B(C6F5)3 1.01 >99 41 (+) 
5 CF3CH2OH 2.75 17 93 (−) 
6 CF3CH2OH 5.51 36 95 (−) 
7 CF3CH2OH 11 44 95 (−) 
8 CF3CH2OH 22 51 95 (−) 
9 CF3CH2OH 70 69    97 (−)[b] 
10 CF3CH2OH 70 94      95 (−)[b,c] 
[a] Determined by GC analysis on a chiral stationary phase. [b] CF3CH2OH as solvent.  
[c] 2 mol% catalyst loading. 
Similar conversion was induced upon the addition of trimethyl borate without 
affecting the enantiomeric excess (entry 1). A stronger influence on the conversion was 
observed in the presence of stronger Lewis acids, BF3 etherate and tris(pentafluoro-
phenyl)borane, however, at the expense of a substantial loss of enantioselectivity and 
unexpected inversion of the product configuration (entries 2 and 3). In contrast, the 
addition of the Brønsted acidic trifluoroethanol resulted in similar low conversion 
when used as additive, but in high conversion and perfect enantiomeric purity when 
utilized as a solvent (entries 5-8 vs. entries 9 and 10). The role of this additive is not 
fully understood; it could form hydrogen bonds to the furan O-atom and prevent its 
coordination to the iridium atom. At the same time trifluoroethanol is a 
non-nucleophilic solvent providing a very weakly coordinating environment, which 
is necessary for high catalytic activity. In any case, the strong rate-enhancing effect of 
trifluoroethanol offered a practically useful solution to overcome reactivity problems 
in the hydrogenation of 3-octylfuran (64).  
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3.4 Enantioselective Hydrogenation of 2-Substituted Furans 
Next, the previously synthesized 2-substituted furans were tested in the 
iridium-catalyzed hydrogenation. The hydrogenation results for 2-phenylfuran (44a) 
are summarized in Table 3.12. 
Table 3.12 Iridium-catalyzed hydrogenation of 2-phenylfuran (44a) with selected complexes. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 
 
(S)-L1d 11 6 
2 
 
(S)-L2c 15 2 
3 
 
L3e 15 3 
4 
 
(S)-L5a 2 8 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
With all four selected iridium complexes the hydrogenation reaction of 2-phenyl-
furan (44a) proceeded only sluggishly. Surprisingly, only low conversion and almost 
racemic product 105 was obtained. Therefore, the hydrogenation of this substrate was 
not further studied. 
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Instead, 2-(4-methoxyphenyl)furan (44b) was investigated and the results of this study 
are summarized in Table 3.13. 
Table 3.13 Iridium-catalyzed hydrogenation of furan 44b with selected complexes. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 
 
(S)-L1d –[c] – 
2 
 
(S)-L2c –[c] – 
3 rac-L2c –[c,d] – 
4 
 
L3e –[c] – 
5 
 
(S)-L5a –[c] – 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on chiral stationary phase. 
[c] Starting material was recovered. [d] Reaction carried out at 60 °C and 100 bar H2 pressure. 
Paralleling the results observed in the case of 2-phenylfuran (44a), also 2-(4-methoxy-
phenyl)furan) (44b) was not reactive at all under standard reaction conditions 
(entry  3). Electron donating groups on the phenyl substituent made the furan even 
less reactive than the phenyl substituted furan 44a, therefore the reaction temperature 
was increased to 100 °C. However, even at this temperature no reaction took place. 
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The substrate with an electron withdrawing group on the 2-substituted furan 44c was 
also tested (Table 3.14). 
Table 3.14 Iridium-catalyzed hydrogenation of furan 44c with selected complexes. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 O
(tBu)2P N
Ph
Ir
COD
BArF
 
(S)-L1e 9 18 (+) 
2 
 
(S)-L2c 80 69 (+) 
3 rac-L2c 52 – 
4 
 
(S)-L5a 1 n.d. 
5 
 
L7d 1 n.d. 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on chiral stationary phase. 
[c] Starting material was recovered. [d] Reaction carried out at 60 °C and 100 bar H2 pressure. 
The results show that the electronic properties of the furan substrate have a great 
influence on the outcome of the hydrogenation reaction. With an electron withdrawing 
substituent on the 2-substituted furan 44c, the hydrogenation proceeded under 
standard conditions with good conversion, but moderate enantioselectivity. 
Encouraged by these findings some additives were investigated in the hydrogenation 
of this substrate (Table 3.15). 
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Table 3.15 Iridium-catalyzed hydrogenation of furan 44c with additives. 
 
entry catalyst structure additive amount (eq.) conv. (%)[a] ee (%)[a] 
1 
 
none – 80 69 (+) 
2 B(OCH3)3 1.74 29 48 (+) 
3 BF3·O(C2H5)2 1.01 63 31 (+) 
4 B(C6F5)3 1.01 82 19 (+) 
5 CF3CH2OH 42 62 14 (−) 
[a] Determined by GC analysis on a chiral stationary phase. 
Both the enantiomeric excess and the conversion during hydrogenation of 
2-(4-(trifluoro-methyl)phenyl)furan (44c) were lower than without additives. Only 
with tris(pentafluorophenyl)borane the furan 44c was converted with comparable 
conversion, but with lower enantioselectivity (19% ee vs. 69% ee). When trifluoro-
ethanol was added to the hydrogenation reaction, the reduced compound 107 was 
obtained with moderate conversion and low enantiomeric excess (entry 4). 
The influence of an alkyl substituent at the 2-position of furan was also 
investigated in the hydrogenation of 2-cyclohexylfuran (66) (Table 3.16). 
Table 3.16 Iridium-catalyzed hydrogenation of furan 66 with selected complexes. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[a] 
1 O
(tBu)2P N
Ph
Ir
COD
BArF
 
(S)-L1e 54 63 (+) 
2 
 
(S)-L2c 
65 80 (+) 
3 96     82 (+)[b] 
4 
 
L3e 1 n.d. 
[a] Determined by GC analysis on a chiral stationary phase. [b] 2 mol% catalyst loading. 
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Hydrogenation of 2-cyclohexylfuran (66) with the catalyst based on the cyclohexane-
annulated bicyclic pyridine-phosphinite ligand L1e proceeded with moderate 
conversion and enantioselectivity (entry 1). The five-membered ring analog of ligand 
L2c promoted the hydrogenation reaction of furan 66 with both higher conversion and 
slightly better enantiomeric excess (entry 2). By increasing the catalyst loading to 
2 mol%, the conversion improved to 96% without affecting the ee (entry 3). The catalyst 
based on the PHOX ligand L3e showed only little activity and low enantiomeric excess 
(entry 4). 
The sterically less hindered 2-alkyl substituted furan 71 was also tested in the 
hydrogenation with various catalysts (Table 3.17). 
Table 3.17 Iridium-catalyzed hydrogenation of 2-octylfuran (71) with various complexes. 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[a] 
1 
 
tBu Ph (S)-L1e 36 75 
2 
 
tBu Ph (S)-L2c 86 58 
3 Ph Ph (S)-L2e 6 19 
4 
 
Ph tBu (S)-L5a 3 45 
5 
 
oTol tBu L7c 2 19 
6 
 
iPr Ph L13 56 12 
[a] Determined by GC analysis on a chiral stationary phase. 
The hydrogenation of 3-octylfuran (71) proved very challenging, too. The reaction 
suffers from low activity and only moderate enantiomeric excess with the ligands 
shown in Table 3.17. The cyclohexane-annulated pyridine-phosphinite complex 
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derived from ligand L1e gave higher enantiomeric excess (75% ee), whereas the 
complex based on the five-membered ring analog L2c reduced the furan to higher 
extent (86%) (entries 1 and 2). The importance of an alkyl group on the phosphorus 
atom is demonstrated by ligand L2e. When the tBu group was exchanged to a phenyl 
group, the activity was strongly reduced (entry 2 vs. entry 3). The phosphino-oxazoline 
derived ligands, Neo-PHOX L5a and Simple-PHOX L7c gave only little conversion 
with moderate to low enantioselectivity (entries 4 and 5). The NHC ligand L13 was 
tested in the hydrogenation of furans for the first time and resulted in moderate 
conversion, but low enantiomeric excess (entry 6). 
An extensive screening of additives was carried out to increase the conversion 
in the hydrogenation of 2-octylfuran (71). The catalyst complex based on ligand L2c, 
which gave the highest conversion with this substrate was investigated using trifluoro-
ethanol as additive or solvent (Table 3.18). 
Table 3.18 Iridium-catalyzed hydrogenation of furan 71 with CF3CH2OH. 
 
entry catalyst structure additive amount (eq.) conv. (%)[a] ee (%)[a] 
1 
 
CF3CH2OH 11 87 69 (+) 
2 CF3CH2OH 22 83 64 (+) 
3 CF3CH2OH 44 78 68 (+) 
4 CF3CH2OH 70 97     65 (+)[b] 
[a] Determined by GC analysis on a chiral stationary phase. [b] CF3CH2OH as solvent. 
The effect on the conversion of the hydrogenation reaction of substrate 71 upon 
addition of the weakly Brønsted acidic trifluoroethanol was contradictory. When used 
as an additive, lower conversion was obtained, but when it was applied as the solvent 
the hydrogenation proceeded almost to completion (97%). The enantiomeric excess 
remained almost constant. Also in case of the catalyst based on the cyclohexane-
annulated bicyclic pyridine-phosphinite L1e an additive screening was performed 
(Table 3.19). 
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Table 3.19 Iridium-catalyzed hydrogenation of 2-octylfuran (71) with additives. 
 
entry catalyst structure additive amount (eq.) conv. (%)[a] ee (%)[a] 
1 
 
B(OCH3)3 1.74   31 65 (+) 
2 BF3·O(C2H5)2 1.01 >99 23 (+) 
3 B(C6F5)3 1.01 >99 20 (−) 
4 CF3CH2OH 70   18    20 (+)[b] 
[a] Determined by GC analysis on a chiral stationary phase. [b] CF3CH2OH as solvent. 
A much larger increase of reactivity was observed when using the stronger Lewis acids 
BF3 etherate and tris(pentafluorophenyl)borane, however, at the expense of a 
substantial loss of enantioselectivity (entries 2 and 3).  
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3.5 Enantioselective Hydrogenation of 3- and 2-Furancarboxylic acid 
ethyl ester 
Optimized conditions for 3-substituted furans were applied to the hydrogenation of 
ethyl 3-substituted furan 110 and 2-substituted furan 111 using the most active and 
selective cyclopentane-annulated bicyclic pyridine-phosphinite catalyst L2c. 3-Furan-
carboxylic acid ethyl ester (110) was reduced, but with low conversion and only 
moderate enantioselectivity (Table 3.20). 
Table 3.20 Iridium-catalyzed hydrogenation of furan 110. 
 
entry catalyst structure ligand solvent T (°C) conv. (%)[a] ee (%)[a] 
1 
 
(S)-L1c CH2Cl2 40 11    71 (−)[b] 
2 
 
(S)-L2c 
CH2Cl2 40 2 59 (−) 
3 CH2Cl2 40 <1    n.d.[b] 
4 PhCl 60 <1 n.d. 
5 PhCl 60 10    42 (−)[b] 
[a] Determined by HPLC analysis on a chiral stationary phase. [b] 2 mol% catalyst loading. 
The catalyst based on the cyclohexane-annulated bicyclic pyridine-phosphinite ligand 
L1c promoted the hydrogenation of 3-furancarboxylic acid ethyl ester (110) with 
higher enantioselectivity (71% ee) than the five-membered ring counterpart L2c, shown 
by KAISER (entry 1 vs. entry 2).[40] 
 
Scheme 3.4 Iridium-catalyzed hydrogenation of furan 111. 
The reduction of 2-furancarboxylic acid ethyl ester (111) in contrast did not give the 
desired reduced product 112, even after increasing the catalyst loading to 2 mol% 
(Scheme 3.4).  
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3.6 Enantioselective Hydrogenation of 2,4-Disubstituted Furans 
The advantage of the hydrogenation of disubstituted furans is represented by the 
potential selective generation of two new stereogenic centers in one reaction step. 
When 2,4-diphenylfuran (79) was reduced under standard conditions with palladium 
on charcoal to give the racemate, both diastereomers calyxolane A 2a and 
calyxolane B 2b were obtained in a ratio of 75:25 (cis:trans). The natural products were 
separated by flash chromatography, analyzed and identified by proton NMR. As for 
the mono-substituted furans, also for substrate 79 standard hydrogenation conditions 
were applied first. With catalyst complex bearing ligand L2c very low conversion was 
obtained (1%) with moderate cis:trans ratio (64:36). Therefore more forcing reaction 
conditions were applied (Table 3.21). 
Table 3.21 Iridium-catalyzed hydrogenation of 2,4-diphenylfuran (79). 
 
entry catalyst structure R R' ligand conv. (%)[a] 
dr 
(cis:trans)[a]
1 
 
tBu H (S)-L1c 2 72:28 
2 tBu Ph (S)-L1e 41 79:21 
3 oTol Ph (R)-L1j 21 73:27 
4 
 
tBu Ph (S)-L2c 52 80:20 
5 tBu Ph (S)-L2c 55   74:26[b] 
6 Ph Ph (S)-L2e 60 81:19 
7 
 
Cy tBu L3b 1 n.d. 
8 Ph tBu L3e 2 80:20 
[a] Determined by GC analysis. [b] 2 mol% catalyst loading. 
Higher temperature as well as higher hydrogen pressure had a positive effect on the 
hydrogenation reaction of 2,4-diphenylfuran (79). However, the conversion was 
moderate and the hydrogenation of substrate 79 was performed without the 
determination of the enantiomeric purity, because no suitable conditions for 
determination of the enantiomeric excess by HPLC were found. 
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Others determined the optical purity by 1H-NMR in the presence of the lanthanide 
chiral shift reagent Pr(hfc)3 (praseodymium(III) tris[3-(heptafluoropropylhydroxy-
methylene)-(+)-camphorate])[45] in cases where selectively the cis diastereomer of 
tetrahydrofuran 2b was formed during the reaction. 
The hydrogenation reaction of disubstituted furan 79, which led to moderate 
conversion (60%) could not be reproduced. Additional purification of the substrate 79 
by flash chromatography did not improve the conversion. Therefore, the enantiomeric 
excess of the hydrogenation mixture was determined by 1H-NMR analysis and Pr(hfc)3 
as the shift reagent of choice (Table 3.22, entry 1). 
Table 3.22 Iridium-catalyzed hydrogenation of 2,4-diphenylfuran (79). 
[Ir(L)COD]BArF (1 mol%)
O O
79 2b
O
2a
110 bar H2, PhCl
100 °C, 24 h
+
 
entry catalyst structure ligand conv. (%)[a] 
dr 
(cis:trans)[a] 
cis 
ee (%)  
trans 
ee (%)  
1 
 
(R)-L2e 35 67:33 39[b] n.d. 
2 (S)-L2e 19 74:26 
38[c] 68[d] 
3 (S)-L2e 16 71:29 
[a] Determined by GC analysis. [b] 1H-NMR analysis with 0.17 eq. Pr(hfc)3. [c] 1H-NMR analysis with 
0.21 eq. Pr(hfc)3. [d] 1H-NMR analysis with 0.19 eq. Pr(hfc)3. 
The following signal splitting of the hydrogenation mixture was obtained after 
addition of 0.17 equivalents of the shift reagent. Unfortunately due to overlap of 
some signals, only the enantiomeric excess of the cis isomer could be determined 
(Figure 3.2). 
 
 
Figure 3.2 Signal splitting of a hydrogenation mixture of tetrahydrofurans 2b and 2a (cis:trans) 
upon addition of Pr(hfc)3. 
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Combined reaction mixtures with similar cis/trans and substrate/product ratios were 
purified by flash chromatography and then the shift reagent was added (entry 2 and 3). 
The signals of both diastereoisomers were split and the enantiomeric excess of each 
could be determined (Figure 3.3). 
 
Figure 3.3 Signal splitting of pure cis (top) and trans (bottom) diastereoisomers upon  
addition of Pr(hfc)3. 
Although the enantiomeric excess remained the same after column chromatography 
for the cis isomer 2b, the difficulty in reliably measuring the enantiomeric excess by 
1H-NMR analysis while both diastereoisomers are present is displayed Figure 3.4. 
 
Figure 3.4 Overlapping spectra of cis and trans diastereoisomers of tetrahydrofurans 2b and 2a. 
The spectra shows the overlap of the significant section of the proton NMR spectrum 
of both purified diastereoisomers of tetrahydrofurans 2b and 2a, recorded under the 
same conditions. 
The influence of an alkyl substituent on the 2,4-disubstituted furan was 
investigated in the asymmetric hydrogenation of 4-methyl-2-phenylfuran (85). The 
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hydrogenation of this substrate 85 with palladium on charcoal gave only the 
corresponding alcohol. When the BArF analog of the CRABTREE catalyst was applied, 
only very low conversion was obtained (1%). Subsequently, different iridium catalysts 
were tested in the hydrogenation of this substrate (Table 3.23). 
Table 3.23 Iridium-catalyzed hydrogenation of 4-methyl-2-phenylfuran (85). 
 
entry catalyst structure ligand conv. (%)[a] 
dr 
(cis:trans)[b,c]
cis 
ee (%)[b] 
trans 
ee (%)[b] 
1 
 
(S)-L1e 32 86:14 5 77 
2 
 
(S)-L2c 60 92:8 28 82 
3 (R)-L2c 31 72:28 rac 97 
4 
 
(R)-L5a 1 82:18 n.d. rac 
5 
 
L7e 2 73:27 18 50 
[a] Determined by GC analysis. [b] Determined by GC analysis on a chiral stationary phase. 
[c] Assignment of diastereomers by comparison of 1H-NMR spectra with literature values.[46] 
The highest conversion and good diastereoselectivity among the iridium-based 
catalysts tested were obtained with the catalyst based on the cyclopentane-annulated 
bicyclic pyridine-phosphinite ligand L2c (entry 2). Other iridium catalysts gave similar 
diastereomeric ratios, but suffered from low conversion. Unfortunately the 
enantiomeric excess for the major diastereomer (cis) did not exceed 28% ee. Additives 
were also investigated to improve the conversion (Table 3.24). 
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Table 3.24 Iridium-catalyzed hydrogenation of furan 85 with additives. 
 
entry catalyst structure[a] additive amount (eq.) conv. (%)[b] 
1 
 
B(OCH3)3 1.74 88 
2 BF3·O(C2H5)2 1.01 –[c] 
3 B(C6F5)3 1.00 –[c] 
4 CF3CH2OH 70 66 
[a] Racemic mixture of [Ir(L2c)COD]BArF. [b] Determined by GC analysis. [c] Only by-products formed. 
Hydrogenation with additives was only performed with the racemic catalyst based on 
ligand L2c to give the racemic product 113. Conversion was improved when the 
reaction was performed in trifluoroethanol (entry 4), whereas the highest conversion 
was obtained with trimethyl borate as an additive (entry 1). With BF3 etherate or 
tris(pentafluorophenyl)borane as additive the starting material 85 was consumed, but 
only a mixture of unidentified products was formed (entries 2 and 3). 
The reactivity of the purely dialkyl substituted furan, 2-hexyl-4-methylfuran 
(86) was also tested. Under standard reaction conditions (100 bar H2, PhCl, 60 °C) the 
hydrogenation with different catalysts bearing N,P ligands gave only low conversion 
(17%). Therefore, the general reactivity of substrate 86 was investigated with the 
CRABTREE catalyst. Only after the solvent was exchanged to dichloromethane, the 
hydrogenation with the BArF analog of the CRABTREE catalyst (2 mol%) resulted in the 
reduced product 114 with 81% conversion. 
The strong solvent dependence of the hydrogenation of 2-hexyl-4-methylfuran 
(86) was investigated with a control experiment. The iridium catalyst based on PHOX 
ligand L3e was submitted to the same hydrogenation reaction conditions optimized 
for furans in chlorobenzene. After removal of the solvent and subsequent flash 
chromatography the catalytically inactive trinuclear iridium complex 115[47] was 
obtained, as clearly shown by 1H-NMR spectra (Figure 3.5). This observation could also 
explain the low conversion of other unreactive furans in chlorobenzene. 
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Figure 3.5 Detail of the hydride region in the proton NMR of the unreactive 
trimer iridium species 115. 
When dichloromethane was utilized as the solvent in the hydrogenation of 2-hexyl-
4-methylfuran (86), the conversion remained still a challenge (6%). Therefore, 
additives were tested such as trifluoroethanol and trimethyl borate (Table 3.25). 
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Table 3.25 Iridium-catalyzed hydrogenation of furan 86 with additives. 
 
entry catalyst structure ligand conditions conv. (%)[b] 
dr 
(cis:trans)[b] 
cis 
ee (%)[c] 
1 
 
(S)-L1e 
A 77 82:18 10 
2 B 59 76:24 11 
3 C 39 77:23 10 
4 
 
(S)-L2c 
A >99 84:16 13 
5 B >99 83:17 18 
6 C 68 87:13 13 
7 D >99 93:7 41 
8 E >99 86:14 55 
9 
 
(S)-L2e 
A 95 80:20 35 
10 B >99 76:24 41 
11 C 99 81:19 44 
12 
 
L3e 
A 5 83:17 15 
13 B 8 82:18 4 
14 C 3 83:17 n.d. 
[a] Determined by GC analysis. [c] Determined by GC analysis on a chiral stationary phase. 
The cyclopentane-annulated bicyclic complexes bearing ligands L2c and L2e proved 
to be highly active in the hydrogenation of furan 86. Depending on the substituents on 
the ligand full conversion was reached with trifluoroethanol as additive or as solvent, 
but also with trimethylborate high conversion could be obtained. The catalyst based 
on the cyclohexane-annulated pyridine-phosphinite complex L1e reduced the 
substrate 86 with lower enantioselectivity and reactivity (entries 1-3). With the catalyst 
bearing PHOX ligand L3e almost no product and low ee were observed (entries 12-14). 
The highest diastereomeric ratio was obtained with the catalyst based on the 
cyclopentane-annulated bicyclic pyridine-phosphinite ligand L2c and the Lewis acidic 
BF3 etherate (entry 7), while the use of tris(pentafluorophenyl)borane resulted in 
enhanced enantioselectivity but lower diastereoselectivity (entries 8). 
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A 2,5-disubstituted analog, 2-octyl-5-phenylfuran, was also tested. However, only 
very low conversion (7%) was achieved using complex [Ir(L2c)COD]BArF under 
standard conditions. 
3.7 Enantioselective Hydrogenation of 3-Substituted Benzofurans 
The iridium-catalyzed hydrogenation of 3,5-dimethylbenzofuran (56a) was 
performed using the standard conditions applied for substituted furans (Table 3.26). 
Table 3.26 Iridium-catalyzed hydrogenation of benzofuran 56a. 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 
 
(S)-L1e 22 51 (+) 
2 
 
(S)-L2c 77 51 (+) 
3 
 
L3e 3 51 (−) 
4 
 
(R)-L5a 14 36 (+) 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
[c] Autoclave leaking resulted in 60 bar H2 pressure after 24 h. 
The catalysts bearing the cyclopentane and cyclohexane-annulated bicyclic pyridine-
phosphinite ligands L1e and L2c reduced substrate 56a with moderate 
enantioselectivity. Whereas, when the cyclopentane-annulated ligand L2c was 
employed the hydrogenation proceeded to a higher extent than in the case of the 
six-membered ring analog L1e (entry 2 vs. entry 1). Phosphino-oxazoline derived 
ligands L3e and L5a gave only low conversion and moderate enantioselectivity 
(entries 3 and 4). 
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Optimization of the hydrogenation conditions for 3-substituted benzofurans by SCHEIL 
has shown that 50 bar hydrogen pressure are sufficient to achieve high conversion at 
60 °C, whereas higher temperature reduces the conversion.[48] The results of the 
iridium-catalyzed hydrogenation of 3,5-dimethylbenzofuran (56a) using the same 
conditions are shown in Table 3.27. 
Table 3.27 Iridium-catalyzed hydrogenation of 3,5-dimethylbenzofuran (56a). 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[b] 
1 
 
tBu H (S)-L1c 16 74 (+) 
2 tBu CH3 (S)-L1d 89 92 (+) 
3 
 
Cy Ph (R)-L2b 76 62 (−) 
4 
 
Cy Ph L15 66 75 (−) 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
In case of the cyclohexane-annulated bicyclic pyridine-phosphinite complex L1d the 
highest activity and enantioselectivity in the reduction of 3,5-dimethyl-
benzofuran (56a) were achieved under these conditions (entry 2). The substituent on 
the pyridine ring had a dramatic influence on the conversion. With a proton on this 
site the conversion dropped significantly (entries 1 vs. 2). Another catalyst based on 
the five-membered ring analog L2b converted benzofuran 56a into compound 116 
with moderate conversion and enantiomeric excess (entry 3). The Thre-PHOX complex 
[Ir(L15)COD]BArF, which was shown to give superior results in the hydrogenation of 
unfunctionalized trisubstituted arylalkenes,[49] afforded the reduced product 116 also 
with moderate levels of conversion and enantioselectivity (entry 4). 
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A brominated derivative of benzofuran 56a, 6-bromo-3,5-dimethylbenzofuran (56b), 
was tested with the same catalysts (Table 3.28). 
Table 3.28 Iridium-catalyzed hydrogenation of 6-bromo-3,5-dimethylbenzofuran (56b). 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[b] 
1 
 
tBu H (S)-L1c 3 52 (+) 
2 
tBu CH3 (S)-L1d 
65 93 (+) 
3 75    91 (+)[c] 
4 
 
Cy Ph (R)-L2b 54 63 (−) 
5 
 
Cy Ph L15 26 59 (−) 
[a] Determined by GC analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
[c] 2 mol% catalyst loading. 
The hydrogenation mixture of dihydrobenzofuran 117 was analyzed after de-
bromination with nBuLi and subsequent hydrolysis to dihydrobenzofuran 116. The 
brominated benzofuran 56b seems to be less reactive than the alkyl substituted benzo-
furan 56a. Under the same reaction conditions the catalyst based on ligand L1d 
provided product 116 with lower conversion than in the reduction of the 
non-brominated substrate (65% vs. 89%). However, the conversion could be further 
increased to 75% with a higher catalyst loading (2 mol%, entry 3). 
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3.8 Enantioselective Hydrogenation of 2-Substituted Benzofurans 
The synthesized 2-aryl substituted benzofurans were also tested in the 
iridium-catalyzed hydrogenation reaction with several catalyst complexes, which 
showed already high activity for 3-substituted benzofurans. For the hydrogenation of 
2-phenylbenzofuran (95a) four different ligands were selected (Table 3.29). 
Table 3.29 Iridium-catalyzed hydrogenation of 2-phenylbenzofuran (95a). 
 
entry catalyst structure R R' ligand p H2 (bar) 
conv. 
(%)[a] 
1 
 
tBu H (S)-L1c 
50 – 
2 100 – 
3 
tBu CH3 (S)-L1d 
50 – 
4 100 – 
5 
 
tBu Ph (S)-L2c 
50 2 
6 100 4 
7 100 –[b] 
8 
 
Cy Ph L15 
50 – 
9 100 1 
[a] Determined by 1H-NMR analysis. [b] CF3CH2OH as solvent. 
2-Phenylbenzofuran (95a) proved to be an extremely challenging substrate for 
hydrogenation, giving no or negligible conversion regardless of the catalyst used. Only 
very low conversion was obtained with the cyclopentane-annulated bicyclic 
pyridine-phosphinite catalyst complex [Ir(L2c)COD]BArF (entry 5) under previously 
utilized hydrogenation conditions for 3-substituted benzofurans. Even at 100 bar 
hydrogen pressure, the conversion did not exceed 4% (entry 6). Also trifluoroethanol 
did not promote the hydrogenation reaction (entry 7). 
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Figure 3.6 Selected hydrogenation results for 2-substituted benzofurans with the catalyst based on 
ligand L2c. Reaction conditions: 1 mol% catalyst, 100 bar H2, CH2Cl2, 60 °C, 24 h. 
Also the hydrogenation of other 2-aryl substituted benzofurans or 2-benzylbenzo-
furan (99) proceeded with no or only very low conversion (Figure 3.6). The electronic 
properties of the aryl substituent had only little influence on the reactivity of the 
substrates. Next 2-alkyl substituted benzofurans were tested as substrates. The results 
observed for the reduction of 2-butylbenzofuran (91) are outlined in Table 3.30. 
Table 3.30 Iridium-catalyzed hydrogenation of 2-butylbenzofuran (91). 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[b] 
1 
 
tBu CH3 (S)-L1d 31 18 (+) 
2 
 
Cy Ph (R)-L2b 75 94 (−) 
3 tBu Ph (S)-L2c >99 99 (+) 
4 
 
Cy Ph L15 96 42 (−) 
[a] Determined by 1H-NMR analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
With the complex based on the cyclohexane-annulated bicyclic pyridine-phosphinite 
ligand L1d low conversion and enantiomeric excess were obtained (entry 1). Much 
higher activity, but also enhanced enantioselectivity, was observed with the 
five-membered ring analog L2 (entry 2 and 3). Depending on the substituents on the 
P-atom, moderate or very high conversion was achieved. With the catalyst bearing the 
Thre-PHOX ligand L15 the substrate 91 was converted to dihydrobenzofuran 119 a 
high extent, but with moderate ee (entry 4). 
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Another 2-substituted benzofuran 92 with a linear alkyl chain as substituent was also 
investigated (Table 3.31). 
Table 3.31 Iridium-catalyzed hydrogenation of 2-decylbenzofuran (92). 
 
entry catalyst structure R R' ligand conv. (%)[a] ee (%)[b] 
1 
 
tBu H (S)-L1c 69 10 (+) 
2 tBu CH3 (S)-L1d 23 20 (+) 
3 
 
tBu Ph (S)-L2c >99 99 (+) 
4 
 
Cy Ph L15 98 42 (−) 
[a] Determined by 1H-NMR analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
A similar trend of reactivity to that of benzofuran 91 was observed for 2-decylbenzo-
furan (92). Moderate conversion was obtained employing the cyclohexane-annulated 
bicyclic pyridine-phosphinite ligand L1c, whereas ortho substitution on the pyridine 
ring gave lower conversion (entry 1 vs. 2). The highest activity was achieved with the 
cyclopentane-annulated ligand L2c giving dihydrobenzofuran 120 with perfect 
enantioselectivity in a quantitative manner (entry 3). With the catalyst based on the 
Thre-PHOX ligand L15 the hydrogenation of benzofuran 92 proceeded with similar 
results as the hydrogenation of substrate 91 (see Table 3.30). 
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A branched alkyl substituent at the 2-position of a benzofuran was also investigated 
in the hydrogenation reaction of compound 93 with two selected catalysts (Table 3.32). 
Table 3.32 Iridium-catalyzed hydrogenation of 2-(prop-1-en-2-yl)benzofuran (93). 
 
entry catalyst structure ligand conv. (%)[a] ee (%)[b] 
1 
 
(S)-L1c 75 24 (+) 
2 
 
(S)-L2c 99 97 (+) 
[a] Determined by 1H-NMR analysis. [b] Determined by HPLC analysis on a chiral stationary phase. 
Moderate conversion was obtained with the cyclohexane-annulated bicyclic pyridine-
phosphinite ligand L1c along with low enantiomeric excess (entry 1), whereas the 
catalyst bearing the five-membered ring analog L2c converted substrate 93 completely 
to the reduced dihydrobenzofuran 121 with excellent enantioselectivity (entry 2). 
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3.9 Investigations on the Deactivating Effect of Aromatic Substituents at 
the C2 
Hydrogenation of 2-alkyl substituted benzofurans proceeded with high conversions 
and very good enantiomeric excesses, in contrast to 2-aryl substituted analogs which 
showed poor or no reactivity. The same trend had already been observed for 2-alkyl 
substituted furans and 2-phenylfuran (44a) (Table 3.12). Conjugation between the aryl 
and the furan π-system as the deactivating effect can be ruled out, since 
2-benzylbenzofuran (99) as well is resistant to hydrogenation. However, formation of 
a catalytically inactive cyclometallated complex by coordination of catalyst to the furan 
O-atom and subsequent insertion of the iridium atom into adjacent C-H bond of the 
aryl or benzyl substituent could provide an explanation. 
Cyclometallation induced by coordination to a heteroatom is a facile process,[50] 
which in case of N,P ligands containing an 2-phenylpyridine unit has been observed 
to cause catalyst deactivation.[51] To obtain evidence for such a process, the 
hydrogenation of 2-phenylbenzofuran (95a) was performed with deuterium gas under 
standard conditions using the catalyst based on ligand L2c. 
[Ir(L2c)COD]BArF (1 mol%)O O
40 bar D2, CH2Cl2, 60 °C, 24 h
95a d-95a
D
 
Figure 3.7 2H-NMR of d-95a (top) in CHCl3 with CDCl3, 
1H-NMR of 95a (middle) and 1H-NMR of d-95a (bottom) in CDCl3. 
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At 40 bar of D2 pressure high deuterium incorporation (80%) at C3 was obtained 
according to 1H-NMR and GC-MS analyses performed after catalyst removal. 
However, no deuterium incorporation at the phenyl substituent was observed. In 
Figure 3.7 a section of the proton NMR spectrum of the deuterated product d-95a, the 
starting material 95a and the deuterium NMR spectrum of d-95a are shown. The 
unexpected deuteration of 2-phenylbenzofuran (95a) at C3 raised the question of the 
behavior of alkyl substituted analogs under the same conditions. Therefore, 
2-decylbenzofuran (92) was submitted to similar conditions using the same catalyst 
(30 bar D2, 60 °C, 4 h). The obtained mixture of the reduced deuterated benzo-
dihydrofuran d-120 and deutarated benzofuran d-92 (71:29, GC-MS) was 
chromatographically separated. The proton NMR spectrum of the deuterated 
product d-92, the starting material 92 and the deuterium NMR spectrum of d-92 shows 
an incorporation of deuterium at the C3 (89%), but also on the alkyl substituent (74%) 
(Figure 3.8). 
[Ir(L2c)COD]BArF (1 mol%)O O
30 bar D2, CH2Cl2, 60 °C, 4 h
92 d-92
nDec C9H19
D
D
H
 
 
Figure 3.8 2H-NMR of d-92 (top) in CHCl3 with CDCl3, 
1H-NMR of 92 (middle) and 1H-NMR of d-92 (bottom) in CDCl3. 
Since deuteration experiments with D2 did not provide any evidence for the formation 
of an iridacycle stemming from cyclometallation, further studies are necessary to 
clarify the deactivating factor in the hydrogenation of 2-aryl substituted furans and 
benzofurans.  
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3.10 Summary 
In conclusion, the best results in the iridium-catalyzed hydrogenation of 3-substituted 
furans were obtained with the cyclopentane-annulated bicyclic pyridine-phosphinite 
ligand L2c. Thereby, both high enantiomeric excess and conversion were achieved for 
five substrates. For furans that are substituted with a linear alkyl chain, trifluoro-
ethanol was required to induce high levels of activity and enantioselectivity. The 
corresponding 2-substituted furans proved to be less reactive than their 3-substituted 
counterparts. Although high conversions were achievable with 2-alkyl furans, the 
enantioselectivity was lower compared to reactions of 3-substituted furans. 
Asymmetric hydrogenation of 2,4-disubstituted furans turned out to be very 
challenging for several reasons, not least because of the problem of controlling cis/trans 
selectivity. 
Surprisingly, in the iridium-catalyzed hydrogenation of 3-substituted benzofurans 
only the catalyst based on the cyclohexane-annulated pyridine-phosphinite ligand L1d 
showed high activity and enatioselectivity, whereas the five-membered ring analog, 
bearing ligand L2c, suffered from moderate activity and enantioselectivity. In contrast, 
the 2-alkyl substituted benzofurans gave superior results. With the iridium catalyst 
based on the cyclopentane-annulated bicyclic pyridine-phosphinite ligand L2c these 
substrates reacted with higher enantiomeric excess than with the NHC ruthenium 
catalyst system developed by GLORIUS. Unfortunately, 2-aryl substituted benzofurans 
could not be reduced by utilization of the iridium catalysts. 
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4 Synthesis of Thiophene 1,1-Dioxides as Substrates for 
Iridium-Catalyzed Asymmetric Hydrogenation 
4.1 Introduction 
The discovery of thiophene (122), which occurs in coal-tar distillates, is one of the 
classic anecdotes in organic chemistry. An important evidence for the presence of 
benzene, in the early days, was the blue color produced after reaction with isatin (123) 
and concentrated sulfuric acid upon heating (Scheme 4.1). In 1882, when VIKTOR MEYER 
failed to demonstrate this test during his lecture, because his assistant, after he ran out 
of commercial benzene, replaced it with a sample he had prepared from benzoic acid, 
it became clear that a contaminant in commercially available benzene rather benzene 
itself was responsible for the color. In fact the blue color could be attributed to the 
thiophene derivative 124. In further investigations, MEYER isolated the impurity and 
characterized it as its sulfonic acid derivative.[30] 
 
Scheme 4.1 Historically important reaction of thiophene (122) with isatin (123). 
Since its discovery many different protocols to synthesize substituted thiophenes were 
reported. In general, such heterocycles can be prepared using similar methods as for 
the synthesis of substituted furans. While mono-substituted thiophenes are usually 
generated by functionalization of the ring, the di- or multisubstituted ones are often 
obtained by cyclization reactions, such as the PAAL-KNORR reaction (Scheme 4.2). 
 
Scheme 4.2 Synthesis of thiophenes via cyclization reactions. 
During this ring-closure, a 1,4-dicarbonyl compound 125 reacts with a source of sulfide 
such as LAWESSON’S reagent or phosphorous pentasulfide to give substituted 
thiophenes 126. By applying this procedure various substitution patterns of thiophene 
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can be obtained. However, this procedure is limited by the synthetic accessibility of 
the required 1,4-dicarbonyl compounds. 
Direct lithiation of mono-substituted thiophenes takes place at the 2-position, 
while two equivalents of lithiating agent can easily produce 2,5-dilithiothiophene from 
thiophene (122).[52] Prefunctionalized thiophenes such as the corresponding boronic 
acids or brominated precursors can be submitted to various cross-coupling reactions 
as shown in Scheme 4.3 and Scheme 4.4. 
 
Scheme 4.3 Synthesis of 3-substituted thiophenes via SUZUKI-MIYAURA cross-coupling. 
Mono-substituted benzyl-thiophenes are generated by coupling of commercially 
available thiophene-3-boronic acid (127) with benzyl chloride derivatives 128.[53] 
Neither electronic properties nor the position of the substituents on the benzyl 
chloride 128 have an effect on the efficiency of the cross-coupling reaction. Although 
only one example of a coupling between thiophene-2-boronic acid and benzylchloride 
was reported, the high yield lies in the same range as for the reaction with 
thiophene-3-boronic acid (127). Even more versatile is the KUMADA coupling of 
3,4-dibromothiophene (130) with either alkyl or aryl Grignard reagents to generate the 
corresponding 3,4-disubstituted thiophenes 131 in high yields (Scheme 4.4).[54] 
130
S
BrBr
Ni(dppp)Cl2 S
Et2O, reflux
131
R
70-100%
R-MgBr
R = CH3, nBu, Ph, PhCH2
+
R
 
Scheme 4.4 Synthesis of 3,4-disubstituted thiophenes via KUMADA cross-coupling. 
The reaction of simple alkyl Grignard reagents can have a different outcome 
depending on the position of the bromine on the thiophene ring. While 3,4-dibromo- 
and 3-bromothiophene react smoothly with butylmagnesium bromide to afford the 
corresponding product in high yield, 2-bromo and 2,5-dibromothiophene formed 
thiophene (122) as a major or sole product instead of the desired coupling product 
2,5-dibutylthiophene, that is not formed at all. The authors assume a rapid 
metal-halogen exchange between reactive alkyl Grignard reagents and the thiophene 
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halides leading to the predominant formation of thiophene (122), whereas more 
stabilized Grignard reagents reacted faster to give the cross-coupling product.[54] 
The corresponding thiophene 1,1-dioxides can easily be obtained by oxidation 
reaction of substituted thiophenes.[55] Since, the S,S-dioxides are no longer aromatic 
they are relatively reactive and can undergo self-dimerization via [4+2] cycloaddition 
followed by SO2 elimination, depending on the substitution pattern (Scheme 4.5).[56] 
Scheme 4.5 Synthesis and reaction of substituted thiophene 1,1-dioxides. 
Therefore stable regioisomers, such as 2,5-disubstituted and also 3,4-disubstituted 
thiophene 1,1-dioxides[57] were chosen as substrates for the iridium-catalyzed 
asymmetric hydrogenation reaction, and their synthesis is described in the sections 
below. 
4.2 Synthesis of 2,5-Disubstituted Thiophene 1,1-Dioxides 
Unsymmetrical 2,5-disubstituted thiophenes were synthesized from commercially 
available mono-substituted precursors such as 2-phenylthiophene (132) and 2-methyl-
thiophene (133) by either metallation or direct arylation of the heterocycle (Scheme 4.6). 
Scheme 4.6 Synthesis of asymmetrical 2,5-disubstituted thiophene 1,1-dioxides. 
Lithiation and subsequent trapping with 1-bromobutane gave 2-butyl-5-phenyl-
thiophene (134) in quantitative yield. Palladium-catalyzed direct arylation with pivalic 
acid (in situ generated potassium pivalate) as accelerator was used to synthesize 
2-methyl-5-phenylthiophene (135) in good yield.[58] Both thiophenes were oxidized to 
the corresponding 1,1-dioxides  136 and 137 using hydrogen peroxide in acetic acid. 
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Although, both substrates were oxidized with full conversion, only moderate yields 
could be achieved after chromatographic purification with subsequent crystallization. 
When thiophene 135 was oxidized using freshly prepared DMDO (dimethyldioxirane) 
from acetone, sodium bicarbonate and Oxone® only 80% conversion was reached but 
with higher yield after purification (47% vs. 21%). 
Symmetrically 2,5-disubstituted thiophene 1,1-dioxides were also prepared as 
test substrates. 2,5-Dibenzylthiophene 1,1-dioxide (141) was synthesized in three steps 
(Scheme 4.7). First thiophene-2-boronic acid (138) reacted in a SUZUKI-MIYAURA 
cross-coupling with benzylchloride to give 2-benzylthiophene (139) in quantitative 
yield.[53] This compound was subjected to deprotonation with nBuLi and SN2 reaction 
with benzylbromide to give 2,5-dibenzylthiophene (140) also in good yield and 
subsequent oxidation resulted in the corresponding 1,1-dioxide 141. 
Scheme 4.7 Synthesis of 2,5-dibenzylthiophene 1,1-dioxide (141). 
Substitution on the benzyl ring was also investigated by using a similar approach for 
the synthesis of 2,5-bis(4-(methylsulfonyl)benzyl)thiophene (143) (Scheme 4.8). 
Palladium-catalyzed coupling yielded the 2-substituted thiophene 142, but this could 
not be further converted into the disubstituted thiophene 143 by metallation and 
alkylation with the corresponding benzylbromide. 
 
Scheme 4.8 Synthesis plan for 2,5-bis(4-(methylsulfonyl)benzyl)thiophene (143). 
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One possible explanation for the unsuccessful transformation in the second step could 
be the lithiation of the methylsulfonyl group in para position of benzylbromide. 
Therefore, a substituent without acidic protons was chosen. Literature known mono-
substitution of thiophene (122) with 4-nitrobenzaldehyde delivered the 2-substituted 
thiophene 144 in 77% yield, but did not give any disubstituted product 145, although 
two equivalents of nBuLi were used (Scheme 4.9). 
 
Scheme 4.9 Synthesis plan for 2,5-disubstituted thiophene 145. 
Alkyl substituted thiophene 1,1-dioxides were also prepared and investigated as 
potential substrates for asymmetric hydrogenation. Their synthesis was performed in 
a straightforward direct metallation of 2-alkyl substituted thiophenes 146 and 147 and 
the corresponding 2,5-disubstituted thiophenes 148 and 149 were obtained in high 
yield (Scheme 4.10). The oxidation of 2,5-dibutylthiophene (149) with hydrogen 
peroxide in acetic acid gave the product in only moderate yield, while the ethyl 
substituted thiophene 148 could be transformed using the urea-hydrogen peroxide 
(UHP) complex in trifluoroacetic anhydride in good yield at room temperature in just 
one hour.[55b] 
Scheme 4.10 Synthesis of 2,5-dialkyl substituted thiophene 1,1-dioxides 150 and 151. 
This procedure using the stable, inexpensive and easily handled reagent UHP was also 
applied to the oxidation of 3,4-disubstituted thiophenes as described in Section 4.3. 
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4.3 Synthesis of 3,4-Disubstituted Thiophene 1,1-Dioxides 
First attempts at synthesizing aryl disubstituted 3,4-thiophenes were based on a 
nickel-catalyzed cross-coupling reaction (see Scheme 4.4).[59] Therefore, 3,4-dibromo-
thiophene (130) was mixed with Ni(dppp)Cl2 in dry THF and the corresponding 
Grignard reagent was added (Table 4.1). After 18 hours only 10% conversion was 
observed in the synthesis of 3,4-diphenylthiophene (131a). Heating the reaction 
mixture to reflux for two hours did not improve the conversion (entry 1). Also when 
the temperature during the addition of the Grignard reagent was decreased to 0 °C the 
same level of conversion was observed. Only after using a freshly opened bottle of 
phenylmagnesium bromide solution the conversion rose to 27% along with formation 
of the homo-coupling by-product (entries 2 and 3). 
Table 4.1 Variation of reaction parameters in the synthesis of  
3,4-disubstituted thiophenes 131a and 131b. 
 
entry Grignard reagent 
addition of 
RMgBr at 
reaction 
conditions 
conv. to 131 
(%)[a] 
1 
PhMgBr 
3.8 M in Et2O 
rt 
18 h at rt then 
2 h reflux 
10 
11 
2 
PhMgBr 
3.8 M in Et2O 
0 °C 12 h reflux 10 
3 
PhMgBr 
3.0 M in Et2O[d] 
0 °C 16 h reflux     27[b] 
4 
BnMgBr 
2.0 M in THF 
0 °C 20 h reflux      –[c] 
5 
BnMgBr 
2.0 M in THF[d] 
0 °C 20 h reflux      –[c] 
[a] Determined by GC-MS analysis. [b] Formation of 47% biphenyl. [c] 1:1 ratio of 2-benzylthiophene 
and bibenzyl determined by 1H-NMR analysis. [d] Freshly opened bottle of Grignard reagent was used. 
The 3,4-dibenzyl substituted thiophene 131b could not be obtained following this 
procedure. While in the reaction with phenyl magnesium bromide some product 131a 
was formed, benzyl magnesium bromide and 3,4-dibromothiophene (130) gave only 
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2-benzylthiophene and the homo-coupling by-product from the Grignard reagent, 
regardless of the quality of the Grignard reagent (entry 4 and 5). 
However, 3,4-diphenthiophene (131a) could be prepared in a efficient manner 
via SUZUKI coupling from 3,4-dibromothiophene (130) and phenyl boronic acid.[60] 
During this cross-coupling reaction no major by-products were formed and the 
product 131a was isolated after purification in quantitative yield (99%). Oxidation of 
3,4-diphenylthiophene (131a) with urea-hydrogen peroxide complex delivered the 
corresponding S,S-dioxide (152) in moderate yield (Scheme 4.11). 
 
Scheme 4.11 Synthesis of 3,4-diphenylthiophene 1,1-dioxide (152). 
Alkyl substituted 3,4-thiophenes in contrast, were synthesized via the above described 
KUMADA coupling (Table 4.1) using 5 mol% of the nickel catalyst and 3,4-dibromo-
thiophene (130) in THF under reflux for 16 hours.[59] The addition of the alkyl Grignard 
reagent was conducted at 0 °C, yielding both thiophenes 131c and 131d in 90% yield 
and were used without further purification (Scheme 4.12). 
 
Scheme 4.12 Synthesis of 3,4-dialkyl thiophene 1,1-dioxides 153 and 154. 
Oxidation of thiophenes 131c and 131d with UHP proceeded with yields that were 
comparable to the yield registered for 3,4-diphenylthiophene 1,1-dioxide (152). The 
highest yield (58%) was obtained for the ethyl substituted 3,4-thiophene 154. 
With these new substrates in hand, investigations on the iridium-catalyzed 
asymmetric hydrogenation using different catalysts based on N,P ligands were made 
that are summarized in the following chapter.
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5 Iridium-Catalyzed Asymmetric Hydrogenation of Thiophene 
1,1-Dioxides 
5.1 Introduction 
The wide occurrence of optically active tetrahydrothiophenes in biological and 
medicinal chemistry makes them interesting core structures for synthetic organic 
chemists. The hydrogenation of thiophenes provides a straightforward synthetic 
approach to obtain the saturated analogs. In general, the hydrogenation of sulfur 
containing substrates remains still a challenge, although the hydrogenation of 
unsubstituted thiophenes and benzothiophenes has been extensively studied by many 
groups due to its industrial importance for hydrodesulfurization (HDS).[61] This 
process is employed to remove sulfur containing molecules as H2S from petroleum 
and other fossil fuel feedstock through reaction with hydrogen, typically catalyzed by 
transition metals. While most of the sulfur containing compounds are susceptible to 
HDS, substituted thiophene or benzothiophene rings are resistant to desulfurization. 
Direct hydrogenation of thiophenes is not only difficult due to their aromaticity, 
but also to the catalyst poisoning ability of sulfur containing compounds, which also 
explains why only two examples of hydrogenation procedures were reported using a 
homogeneous catalyst up to date (Scheme 5.1).[23a, 62] 
 
Scheme 5.1 Examples of hydrogenation of thiophenes by BOROWSKI (a) and GLORIUS (b). 
The first example of hydrogenation of thiophenes was reported in 2003 by BOROWSKI, 
who described the reduction of 2-methylthiophene to the corresponding racemic 
tetrahydrothiophene using a ruthenium (bis)dihydrogen complex, but only with low 
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conversion (example a).[62] Enantioselective reduction with a broader scope was 
recently demonstrated by GLORIUS (example b).[23a] Using a ruthenium catalyst with a 
monodentate N-heterocyclic carbene, 2,5-disubstituted thiophenes were reduced in 
moderate to perfect yield and high enantioselectivity. Electron withdrawing 
substituents on the phenyl ring resulted in higher yield. A 3,4-disubstituted thiophene 
was also reduced with good yield but low enantiomeric excess, while mono-
substituted tetrahydrothiophenes were quantitatively obtained as racemates. 
Although the examples discussed above represent important advances in the 
hydrogenation of substituted thiophenes, the substrate scope that they cover is still 
very limited. Especially in the case of asymmetric hydrogenation, only two 
compounds with a particular substitution pattern could be reduced with synthetically 
useful levels of yields and enantiomeric excess. Therefore, methods that broaden the 
applicability of this reaction would certainly be of high value. 
5.2 Enantioselective Hydrogenation of 2,5-Disubstituted Thiophene 
1,1-Dioxides 
The two asymmetrically substituted thiophenes 134 and 135 were subjected to 
hydrogenation after they were synthesized as described in Section 4.2. The asymmetric 
hydrogenation was performed with both catalysts bearing ligand L1e and L2c in 
CH2Cl2 at 60 °C and 100 bar hydrogen pressure for 24 hours. Since no reduction 
occurred, it was envisaged that a way to improve the reactivity of thiophenes towards 
hydrogenation could be based on reducing or removing their aromaticity. To this end, 
it was decided to employ thiophene 1,1-dioxides as non-aromatic thiophene 
surrogates. Upon hydrogenation, the resulting cyclic sulfones could be further 
reduced to afford the desired tetrahydrothiophenes. 
From the hydrogenation of furans and benzofurans it is known that the catalysts 
based on the cyclopentane- and cyclohexane-annulated bicyclic pyridine-phosphinite 
ligands L1 and L2 perform best in terms of enantioselectivity and activity (Section 3.10), 
therefore these two catalysts were tested in the hydrogenation of the sulfur containing 
substrates 136 and 137 as shown in Table 5.1 and Table 5.2. 
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Table 5.1 Iridium-catalyzed hydrogenation of 2-butyl-5-phenylthiophene 1,1-dioxide (136).[a] 
 
entry catalyst structure ligand T (°C) 155 (%)[b] 156 (%)[b] 157 (%)[b] 
1 
 
(S)-L1e 60 68 14 18 
2 
 
(R)-L2c 
60 51 18 31 
3 rt 51 18     31[c] 
4 
 
L3c 60 – 20     24[d] 
[a] Conversion was determined by 1H-NMR analysis and was complete unless noted. [b] Determined 
by GC-MS analysis. [c] Reaction performed on 0.2 mmol scale. [d] Reaction performed at 85 bar H2 
pressure with 40% conversion. 
Hydrogenation of thiophene 1,1-dioxide 136 proceeded with full conversion at 60 °C 
with both catalysts based on pyridine-phosphinite ligands L1 and L2 (entries 1 and 2). 
Even at room temperature substrate 136 was completely converted without affecting 
the ratio of the products (entry 2 vs. 3). When the achiral catalyst bearing the PHOX 
ligand L3c was used, only moderate conversion was achieved (entry 4). Asymmetric 
hydrogenation on a 0.2 mmolar scale was performed with catalyst bearing ligand L2c 
(entry 3), the products were separated on a semi-preparative HPLC with a chiral 
stationary phase and the product ratio was determined. Unfortunately, only one of the 
two mono-reduced products was obtained in its pure form. From the multiplicity and 
the chemical shift of significant signals in the proton NMR spectrum, such as the 
olefinic proton (ddt, 6.39 ppm) and the proton at the stereogenic center (dd, 4.42 ppm), 
this compound was identified as 2-butyl-5-phenyl-4,5-dihydrothiophene (155) and its 
structure was confirmed by 2D-NMR analysis. This leads to the assumption that the 
double bond in conjugation to the phenyl ring is hydrogenated first. However, the 
enantiomeric excess could not be determined by HPLC analysis on a chiral stationary 
phase, due to peak overlap with the corresponding tetrahydrothiophene 156. 
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Hydrogenation of 2-methyl-5-phenylthiophene 1,1-dioxide (137) was performed using 
the same catalysts as used for substrate 136 (Table 5.2). 
Table 5.2 Iridium-catalyzed hydrogenation of 2-methyl-5-phenylthiophene 1,1-dioxide (137).[a] 
 
entry catalyst structure ligand T (°C) 158 (%)[b] 159 (%)[b] 160 (%)[b] 
1 
 
(S)-L1e 
60 58 35 7 
2 rt 72 8 20 
3 rt 71 –     29[c] 
4 rt 55 12 33 
5 
 
(R)-L1j rt 30 17 53 
6 
 
(R)-L2c 
60 32 49 19 
7 rt 42 15 43 
8 
 
L3c 60 9 15     42[d] 
[a] Conversion was determined by 1H-NMR analysis and was complete unless noted. [b] Determined 
by GC-MS analysis. [c] Reaction performed on 0.2 mmol scale. [d] Reaction performed at 85 bar H2 
pressure with 66% conversion. 
The hydrogenation reaction of 2-methyl-5-phenylthiophene 1,1-dioxide (137) was also 
not particularly selective. The use of the catalysts shown in Table 5.2 resulted in all 
three possible reduction products, except for one hydrogenation performed with the 
catalyst bearing ligand L1e at room temperature (entry 3). This experiment was 
performed on a larger scale (0.2 mmol) to subsequently perform a semi-preparative 
separation. Both mono-reduced products 158 and 160 were obtained in pure form and 
identified by 1H-NMR analysis (Table 5.3). The ee values for both products 158 and 160 
were found to be >99%. Since this hydrogenation could not be reproduced (entry 4), 
the high enantiomeric excesses could not be confirmed due to peak overlap. The 
catalysts based on ligands L1j and L2c reduced the substrate completely, but not very 
selectively (entries 5 and 6). The reaction temperature had no influence on the product 
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distribution (entry 6 vs. 7). In analogy to thiophene 1,1-dioxide 136, only moderate 
conversion was obtained upon the reduction of 2-methyl-5-phenylthiophene 
1,1-dioxide (137) with the achiral catalyst based on PHOX ligand L3c. For the other 
reactions (entries 5-8) the ee value again could not be determined due to peak overlap 
of the signals corresponding to 2,3-dihydrothiophene 1,1-dioxides 158, 160 and 
tetrahydrothiophene 1,1-dioxide 159. 
The comparison of the chemical shifts of protons H1 and H2 for both 
4,5-dihydrothiophene 1,1-dioxides 155 and 158 and both 2,3-dihydrothiophene 
1,1-dioxides 157 and 160 shows a high degree of similarity (Table 5.3). Based on the 
structure of dihydrothiophene 155, which was confirmed by two-dimensional NMR 
analysis, the assignment of the 1H-NMR spectra of purified dihydrothiophenes 158 
and 160 was made by analogy. 
Table 5.3 Comparison of the 1H-NMR shifts of H1 and H2 of 155 and 157 with those of 156 and 158. 
 
compound 
 
1H-NMR shift 
[ppm]     
H1 (multiplicity) 6.39 (ddt) 6.71 (dd) 6.41 (mc) 6.72 (dd) 
H2 (multiplicity) 4.42 (dd) 3.35 (mc) 4.42 (dd) 3.46 (dq) 
1H-NMR in CDCl3. 
The fully hydrogenated compounds 156 and 159 are assumed to be the meso 
compounds based on the hydrogenation results for 2,5-dibenzylthiophene 
1,1-dioxide (141), 2,5-dibutylthiophene 1,1-dioxide (151) and 2,5-diethylthiophene 
1,1-dioxide (150) (see below). 
To facilitate the analysis of the product mixtures symmetrical 2,5-disubstituted 
substrates were considered for further investigations, in order to reduce the number 
of possible products. While 2,5-diphenylthiophene 1,1-dioxide, as well as 2,5-di-
methylthiophene 1,1-dioxide were not particularly reactive in the iridium-catalyzed 
hydrogenation reaction as shown by TOSATTI, they were not further investigated.[42] 
Instead, 2,5-dibenzylthiophene 1,1-dioxide (141) was tested with catalysts based on the 
annulated pyridine-phosphinite ligands L1e and L2c (Table 5.4). 
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Table 5.4 Iridium-catalyzed hydrogenation of 2,5-dibenzylthiophene 1,1-dioxide (141). 
 
entry catalyst structure T (°C) 
p H2 
(bar) 
meso-161 (%)[a] 162 (%)[a] 
ee (%) of 
162[b] 
1 
 
60 100 89 8 >99 
2 rt 100 87 9 >99 
3 rt 50 89 7 >99 
4 
 
60 100 78 19 >99 
5 rt 100 71 23 >99 
6 rt 50 78 18 >99 
7    rt[c] 50 78 19 >99 
8    rt[d] 50 72 22 >99 
9 
 
   rt[e] 50 86 8 – 
10    rt[e] 50 79 12 – 
[a] Determined by 1H-NMR analysis, conversion was complete unless noted. [b] Determined by HPLC 
on a chiral stationary phase. [c] Reaction time 6 h. [d] Reaction was performed with the (S)-enantiomer.  
[e] 2 mol% of a mixture of both enantiomers of catalyst bearing ligand L2c was used. 
Asymmetric hydrogenation of 2,5-dibenzylthiophene 1,1-dioxide (141) proceeded 
with full conversion with both selected catalysts. In general, a higher amount of the 
fully reduced meso-161 product was obtained with the catalyst bearing the 
cyclohexane-annulated bicyclic pyridine-phosphinite ligand L1e (entries 1-3). For the 
reduction with the five membered ring analog based on ligand L2c no or only little 
effect was observed upon variation of the reaction temperature (entry 4 vs. 5), 
hydrogen pressure (entry 5 vs. 6) or reaction time (entry 6 vs. 7). Although, high 
enantiomeric excess could be achieved for the mono-hydrogenated product 162, it was 
only formed in 23% regardless of the reaction conditions (entry 5). 
Tetrahydrothiophene 1,1-dioxide meso-161 was identified by 1H-NMR analysis 
and the two reference compounds, 2,5-diphenyltetrahydrothiophene 1,1-dioxide (163) 
and 2,5-diphenyltetrahydrothiophene 1-oxide (166) that were prepared by stepwise 
deprotonation and substitution of tetrahydrothiophene 1,1-dioxide (165) and 
tetrahydrothiophene 1-oxide (164), respectively (Scheme 5.2). While the reaction of 
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tetrahydrothiophene 1,1-dioxide (165) gave the product 163 as a mixture of both 
diastereomers (60:40, cis:trans), tetrahydrothiophene 1-oxide (164) reacted with nBuLi 
and benzylbromide to selectively form the corresponding cis isomer of compound 166, 
due to site selective coordination and attack from the back by benzylbromide together 
with mono-substituted product, which was separated by semi-preparative HPLC on 
an achiral stationary phase. Suitable crystals for X-ray analysis of both fully reduced 
compounds 163 and 166 were obtained, the structure of the latter is shown in 
Scheme 5.2. 
nBuLi, −78 °C 
then
benzylbromide
−78 °C to rt, 15 h
S
OO OnS
163
Ph Ph
164, n = 1
165, n = 2
nBuLi, −78 °C 
then
benzylbromide
−78 °C to rt, 21 h
69%
60:40 cis:trans
41%
S
O
166
Ph Ph
nBuLi, −78 °C 
then
benzylbromide
−78 °C to rt, 22 h
separation on 
semi-prep HPLC  
Scheme 5.2 Synthesis of reference compounds 163 and 166. 
Analysis of the reaction mixture resulting from asymmetric hydrogenation (Table 5.4) 
revealed a by-product 167 in small amounts (3-7%, 1H-NMR). This [2+2] cycloaddition 
product 167 was isolated, analyzed by two-dimensional NMR and its structure was 
confirmed by X-ray analysis (Figure 5.1). 
 
Figure 5.1 Structure of [2+2] cycloaddition product 167. 
The by-product 167 was not formed during the hydrogenation as initially assumed, 
but was already present in the starting material 141 in amounts ranging from 4% to 
59% depending on the age of the substrate. The sample containing 59% of the [2+2] 
cycloaddition product had been stored on the benchtop in a glass bottle for three 
months. Formation of the cyclized product 167 by thermal cycloaddition could be 
excluded, since the amount did not increase upon heating of 2,5-dibenzylthiophene 
1,1-dioxide (141) either neat or in CD3CN to 80-90 °C for 17 to 19 hours. This reaction 
could also be light-induced by sunlight as it is known for unsubstituted and 
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mono-substituted benzothiophene 1-oxides[63] and 1,1-dioxides[64] and for 3,4-dichloro-
thiophene 1,1-dioxide[65] when exposed to sunlight or irradiation with a mercury arc 
lamp (313 or 356 nm). Therefore, the photodimerization reaction was investigated in 
collaboration with Prof. Wenger (University of Basel). A sample of 2,5-dibenzyl-
thiophene 1,1-dioxide (141) in acetonitrile (c = 5×10−4 M), containing 4% of the cyclized 
product 167, was irradiated with a xenon lamp for the indicated time and the 
absorption of this solution was recorded subsequently (Figure 5.2). In orange the 
absorption of the sample before irradiation is shown and in black the absorption of the 
pure dimer 167. 
 
Figure 5.2 Irradiation of 2,5-dibenzylthiophene 1,1-dioxide (141) with a Xe lamp in CH3CN. 
While the absorption spectrum after irradiation for 30 minutes (green) does not change 
dramatically, the significant maximum value for 2,5-dibenzylthiophene 
1,1-dioxide (141) at around 300 nm disappears after irradiating for 210 minutes. 
Evaporation of the solvent with subsequent proton NMR analysis of this irradiated 
sample showed an increased formation of the dimer 167 (mono:dimer, 1.0:1.4). 
Experiments at higher concentration (c = 3×10−2 M) using a 300 W xenon arc light source 
did not result in higher yield. Since no adequate apparatus was available the 
investigations were terminated at this point. 
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Alkyl 2,5-disubstituted substrates such as 2,5-dibutylthiophene 1,1-dioxide (151) and 
2,5-diethylthiophene 1,1-dioxide (150) were also investigated in the asymmetric 
iridium-catalyzed hydrogenation. The results obtained for substrate 151 with selected 
catalysts are shown in Table 5.5. 
Table 5.5 Iridium-catalyzed hydrogenation of 2,5-dibutylthiophene 1,1-dioxide (151).[a] 
 
entry catalyst structure ligand T (°C) meso-168 (%)[b] 169 (%)[b] 
1 
 
(S)-L1e 
60 86 14 
2 rt 80 20 
3 
 
(R)-L2c 
60 86 14 
4 rt 84 16 
[a] Conversion was determined by 1H-NMR analysis and was complete unless noted. [b] Determined 
by GC-MS. 
The hydrogenation proceeds to completion at elevated and also at room temperature 
to give the meso compound 168 as the main product. Unfortunately, the enantiomeric 
excess of the mono-reduced product 169 could not be determined, since the 
enantiomers could not be separated by GC analysis with a chiral stationary phase. In 
order to reduce the molar weight and thereby shorten the retention time of the 
compound, a reduction of the sulfone 169 to the corresponding sulfide was envisioned. 
Lithium aluminum hydride was used in large excess (10 eq.), but the product was only 
formed as the minor component (up to 35%) together with unidentified by-products, 
which could not be separated. 
As an alternative substrate, 2,5-diethylthiophene 1,1-dioxide (150), having a 
lower molecular mass than 151, was synthesized (see Section 4.2) and submitted to the 
same hydrogenation conditions (Table 5.6). 
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Table 5.6 Iridium-catalyzed hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150). 
 
entry catalyst structure 
reaction time
(h) 
trans-170 
(%)[a] 
meso-170 
(%)[a] 
171 
(%)[a] 
ee (%) of 
171[b] 
1 
 
24 0.3 60 40 99 (−) 
2 6 – 41 59 98 (−) 
3 
 
24 2 30 70 >99 (+) 
4 6 – 16 84 >99 (+) 
[a] Determined by GC analysis, conversion was complete unless noted. [b] Determined by GC analysis 
on a chiral stationary phase. 
Asymmetric hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150) proceeded with 
complete conversion to afford both fully hydrogenated products trans-170 and 
meso-170 together with the mono-reduced product 171. For substrate 150 the reaction 
time had some impact on the product ratio. When the hydrogenation was carried out 
for a prolonged reaction time (24 h) with the catalyst bearing ligand L1e, the meso-170 
isomer was formed as the major product, whereas after a reaction time of only six 
hours the mono-hydrogenated product 171 was the main product (entry 1 vs. 2). The 
product distribution resulting from the hydrogenation of substrate 150 with the 
catalyst based on L2c was not very much affected by the reaction time, as in both cases 
the main product was 2,3-dihydrothiophene 171 (entries 3 and 4). Although the 
hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150) required still some 
optimization, the enantiomeric excess determined for 2,3-dihydrothiophene 171 was 
very high with the catalyst based on the cyclohexane-annulated pyridine-phosphinite 
ligand L1e (entry 2) and even higher with the complex based on ligand L2c (entries 3 
and 4). As the amount of both undesired fully reduced product trans-170 and meso-170 
was reduced by shorter reaction time, further catalyst screening was performed under 
these conditions (50 bar H2, 6 h) (Table 5.7). 
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Table 5.7 Catalyst screening for the hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150). 
 
entry catalyst structure ligand 
conv. 
(%)[a] 
meso-170 
(%)[a] 
171 
(%)[a] 
ee (%) of 
171[b] 
1 
 
(S)-L2c >99.9[c] 15 85     >99 (−) 
2 
 
L3e 6 52 48 41 (+) 
3 
 
(S)-L5a 13 74 26 58 (−) 
4 
 
L7e 25 37 63 46 (+) 
5 
 
L13 >99.9[d] 23 76 89 (−) 
6 
 
L14 >99.9[e] 45 55 32 (+) 
7 
 
L15 3 – 3 36 (+) 
[a] Determined by GC analysis. [b] Determined by GC analysis on a chiral stationary phase. [c] 0.2% of 
trans-170 product was formed. [d] 1% of trans-170 product was formed. [e] 0.1% of trans-170 product 
was formed. 
In general low conversion was obtained for the hydrogenation of 2,5-diethylthiophene 
1,1-dioxide (150) with the tested oxazoline based N,P ligands, only pyridine-based 
catalysts bearing ligands L2c, L13 and L14 brought the reaction to its completion 
(entries 1, 5 and 6). Both the selectivity and the enantiomeric excess were moderate for 
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all catalytic systems, except for the catalysts bearing the cyclohexane-annulated 
bicyclic pyridine-phosphinite ligand L2c (entry 1) and the N-heterocyclic carbene 
ligand L13 (entry 5). Having found the most active and selective catalyst, the 
asymmetric hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150) was further 
optimized. First, the reaction time was varied in the hydrogenation using the catalyst 
bearing ligand L2c (Table 5.8). 
Table 5.8 Catalyst screening for the hydrogenation of 2,5-diethylthiophene 1,1-dioxide (150). 
 
entry reaction time (h) trans-170 (%)[a] meso-170 (%)[a] 171 (%)[a] ee (%) of 171[b] 
1 3 0.2 14 86 >99 (+) 
2 1 0.1 13 87 >99 (+) 
3 0.5 – 12 88 >99 (+) 
[a] Determined by GC analysis, conversion was complete unless noted. [b] Determined by GC analysis 
on a chiral stationary phase. 
This reaction parameter had essentially no impact on the amount of undesired fully 
reduced products trans-170 and meso-170. Surprisingly, only 30 minutes were needed 
to drive the hydrogenation reaction to completion without any formation of the 
trans-170 product (entry 3). Furthermore, the effect of hydrogen pressure in the 
hydrogenation of thiophene 1,1-dioxide 150 with the same catalyst was investigated 
(Table 5.9).
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Table 5.9 Optimization of the hydrogenation conditions for 2,5-diethylthiophene 1,1-dioxide (150). 
 
entry reaction time (min) conv. (%)[a] meso-170 (%)[a] 171 (%)[a] ee (%) of 171[b] 
1 60 >99.9 15 85 >99 (+) 
2    60[c] >99.9 9 91 >99 (+) 
3 30 >99.9 5 95 >99 (+) 
4 20 >99.9 4 96 >99 (+) 
5 15 99.6 3 97 >99 (+) 
6 10 96 2 98 >99 (+) 
7     10[d] 86 1 99 >99 (+) 
[a] Determined by GC analysis, no trans-170 product was formed. [b] Determined by GC analysis on a 
chiral stationary phase. [c] Reaction performed at 0 °C. [d] Reaction performed on a 0.1 mmol scale. 
Under a reduced hydrogen pressure of no trans-170 product was detected. By 
decreasing the reaction temperature to 0 °C the formation of the undesired fully 
reduced product meso-170 was reduced (entry 2). Shorter reaction time had the same 
beneficial effect on the product distribution (entry 3-6), but to reach full conversion the 
reaction had to be run for a minimum of 20 minutes (entry 4). Variation of reaction 
parameters, such as temperature, time or hydrogen pressure did not have any effect 
on the excellent enantiomeric excess observed for mono-hydrogenated product 171. 
The efficiency of this catalytic system was then tested by reducing the catalyst loading 
(Table 5.10). 
Table 5.10 Iridium-catalyzed hydrogenation of substrate 150 using 0.5 mol% catalyst loading. 
 
entry reaction time (min) conv. (%)[a] meso-170 (%)[a] 171 (%)[a] ee (%) of 171[b] 
1 60 75 2 98 >99 (+) 
2 90 91 2 98 >99 (+) 
3 120 >99.9 6 94 >99 (+) 
4 180 >99.9 12 88 >99 (+) 
[a] Determined by GC analysis, no trans-170 product was formed. [b] Determined by GC analysis on a 
chiral stationary phase. 
Hydrogenation of Thiophene 1,1-Dioxides 
86 
With lower catalyst loading (0.5 mol%) the amount of the meso-170 product also 
decreased, but at expense of conversion (entry 1). Prolonged reaction time of 90 
minutes resulted in the same ratio of products meso-170 and mono-hydrogenated 
product 171, but still no full conversion was achieved (entry 2). Although, after two 
hours the reaction proceeded in a quantitative manner, the proportion of product 
meso-170 increased (entry 3) and doubled upon prolongation of the reaction time for 
another hour (entry 4). 
The mono-hydrogenated sulfone 171 stemming from a hydrogenation with the 
catalyst bearing ligand L2c (50 bar H2, rt, 1 h) was re-submitted after catalyst removal 
to identical hydrogenation conditions. Surprisingly, the remaining double bond was 
not reduced carrying out the reaction for one hour at 50 bar hydrogen pressure. This 
observation may be explained by the following reaction pathway (Scheme 5.3). 
 
Scheme 5.3 Possible reaction pathway for iridium-catalyzed hydrogenation of 
2,5-disubstituted thiophene 1,1-dioxides. 
Upon hydrogenation of the first C=C bond the iridium center remains bound to the 
heterocycle forming an allyl-complex A. This complex can undergo reductive 
elimination to give either the p complex B, which upon decomplexation furnishes the 
mono-hydrogenated product P1 or the iridium complex C. Further reduction of 
complex B is presumably very slow or does not proceed at all, while hydrogenation of 
the disubstituted double bond in complex C is faster to give the meso compound D. 
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5.3 Enantioselective Hydrogenation of 3,4-Disubstituted Thiophene 
1,1-Dioxides 
3,4-Diaryl and dialkylsubstituted thiophene 1,1-dioxides were also investigated as 
substrates (Table 5.11). 
Table 5.11 Iridium-catalyzed hydrogenation of 3,4-disubstituted substrates. 
 
entry R T (°C) p H2 (bar) conv. (%)[a] a (%)[a] b (%)[a] c (%)[a] 
ee of c 
(%)[b] 
1 Ph 60 100 89 – 17 83 18 
2 CH3 60 100 48 36 21 48 39 
3 CH3 60 50 50 – 50 50 42 
4 CH3    rt[c] 50 7 – – 99 rac 
5 Et 60 100 75 16 32 52     n.d.[d] 
6 Et 60 50 41 – 36 64     n.d.[d] 
7 Et    rt[c] 50 16 – – 99     n.d.[d] 
[a] Determined by 1H-NMR analysis. [b] Determined by GC or HPLC analysis on a chiral stationary 
phase. [c] Reaction performed with racemic catalyst bearing ligand L2c for 4 h. [d] Enantiomeric excess 
could not be determined, due to peak overlap of thiophene 1,1-dioxide 154 with mono-hydrogenated 
product 154c. 
Unfortunately, 3,4-disubstituted thiophene 1,1-dioxides 152, 153 and 154 proved to be 
less reactive than their 2,5-disubstituted counterparts (Section 5.2). In addition to the 
4,5-dihydrothiophene 1,1-dioxides 152c, 153c and 154c, the isomers 2,5-dihydro-
thiophene 1,1-dioxides 152b, 153b and 154b were observed. All products shown 
above, were identified by proton NMR analysis and their structures confirmed by 
two-dimensional NMR spectroscopy. 3,4-Diphenylthiophene 1,1-dioxide (152) was 
reduced only to 89%, the major product being the mono-hydrogenated compound 
152c. Unfortunately, the observed enantiomeric excess reached only 18% (entry 1). 
Although higher ee was obtained in the hydrogenation of 3,4-dimethylthiophene 
1,1-dioxide (153) it was still moderate (entries 2 and 3). While the reduction of substrate 
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153 at higher hydrogen pressure resulted in additional formation of the undesired 
fully reduced compound 153a, lowering the hydrogen pressure gave a 1:1 mixture of 
dihydrothiophene 1,1-dioxides 153b and 153c (entry 2 vs. entry 3). Although the 
hydrogenation of 3,4-diethylthiophene 1,1-dioxide (154) proceeded with higher 
conversion at higher hydrogen pressure in higher conversion, those conditions 
fostered the formation of the meso compound 154a (entry 5). At 50 bar hydrogen 
pressure only the two dihydrothiophene 1,1-dioxides 154b and 154c were formed. The 
enantiomeric excess of 2,5-dihydrothiophene 1,1-dioxide could not be determined, due 
to peak overlap with the starting material 154. Both 3,4-dialkyl substituted substrates 
153 and 154 were transformed only with low levels of conversion at room temperature 
with the racemic catalyst based on ligand L2c (entries 4 and 7). 
Overall, the results obtained with 3,4-disubstituted thiophene 1,1-dioxides are 
inferior to those obtained with their 2,5-disubstituted counterparts. 
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6 Iridium-Catalyzed Asymmetric Hydrogenation of Other Heterocycles 
6.1 Introduction 
To broaden the substrate scope of asymmetric iridium-catalyzed hydrogenation of 
heterocycles, the hydrogenation protocols developed for furans, benzofurans and 
thiophene 1,1-dioxides were applied to substituted thiazoles, oxazoles and indolizines. 
Reduced heterocycles of this type occur in many bioactive natural products and 
pharmaceuticals as shown by some examples in Figure 6.1. 
 
Figure 6.1 Structure motifs of reduced heterocycles in drugs or natural products. 
Penicillin G (172) is a naturally occurring substance with antibiotic properties 
produced by the mold fungus Penicillium notatum. It was discovered by ALEXANDER 
FLEMING, who was awarded with the Nobel Prize in 1945. Linezolid (173) is a synthetic 
antibiotic which is active against most Gram-positive bacteria, that are resistant to 
other antibiotics.[66] Monomorine (174) is a natural alkaloid extracted from ants or toad 
skin,[67] which is probably used as defense agent against predators. An efficient way to 
access these kinds of core structures is the asymmetric reduction of the corresponding 
unsaturated compounds. While the asymmetric hydrogenation of substituted 
thiazoles has not been reported to date, 2,4- and 2,5-disubstituted oxazoles were 
reduced with a chiral ruthenium catalyst to give the enantioenriched products 176 and 
178 (Scheme 6.1).[68] 
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Scheme 6.1 Asymmetric hydrogenation of 2,4- and 2,5-disubstituted oxazoles. 
To obtain high conversion for the hydrogenation of 2,4-disubstituted oxazoles 175 the 
addition of TMG was crucial. Higher enantiomeric excess was induced in the 
asymmetric reduction of 2,5-disubstituted oxazoles 177 when changing the solvent to 
toluene. Diaryl and mixed alkyl/aryl substituted 4,5-dihydrooxazoles were obtained 
in high yield with excellent enantiomeric excess, whereas the hydrogenation of 
alkyl/aryl substituted oxazoles resulted in lower levels of enantiomeric excess for both 
substitution patterns. 
Asymmetric hydrogenation of indolizine with a ruthenium catalyst based on an 
N-heterocyclic carbene ligand was realized in the research group of GLORIUS 
(Scheme 6.3).[69] 
 
Scheme 6.2 Asymmetric hydrogenation of disubstituted indolizines. 
Differently substituted indolizines were reduced enantioselectively in high yield. 
Simultaneously with elongation of the alkyl substituent at the 5-position the ee 
dropped for 3,5-substituted indolizines. Although functional group tolerance was 
shown by means of one substrate, the substrate scope is still limited, since 
hydrogenation of derivatives with other substitution patterns resulted in moderate or 
no enantioselectivity at all. 
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6.2 Attempted Enantioselective Hydrogenation of Thiazoles and Oxazoles 
The commercially available heterocycles 181, 182 and 183 were tested as substrates 
using the conditions and the catalysts shown in Scheme 6.3. 
Scheme 6.3 Hydrogenation of thiazole 181 and oxazoles 182 and 183. 
Only starting materials were recovered after applying the hydrogenation conditions 
successfully used for the reduction of furans and thiophene 1,1-dioxides. Neither the 
BArF analog of the CRABTREE catalyst could promote the reduction even under harsh 
conditions, nor the iridium catalyst based on the cyclopentane-annulated bicyclic 
pyridine-phosphinite ligand L2c. The reactivity of these substrates must be very low 
perhaps due to inhibition of the catalyst as a result of coordination of the N-atom with 
the metal center. 
6.3 Attempted Enantioselective Hydrogenation of Indolizines 
In a two-step synthesis starting from 2-bromo-6-methylpyridine (184) and 
1-heptyne (185) 2-(hept-1-yn-1-yl)-6-methylpyridine (186) was obtained in a quanti-
tative manner (Scheme 6.4).[69] Alkynyl pyridine 186 underwent a copper assisted cyclo-
isomerization to give the light sensitive 3-butyl-5-methylindolizine (187). 
Indolizine 187 was weighted in the glove box to perform the hydrogenation reaction 
using the catalyst bearing ligand L2c. 
 
Scheme 6.4 Synthesis and hydrogenation of 3-butyl-5-methylindolizine (187). 
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Again no reaction was observed even under forcing hydrogenation conditions and 
therefore this scaffold was not further investigated.
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7 Experimental Section 
7.1 Working Techniques 
The synthesis of air- and moisture-sensitive compounds was carried out using dried 
glassware under argon and standard Schlenk techniques. Flash chromatographic 
purifications were performed on Merck silica gel 60 (40-63 mm particle size). The 
eluents were of technical grade and distilled prior to use. Solvents were collected from 
a purification column system (PureSolv, Innovative Technology Inc.) or purchased 
from Aldrich or Fluka in sure/sealed bottles over molecular sieves. The hydrogenation 
experiments were set up under air, unless otherwise noted. 
7.2 Analytical Methods 
NMR Spectroscopy: NMR spectra were recorded on a Bruker Advance 400 (400 MHz) 
instrument. The chemical shift δ value is given in ppm and referenced to the residual 
solvent peaks: 7.26 ppm (1H-NMR) and 77.16 ppm (13C-NMR) for CHCl3, and 2.50 ppm 
(1H-NMR) and 39.43 ppm (13C-NMR) for DMSO. Multiplets were assigned with s 
(singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet) or br (broad). 
Mass Spectrometry (MS): Mass spectra were recorded by Dr. H. Nadig (Department 
of Chemistry, University of Basel) on a VG70-250 (electron ionization, EI) or a MAR 
312 (fast atom bombardment, FAB) mass spectrometer. FAB was performed using 
3-nitrobenzyl alcohol as a matrix. GC-MS spectra were measured on a 5890 Series II 
with Macherey-Nagel OPTIMA1 Me2Si column (25 m × 0.2 mm × 0.35 μm) and a 
HP6890 gas chromatograph with a HP5970A detector equipped with a 
Macherey-Nagel OPTIMA5 5% polyphenylmethylsiloxane column (30 m × 0.25 mm 
× 0.25 μm) using a mass selective detector (EI). The signals are given in mass to charge 
ratio (m/z). The fragmentation pattern and intensities are given in brackets. All values 
are rounded to the nearest whole number. 
High Resolution Mass Spectrometry (HRMS): High resolution mass spectra were 
recorded by O. Greter (Mass Spectrometry Service Facility at LOC, ETH Zürich) on a 
Waters Micromass AutoSpec Ultima MassLynx 4.0 Micromass (electron ionization, EI) 
mass spectrometer with an EBE-triSector mass analyzer. The signals are given in mass 
to charge ratio (m/z). The fragmentation pattern and intensities are given in brackets. 
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Infrared Spectroscopy (IR): Infrared spectra were recorded on a Shimadzu 
FTIR-8400S spectrometer. Absorption bands are given in wave numbers ν~ [cm−1]. The 
peak intensity is assigned with s (strong), m (medium) and w (weak). 
Melting Point (m.p.): Melting points were measured on a Büchi 535 melting point 
apparatus and are uncorrected. 
Optical Rotation ([α]D20): Optical rotations were measured on a Perkin Elmer 
Polarimeter 341 in a 1 dm cuvette at 20 °C. The mass concentration (c) is given in 
g/100 mL. 
Gas Chromatography (GC): Gas chromatograms were recorded on a Carlo Erba 
HRGC Mega2 Series 800 (HRGS Mega2) instrument. Separations on achiral phases 
were performed on a Restek Rtx-1701 column (30 m × 0.25 mm × 0.25 μm). For GC on 
chiral phases β- and γ-cyclodextrin columns (30 m × 0.25 mm × 0.25 μm) were used. 
High Performance Liquid Chromatography (HPLC): HPLC analyses were performed 
on Shimadzu systems with SCL-10A system controller, CTO-10AC column oven, 
LC10-AD pump system, DGU-14a degasser and SPD-M10A diode array or UV/VIS 
detector. For ee determination columns from Daicel Chemical Industries Ltd. were 
used. 
Thin Layer Chromatography (TLC): TLC plates were purchased from 
Macherey-Nagel (Polygram SIL G/UV254, 0.2 mm silica with fluorescence indicator, 
40 × 80 mm). 
Elemental Analysis (EA): Elemental analyses were measured at the Department of 
Chemistry, University of Basel, Microanalytical Laboratory by W. Kirsch and S. 
Mittelheiser on a Leco CHN-900 analyzer or a Vario Micro Cube by Elementar (C-, H, 
N-detection). The data are indicated in mass percent. 
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7.3 General Hydrogenation Procedures 
General Hydrogenation Procedure with Pd/C: A high pressure steel autoclave 
(Premex Reactor AG, HMP-005) with glass insert and a magnetic stirring bar was 
charged with Pd/C (10 mol%), 0.2 mmol of substrate and 1.0 mL EtOAc. The sealed 
hydrogenation vessel was attached to a high pressure hydrogen line and purged with 
H2. At 50 bar hydrogen pressure the mixture was stirred for 4 hours at room 
temperature. After H2 was released, the solution was filtered over a Chromafil O-20/15 
organic solvent stable filter (0.2 μm pore size) and the solution was analyzed after 
removal of the solvent. 
General Hydrogenation Procedure with Iridium Catalysts: A high pressure steel 
autoclave (Premex Reactor AG, HMP-005) with glass insert and a magnetic stirring bar 
was charged with catalyst (0.001 mmol), substrate (0.1 mmol) and 0.25 mL of degased 
solvent. The sealed hydrogenation vessel was attached to a high pressure hydrogen 
line and purged with H2. At specified hydrogen pressure the mixture was stirred for 
indicated time at the corresponding temperature. After H2 was released, the solution 
was concentrated and diluted with 0.2 mL of nhexane:MTBE (4:1) and filtered over a 
plug of silica gel in a pasteur pipette. The solution was analyzed after removal of the 
solvent. 
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7.4 Synthesis and Characterization of Substituted Furans and Benzofurans 
3-Phenylfuran (41a) 
Following a modified procedure of PRIDGEN et al.,[26] Ni(dppe)Cl2 (41.3 mg, 
0.08 mmol, 1.04 mol%) was dissolved under slightly positive argon flow 
in dry THF (30 mL) in a 250 mL two-necked flask equipped with a reflux 
condenser. First 3-bromofuran (1.14 g, 7.52 mmol, 1.00 eq.) then phenyl 
magnesium bromide (1.0 M in THF, 8.30 mL, 8.30 mmol, 1.10 eq.) was 
added dropwise via syringe, the latter over a period of 20 min. The reaction mixture 
was stirred for three hours, quenched with an aqueous saturated NH4Cl solution 
(50 mL) and was transferred to a separation funnel. After separation of the phases, the 
aqueous phase was extracted with MTBE (3×100 mL) and the combined organic phases 
were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The obtained orange crystals were purified first by bulb to bulb distillation (1.0 torr, 
120 °C) and subsequent flash chromatography (silica gel, 40×4 cm, npentane) to give 
the title compound 41a as colorless crystals (651 mg, 4.51 mmol, 60%). 
m.p. 56–58 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.77 (dd, 4JHH = 1.6, 0.9 Hz, 
1H, OCH), 7.51–7.48 (m, 3H, 2 HCar, OCHCH), 7.49–7.48 (m, 2H, HCar), 7.41 (tt, 
3,4JHH = 7.4, 1.7 Hz, 2H, HCar), 7.30 (tt, 3,4JHH = 7.4, 1.3 Hz, 1H, HCar), 6.74 (dd, 3,4JHH = 1.8, 
0.8 Hz, 1H, OCHCH); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 143.8 
(OCHCH), 138.6 (OCH), 132.6 (Cfuran), 128.9 (2 HCar), 127.1 (HCar), 126.6 (Car), 126.0 
(2 HCar), 109.0 (OCHCH); MS (EI), m/z (%) 144 (M+, 100), 115 (80); IR (ν~ [cm−1]) 3147w, 
3127w, 3079w, 3061w, 3021w, 2022w, 1948w, 1888w, 1816w, 1701w, 1653w, 1587w, 
1512m, 1491w, 1448m, 1367w, 1302w, 1238w, 1184w, 1161s, 1099w, 1075m, 1052m, 
1026w, 1015s, 922m, 907m, 871s, 795m, 750s, 690s, 674s, 668s; EA: calculated for 
C10H8O: C = 83.31, H = 5.59; measured: C = 82.53, H = 5.75; Rf = 0.46 (silica gel, 
nhexane:EtOAc, 2:1); GC (γ-Cyclodextrin-trifluoroacetyl, Chiraldex, 30 m × 0.25 mm, 
60 kPa H2, 95 °C, 32 min, 5.0 K/min, 160 °C, 5 min): tR = 17.5 min. The NMR spectra 
were consistent with the literature data.[70] 
O
C10H8O
144.17 g/mol
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3-(4-Methoxyphenyl)furan (41b) 
Compound 41b was synthesized following the procedure described for 
the synthesis of 3-phenylfuran (41a) using Ni(dppe)Cl2 (23.1 mg, 
0.04 mmol, 0.94 mol%), 3-bromofuran (647 mg, 4.27 mmol, 1.00 eq.) in 
THF (30 mL) and 4-methoxyphenylmagnesium bromide (1.0 M in THF, 
4.80 mL, 4.80 mmol, 1.12 eq.). The obtained orange crystals were purified 
first by bulb to bulb distillation (1.0 torr, 170 °C) and subsequent flash chromatography 
(silica gel, 40×4 cm, npentane:EtOAc, 50:1) to give the title compound 41b as colorless 
crystals (570 mg, 3.27 mmol, 77%). 
m.p. 107–108 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.66 (dd, 4JHH = 1.4, 
1.1 Hz, 1H, OCH), 7.46 (t, 3JHH = 1.7 Hz, 1H, OCHCH), 7.41 (t, 3JHH = 8.9 Hz, 2H, HCar), 
6.92 (d, 3JHH = 8.8 Hz, 2H, HCar), 6.66 (dd, 3,4JHH = 1.8, 0.9 Hz, 1H, OCHCH), 3.83 (s, 3H, 
CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 158.9 (Car), 143.6 (OCHCH), 
137.8 (OCH), 127.2 (2 HCar), 126.2 (Cq), 125.2 (Cq), 114.4 (2 HCar), 109.0 (OCHCH), 55.5 
(CH3); GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 9.8 min), 
m/z (%) 174 (M+, 100), 159 (80), 131 (48), 103 (12), 102 (18), 77 (31), 76 (10), 63 (10), 51 
(13); IR (ν~ [cm−1]) 3145w, 3125w, 3020w, 2964w, 2839w, 2051w, 1700w, 1611w, 1585m, 
1571m, 1517s, 1500w, 1492w, 1466w, 1452w, 1443w, 1428w, 1419w, 1360w, 1310m, 
1296s, 1246s, 1236s, 1182m, 1158s, 1112m, 1097w, 1051w, 1024s, 1016s, 922m, 874s, 834s, 
782s, 737m, 730m, 721m, 695w, 636m; EA: calculated for C10H8O: C = 75.85, H = 5.79; 
measured: C = 75.83, H = 6.03; Rf = 0.18 (silica gel, npentane:EtOAc, 50:1); 
GC (γ-Cyclodextrin-trifluoroacetyl, Chiraldex, 30 m × 0.25 mm, 80 kPa H2, 95 min, 
30 min, 5.0 K/min, 160 °C, 10 min): tR = 41.0 min. The NMR spectra were consistent 
with the literature data.[70] 
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3-(4-Trifluoromethyl)phenyl)furan (41c) 
Compound 41c was synthesized following the procedure described for 
the synthesis of 3-phenylfuran (41a). The Grignard reagent was freshly 
prepared from magnesium (117 mg, 4.81 mmol, 1.11 eq.) and 
4-bromobenzotrifluoride (0.62 mL, 4.35 mmol, 1.00 eq.) in Et2O (5 mL). 
The solution was added to Ni(dppe)Cl2 (30.2 mg, 0.06 mmol, 1.22 mol%) 
and 3-bromofuran (0.44 mL, 4.70 mmol, 1.08 eq.) in Et2O (15 mL). The obtained dark 
red crystals were purified first by bulb to bulb distillation (0.2 torr, 150 °C) and 
subsequent flash chromatography (silica gel, 40×4 cm, npentane) to give the title 
compound as colorless crystals (682 mg, 3.22 mmol, 52%). 
m.p. 55–56 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.80 (sbr, 1H, OCH), 7.63 
(d, 3JHH = 8.2 Hz, 2H, HCar), 7.58 (d, 3JHH = 8.2 Hz, 2H, HCar), 7.51 (t, 3JHH = 1.5 Hz, 1H, 
OCHCH), 6.73 (dd, 3,4JHH = 1.9, 0.9 Hz, 1H, OCHCH); 13C{1H}-NMR (100.6 MHz, CDCl3, 
300 K): δ (ppm) 144.3 (OCHCH), 139.5 (OCH), 136.2 (Cfuran), 129.1 (q, 2JCF = 33 Hz, Car), 
126.1 (2 HCar), 125.9 (q, 3JCF = 3.8 Hz, 2 HCar), 125.5 (Car), 124.3 (q, 1JCF = 271 Hz, CF3), 
108.8 (OCHCH); 19F{1H}-NMR (376.5 MHz, CDCl3, 300 K): δ (ppm) −62.7 (CF3); GC-MS 
(EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 6.3 min), m/z (%) 212 
(M+, 100), 193 (13), 183 (34), 164 (13), 133 (22), 115 (55), 63 (11); IR (ν~ [cm−1]) 3167w, 
3132w, 2358w, 2323w, 1696w, 1617m, 1594w, 1523w, 1497w, 1421w, 1318s, 1291m, 
1238w, 1230m, 1177w, 1161s, 1123s, 1108s, 1102s, 1067s, 1053s, 1016s, 1010m, 957w, 
922w, 872m, 844s, 789s, 773m, 741m, 731m; EA: calculated for C11H7F3O: C = 62.27, H = 
3.33; measured: C = 61.94, H = 3.39; Rf = 0.22 (silica gel, npentane); GC (γ-Cyclodextrin-
trifluoroacetyl, Chiraldex, 30 m × 0.25 mm, 60 kPa H2, 95 min, 32 min, 5.0 K/min, 160 °C, 
5 min): tR = 21.3 min. The NMR spectra were consistent with the literature data.[70] 
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3-Octylfuran (64) 
Compound 64 was synthesized following the procedure described for the 
synthesis of 3-phenylfuran (41a). The Grignard reagent was freshly 
prepared from magnesium (629 mg, 25.9 mmol, 1.20 eq.) and 
1-bromooctane (4.40 mL, 24.8 mmol, 1.15 eq.) in Et2O (10 mL). The solution 
was added to 3-bromofuran (2.00 mL, 21.6 mmol, 1.00 eq.) and Ni(dppe)Cl2 (139 mg, 
0.26 mmol, 1.22 mol) in Et2O (30 mL). The brown oil was purified by flash 
chromatography (silica gel, 40×4 cm, npentane) and bulb to bulb distillation (0.3 torr, 
60 °C), yielding the product as a pale yellow oil (537 mg, 2.98 mmol, 14%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.34 (t, 3JHH = 1.7 Hz, 1H, OCHCH), 7.20 
(dq, 4JHH = 1.9, 1.0 Hz, 1H, OCH), 6.27 (dd, 3,4JHH = 1.9, 0.9 Hz, 1H, OCHCH), 2.40 (t, 
3JHH = 7.5 Hz, 2H, CH2), 1.55 (mc, 2H, CH2), 1.31 (m, 10H, CH2), 0.89 (t, 3JHH = 6.9 Hz, 3H, 
CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 142.7 (OCHCH), 138.9 (OCH), 
125.5 (Cfuran), 111.2 (OCHCH), 32.0 (CH2), 30.2 (CH2), 29.6 (CH2), 29.5 (CH2), 29.4 (CH2), 
24.9 (CH2), 22.8 (CH2), 14.3 (CH3); GC-MS (EI, 70 eV, Me2Si, 60 °C, 2 min, 10 °C/min, 
270 °C, 10 min, tR = 11.4 min), m/z (%) 180 (M+, 13), 95 (28), 82 (100), 81 (52), 53 (18), 41 
(21); IR (ν~ [cm−1]) 2955m, 2924s, 2854s, 1502w, 1466w, 1379w, 1161w, 1065w, 1026w, 
874s, 777s, 721w; EA: calculated for C12H20O: C = 79.94, H = 11.18; measured: C = 79.28, 
H = 10.99; Rf = 0.39 (silica gel, npentane); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, 
MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 95 °C, 50 min, 0.1 °C/min, 96 °C, 0 min, 
10 °C/min, 180 °C, 10 min): tR = 24.4 min. The NMR spectra were consistent with the 
literature data.[71] 
3-Cyclohexylfuran (65) 
Compound 65 was synthesized following the procedure described for the 
synthesis of 3-phenylfuran (41a). The Grignard reagent was freshly 
prepared from magnesium (204 mg, 8.41 mmol, 1.81 eq.) and 
cyclohexylbromide (1.03 mL, 8.25 mmol, 1.77 eq.) in Et2O (5 mL). The 
solution was added to Ni(dppe)Cl2 (28.8 mg, 0.05 mmol, 1.17 mol%) and 
3-bromofuran (0.43 mL, 4.65 mmol, 1.00 eq.) in Et2O (15 mL). The obtained dark red 
crystals were purified first by bulb to bulb distillation (0.2 torr, 25 °C) and subsequent 
flash chromatography (silica gel, 30×2 cm, npentane) to give the title compound as 
colorless oil (276 mg, 1.84 mmol, 40%). 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.34 (t, 3JHH = 1.6 Hz, 1H, OCH), 7.19 (d, 
4JHH = 0.7 Hz, 1H, OCHCH), 6.30 (d, 4JHH = 0.8 Hz, 1H, OCHCH), 2.42 (tt, 2,3JHH = 11.0, 
3.6 Hz, 1H, CH), 1.93 (d, 2JHH = 11.6 Hz, 2H, CH2), 1.82–1.67 (m, 3H, CH2), 1.42–1.17 (m, 
5H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 142.6 (OCHCH), 137.7 
(OCH), 131.5 (Cfuran), 109.8 (OCHCH), 34.7 (CH), 33.8 (2 CH2), 26.5 (2 CH2), 26.3 (CH2); 
GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 5.2 min), m/z 
(%) 150 (M+, 58), 121 (22), 109 (14), 108 (24), 107 (42), 95 (52), 94 (55), 93 (14), 91 (23), 82 
(100), 81 (50), 79 (61), 78 (10), 77 (48), 67 (19), 66 (16), 65 (26), 55 (11), 53 (28), 51 (20), 41 
(33); IR (ν~ [cm−1]) 2922w, 2851m, 2666w, 2365w, 2323w, 1700w, 1560w, 1500w, 1447w, 
1385w, 1358w, 1300w, 1259w, 1245w, 1213w, 1178w, 1160m, 1067w, 1030m, 1010w, 
963w, 890w, 874s, 777s, 735s, 721w; EA: calculated for C10H14O: C = 79.96, H = 9.39; 
measured: C = 79.56, H = 9.54; Rf = 0.37 (silica gel, npentane); GC (6-Methyl-2,3-pentyl-
γ-cyclodextrin (60% in polysiloxane PS086), 30 m × 0.25 mm × 0.125 μm, 60 kPa H2, 
60 min, 30 min, 1.0 K/min, 100 °C, 5 min, 10.0 K/min, 180 °C, 5 min): tR = 41.2 min. The 
NMR spectra were consistent with the literature data.[72] 
2-Phenylfuran (44a) 
Following a modified procedure of NEGISHI et al.,[27] in a 100 mL 
three-necked flask furan (0.59 mL, 8.03 mmol, 1.20 eq.) was dissolved in 
dry THF (10 mL) under argon and cooled to −78 °C. At this temperature 
nBuLi (1.6 M in hexanes, 10.0 mL, 16.0 mmol, 2.40 eq.) was added via 
syringe over a period of 10 min. The reaction mixture was stirred at this temperature 
for additional hour and another hour at room temperature. In a 25 mL Schlenk tube 
ZnCl2 (1.35 g, 9.69 mmol, 1.45 eq.) was dried by heating under vacuum. After cooling 
down to room temperature, zinc chloride was dissolved in 5 mL THF and the lithiated 
furan in Et2O was added and stirred for one hour at room temperature. In a 250 mL 
three-necked flask Pd(PPh3)4 (86.0 mg, 0.07 mmol, 1.11 mol%) was dissolved in THF 
(20 mL) and iodobenzene (0.75 mL, 6.66 mmol, 1.00 eq.) was added. Then the zinc 
chloride solution was added and the resulting mixture stirred at room temperature for 
21 h. The reaction mixture was poured in a separation funnel onto ice cold aqueous 
3 M HCl (20 mL) and Et2O (20 mL). The phases were separated and the aqueous phase 
was extracted with Et2O (3×50 mL). The combined organic phases were washed with 
aqueous saturated NaHCO3 solution (75 mL) and with brine (75 mL), dried over 
MgSO4 and the solvent was removed under reduced pressure. The crude material was 
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purified by flash chromatography (silica gel, 25×4 cm, npentane) yielding the product 
44a as a colorless oil (123 mg, 0.78 mmol, 12%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.66–7.68 (m, 2H, HCar), 7.46 (m, 1H, 
OCH), 7.36–7.40 (m, 2H, HCar), 7.23–7.27 (m, 1H, HCar), 6.65 (d, 3JHH = 3.3 Hz, 1H, 
OCHCHCH), 6.47 (dd, 3JHH = 3.3, 1.8 Hz, 1H, OCHCH); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 154.2 (Cfuran), 142.2 (OCH), 131.0 (Car), 128.8 (2 HCar), 127.5 
(HCar), 123.9 (2 HCar), 111.8 (OCHCHCH), 105.1 (OCHCH); GC-MS (EI, 70 eV, 5% 
polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min, 
tR = 7.0 min), m/z (%) 144 (M+, 100), 116 (24), 115 (93), 89 (11); IR (ν~ [cm−1]) 3063w, 3026w, 
1769w, 1726w, 1683m, 1597w, 1506m, 1476m, 1447m, 1279w, 1218m, 1256m, 1068m, 
1023m, 1009s, 903s, 885m, 805w, 758s, 735s, 691s, 680m, 664s, 593m, 518s, 511s, 502s; 
Rf = 0.17 (silica gel, npentane); HPLC (IC, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 
220 nm): tR = 7.9 min, enantiomers: tR1 = 19.8 min, tR2 = 23.2 min. The NMR spectra were 
consistent with the literature data.[73] 
2-(4-Methoxyphenyl)furan (44b) 
Compound 44b was synthesized following the procedure described 
for the synthesis of 2-phenylfuran (44a) using furan (0.59 mL, 
8.03 mmol, 1.20 eq.), nBuLi (1.6 M in hexanes, 10.0 mL, 16.0 mmol, 
2.38 eq.), ZnCl2 (1.15 g, 8.28 mmol, 1.23 eq.), Pd(PPh3)4 (84.0 mg, 
0.07 mmol, 1.07 mol%) and 4-iodoanisole (1.60 mL, 6.70 mmol, 1.00 eq.). The crude 
material was purified by flash chromatography (silica gel, 27×4 cm, 
cyclohexane:EtOAc, 20:1) and bulb to bulb distillation (0.2 torr, 100 °C) yielding 44b as 
a colorless solid (167 mg, 0.96 mmol, 14%). 
m.p. 51–53 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.61 (d, 3JHH = 8.9 Hz, 2H, 
HCar), 7.43 (dd, 3,4JHH = 1.8, 0.7 Hz, 1H, OCH), 6.92 (d, 3JHH = 8.9 Hz, 2H, HCar), 6.52 (dd, 
3,4JHH = 3.3, 0.7 Hz, 1H, OCHCHCH), 6.45 (dd, 3JHH = 3.3, 1.8 Hz, 1H, OCHCH), 3.84 (s, 
3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 159.1 (CarOCH3), 154.2 
(Cfuran), 141.5 (OCH), 125.4 (2 HCar), 124.2 (Car), 114.3 (2 HCar), 111.7 (OCHCHCH), 103.5 
(OCHCH), 55.5 (OCH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 
100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 12.0 min), m/z (%) 174 (M+, 100), 159 (81), 
145 (11), 131 (36), 103 (15), 102 (12), 77 (18); IR (ν~ [cm−1]) 3119w, 3005w, 2961w, 2936w, 
2835w, 1610m, 1585m, 1570m, 1508m, 1481m, 1466m, 1441m, 1300m, 1242m, 1178m, 
O
OMe
C11H10O2
174.20 g/mol
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1005s, 1013s, 903m, 833s, 793s, 729s, 665m, 596s; Rf = 0.33 (silica gel, 
cyclohexane:EtOAc, 20:1). The NMR spectra were consistent with the literature data.[74] 
2-(4-Trifluoromethyl)phenylfuran (44c) 
Compound 44c was synthesized following the procedure described 
for the synthesis of 2-phenylfuran (44a) using furan (0.59 mL, 
8.03 mmol, 1.19 eq.), nBuLi (1.6 M in hexanes, 10.0 mL, 16.0 mmol, 
2.38 eq.), ZnCl2 (1.15 g, 8.28 mmol, 1.23 eq.), Pd(PPh3)4 (78.5 mg, 
0.07 mmol, 1.00 mol%) and 4-bromobenzotrifluoride (0.94 mL, 6.72 mmol, 1.00 eq.). 
The crude material was purified by flash chromatography (silica gel, 27×4 cm, 
npentane, material immobilized on silica gel) yielding the product as a colorless solid 
(534 mg, 2.52 mmol, 37%). 
m.p. 82–83 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.77 (d, 3JHH = 8.1 Hz, 2H, 
HCar), 7.63 (d, 3JHH = 8.2 Hz, 2H, HCar), 7.52 (d, 3JHH = 1.3 Hz, 1H, OCH), 6.77 (d, 
3JHH = 3.4 Hz, 1H, OCHCHCH), 6.51 (dd, 3JHH = 3.4, 1.8 Hz, 1H, OCHCH); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 152.7 (Cfuran), 143.2 (OCH), 134.1 (Car), 129.1 (q, 
2JCF = 32.4 Hz, Car), 127.8 (Car), 125.9 (q, 3JCF = 3.8 Hz, 2 HCar), 124.3 (q, 1JCF = 272 Hz, CF3), 
123.9 (2 HCar), 112.1 (OCHCHCH), 107.1 (OCHCH); 19F{1H}-NMR (376.5 MHz, CDCl3, 
300 K): δ (ppm) −62.5 (CF3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 
100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 7.2 min), m/z (%) 212 (M+, 100), 183 (47), 
133 (17), 115 (55), 81 (10); IR (ν~ [cm−1]) 2362w, 1617m, 1480m, 1419m, 1321s, 1285m, 
1154w, 1109s, 1069s, 1010s, 903m, 884m, 846s, 809s, 745s; Rf = 0.30 (silica gel, npentane); 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 
30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min): 
tR = 12.3 min; HPLC (IC, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 220 nm): tR = 7.3 min.  
The NMR spectra were consistent with the literature data.[74] 
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2-Cyclohexylfuran (66) 
Following a modified procedure of POLITIS et al.,[36] freshly pestled 
magnesium (316 mg, 13.0 mmol, 2.62 eq.) was added with a grain of 
iodine in a 50 mL three-necked flask equipped with a dropping funnel 
and a reflux condenser, in dry Et2O (1 mL). Iodocyclohexane (1.60 mL, 
12.1 mmol, 2.44 eq.) in Et2O (5 mL) was added over a period of 30 min. The flask was 
rinsed with Et2O (5 mL) and the mixture was refluxed for one hour. In a 100 mL three-
necked flask equipped with a thermometer, Ni(dppe)Cl2 (68.4 mg, 0.13 mmol, 
2.61 mol%) and 2-bromofuran (0.46 mL, 4.96 mmol, 1.00 eq.) were dissolved in Et2O 
(15 mL) and the resulting solution was cooled to −2 °C. Over a period of 10 min the 
freshly prepared Grignard compound was added. After complete addition the 
reaction mixture was refluxed for 22 hours. It was quenched carefully with an aqueous 
5% HCl solution (40 mL) and the flask was rinsed with Et2O (20 mL). The phases were 
separated, the aqueous phase was extracted with Et2O (50 mL), the organic phases 
were washed with water (2×40 mL), dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The crude material was purified by flash 
chromatography (silica gel, 22×4 cm, npentane) yielding the product 66 as a colorless 
oil (558 mg, 3.71 mmol, 75%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.29 (d, 3JHH = 1.1 Hz, 1H, OCH), 6.27 (dd, 
3JHH = 3.1, 1.9 Hz, 1H, OCHCH), 5.94 (d, 3JHH = 3.1 Hz, 1H, OCHCHCH), 2.66–2.56 (m, 
1H, CH2), 2.07–1.95 (m, 2H, CH2), 1.85–1.65 (m, 3H, CH2), 1.43–1.20 (m, 5H, CH2); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 161.2 (Cfuran), 140.5 (OCH), 110.0 
(OCHCH), 102.7 (OCHCHCH), 37.4 (CH), 31.7 (2 CH2), 26.3 (CH2), 26.1 (2 CH2); GC-MS 
(EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 250 °C, 
10 min, tR = 5.5 min), m/z (%) 150 (M+, 44), 135 (10), 121 (13), 108 (13), 107 (100), 94 (56), 
81 (27), 79 (21), 77 (11); IR (ν~ [cm−1]) 2926m, 2853w, 1589w, 1448w, 1011w, 934w, 881w, 
795w, 723s, 598m; EA: calculated for C10H14O: C = 79.96, H = 9.39; measured: C = 79.51, 
H = 9.25; Rf = 0.36 (silica gel, npentane); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, 
MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 60 °C, 1 °C/min, 120 °C, 10 °C/min, 180 °C, 
10 min): tR = 27.8 min. The NMR spectra were consistent with the literature data.[75] 
O
C10H14O
150.22 g/mol
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2-Octylfuran (71) 
In a 100 mL three-necked flask equipped with a thermometer, nBuLi (1.6 M 
in hexanes, 19.0 mL, 30.4 mmol, 1.02 eq.) was dissolved in dry THF (20 mL) 
and cooled to −15 °C. The furan (2.20 mL, 29.9 mmol, 1.00 eq.) was added 
dropwise over a period of 5 min. The reaction mixture was stirred for additional 10 min 
at −15 °C, was then allowed to warm up to room temperature and stirred for 1 d. To 
the orange mixture 1-bromooctane (5.91 g, 30.0 mmol, 1.00 eq.) was added dropwise 
over a period of 10 min. The mixture was stirred for 1 d and quenched with ice. After 
separating the phases, the aqueous phase was extracted with Et2O (3×50 mL). The 
combined organic phases were washed with aqueous saturated NaHSO3 solution 
(40 mL), dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. The yellow oil was purified first by flash chromatography (silica gel, 
27×4 cm, npentane) and subsequent bulb to bulb distillation (0.3 torr, 65 °C), yielding 
the product 71 as a colorless oil (437 mg, 2.42 mmol, 8%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.29 (dd, 3,4JHH = 1.8, 0.7 Hz, 1H, OCH), 
6.27 (dd, 3JHH = 3.1, 1.9 Hz, 1H, OCHCH), 5.97 (dd, 3,4JHH = 3.1, 0.8 Hz, 1H, OC18H17CH), 
2.61 (t, 3JHH = 7.6 Hz, 2H, CH2), 1.63 (mc, 2H, CH2CH2), 1.39–1.21 (m, 10H, CH2), 0.88 (t, 
3JHH = 6.9 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 156.8 (Cfuran), 
140.8 (OCH), 110.2 (OCHCH), 104.7 (OC(C8H17)CH), 32.0 (CH2), 29.5 (CH2), 29.4 (CH2), 
29.4 (CH2), 28.2 (CH2), 28.1 (CH2), 22.8 (CH2), 14.3 (CH3); GC-MS (EI, 70 eV, Me2Si, 
60 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 7.9 min), m/z (%) 180 (M+, 14), 95 (25), 82 
(31), 81 (100), 53 (19), 41 (20); IR (ν~ [cm−1]) 2951m, 2923s, 2853m, 1507m, 1465w, 1147w, 
1074w, 1006w, 885w, 722s, 668s; EA: calculated for C12H20O: C = 79.94, H = 11.18; 
measured: C = 79.88, H = 11.02; Rf = 0.45 (silica gel, npentane); GC (β-Cyclodextrin, 
Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 95 °C, 45 min, 
10 °C/min, 180 °C, 10 min): tR = 20.2 min. The NMR spectra were consistent with the 
literature data.[76] 
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2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran (77) 
Following a modified procedure of EARL et al.,[77] in a 100 mL 
three-necked flask equipped with a thermometer and a reflux 
condenser, pTsOH∙H2O (2.30 g, 0.01 mmol, 0.002 mol%) was added to 
3,4-dihydro-2Hpyran (45.9 g, 0.53 mol, 1.06 eq.) and heated to 60 °C. 
Propargyl alcohol (28.3 g, 0.50 mol, 1.00 eq.) was added via dropping funnel over a 
period of 35 min, while the inner temperature was kept at 60-65 °C. After complete 
addition, the reaction mixture was stirred at 60 °C for two more hours. Finally the 
mixture was neutralized with solid Na2CO3 (850 mg) and stirred for one hour at room 
temperature. The pale yellow mixture was filtered and distilled (1.0 torr, 54–57 °C) to 
give the product as a colorless oil (65.8 g, 0.47 mol, 94%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 4.81 (t, 3JHH = 3.4 Hz, 1H, CH), 4.25 (dq, 
2,4JHH = 16.0, 2.4 Hz, 2H, CH2), 3.83 (mc, 1H, CH2), 3.55–3.50 (m, 1H, CH2), 2.40 (t, 
4JHH = 2.4 Hz, 1H, CH), 1.88–1.69 (m, 2H, CH2), 1.66–1.47 (m, 4H, CH2); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 97.0 (HC), 79.9 (Cq), 74.1 (HC), 62.1 (CH2), 54.1 
(CH2), 30.3 (CH2), 25.5 (CH2), 19.1 (CH2); GC-MS (EI, 70 eV, Me2Si, 80 °C, 2 min, 
10 °C/min, 270 °C, 10 min, tR = 4.9 min), m/z (%) 139 (11), 85 (100), 83 (13), 82 (15), 81 
(12), 69 (12), 67 (14), 57 (36), 56 (47), 55 (50), 54 (16), 53 (23), 43 (23), 42 (16), 41 (79);  
IR (ν~ [cm−1]) 3286w, 2942m, 2927m, 2879w, 2852w, 1454w, 1441w, 1390w, 1345w, 
1264w, 1202m, 1183w, 1119s, 1079m, 1057m, 1023s, 975w, 947m, 901s, 870s, 816m, 
621m, 607m, 602w, 509s, 506s; Rf = 0.43 (silica gel, cyclohexane:EtOAc, 10:1). The NMR 
spectra were consistent with the literature data.[77] 
1-Phenyl-4-((tetrahydro-2H-pyran-2-yl)oxy)but-2-yn-1-ol (77a) 
Following a modified procedure of OBRECHT et al.,[37] in a 100 mL 
three-necked flask 2-(prop-2-yn-1-yloxy)tetrahydro-2H-pyran 
(1.57 g, 11.2 mmol, 1.00 eq.) was dissolved in THF (30 mL) and 
cooled to −78 °C. Then nBuLi (1.6 M in hexanes, 7.70 mL, 
12.3 mmol, 1.10 eq.) was added dropwise over a period of 
15 min. After the addition was completed, the pale yellow reaction mixture was 
warmed to −30 °C and stirred for 30 min at this temperature. Then, benzaldehyde 
(1.36 g, 12.7 mmol, 1.13 eq.) was added at −78 °C and the resulting reaction mixture 
was stirred for 30 min. Finally the mixture was warmed to 0 °C, stirred for 30 min and 
transferred to a separation funnel containing a mixture of Et2O (50 mL), aqueous 
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saturated NH4Cl solution (30 mL) and ice. After phase separation, the aqueous phase 
was extracted with EtOAc (2×50 mL). The combined organic phases were washed with 
brine (2×50 mL), dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The yellow oil was purified by flash chromatography (silica gel, 
40×4 cm, cyclohexane:EtOAc, 5:1) to give the product as a yellow oil (2.67 g, 10.8 mmol, 
96%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.54 (d, 3JHH = 6.9 Hz, 2H, HCar), 7.40–7.31 
(m, 3H, 3 HCar), 5.52 (dt, 3,4JHH = 6.2, 1.8 Hz, 1H, CH), 4.82 (t, 3JHH = 3.4 Hz, 1H, CH), 4.36 
(qt, 2,4JHH = 16.0, 1.7 Hz, 2H, CH2), 3.84 (mc, 1H, CH2), 3.55–3.50 (m, 1H, CH2), 2.33 (d, 
3JHH = 6.1 Hz, 1H, OH), 1.89–1.69 (m, 2H, CH2), 1.67–1.48 (m, 4H, CH2); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 140.5 (Car), 128.8 (2 HCar), 128.6 
(HCar), 126.8 (2 HCar), 97.0 (CH), 85.8 (Cq), 82.9 (Cq), 64.8 (CH), 62.2 (CH2), 54.5 (CH2), 
30.4 (CH2), 25.5 (CH2), 19.2 (CH2); MS (FAB), m/z (%) 229 (14), 145 (37), 128 (10), 117 
(19), 85 (100); IR (ν~[cm−1]) 3403w, 2944m, 2870w, 2852w, 2228m, 1716m, 1643s, 1597s, 
1580s, 1450s, 1443m, 1391w, 1353w, 1313s, 1259s, 1202m, 1176m, 1102s, 1070m, 1057m, 
1031s, 1023s, 955m, 901s, 872m, 815m; EA: calculated for C15H18O3: C = 73.15, H = 7.37; 
measured: C = 72.34, H = 7.59; Rf = 0.40 (silica gel, cyclohexane:EtOAc, 1:1). The NMR 
spectra were consistent with the literature data.[78] 
1-Phenyl-4-((tetrahydro-2H-pyran-2-yl)oxy)but-2-yn-1-one (77b) 
Following a modified procedure of OBRECHT et al.,[37] in a 250 mL 
two-necked flask 1-phenyl-4-((tetrahydro-2H-pyran-2-yl)oxy)-
but-2-yn-1-ol (1.60 g, 6.51 mmol, 1.00 eq.) was dissolved in 
CH2Cl2 (100 mL) and MnO2 (6.61 g, 66.9 mol, 10.3 eq.) was 
added. The suspension was stirred at room temperature for five 
hours and then filtered over a pad of celite. After removing the solvent under reduced 
pressure, the crude product was filtered over a pad of silica gel (1×5 cm) and washed 
with cyclohexane:EtOAc (10:1). The solvent was removed and the product was 
obtained as a yellow oil (1.54 g, 6.31 mmol, 97%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 8.14 (d, 3JHH = 7.1 Hz, 2H, HCar), 7.62 (tt, 
3,4JHH = 7.4, 1.5 Hz, 1H, HCar), 7.50 (t, 3JHH = 7.7 Hz, 2H, HCar), 4.90 (t, 3JHH = 3.4 Hz, 1H, 
CH), 4.55 (s, 2H, CH2), 3.88 (mc, 1H, CH2), 3.60–3.55 (m, 1H, CH2), 1.91–1.74 (m, 2H, 
CH2), 1.72–1.50 (m, 4H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 177.7 
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(C=O), 136.6 (Car), 134.4 (HCar), 129.8 (2 HCar), 128.7 (2 HCar), 97.5 (CH), 90.6 (Cq), 83.7 
(Cq), 62.3 (CH2), 54.2 (CH2), 30.3 (CH2), 25.4 (CH2), 19.1 (CH2); GC-MS (EI, 70 eV, Me2Si, 
100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 16.4 min), m/z (%) 159 (14), 144 (55), 131 
(15), 116 (15), 115 (100), 114 (13), 105 (32), 89 (14), 85 (15), 77 (46), 66 (22), 63 (10), 55 
(19), 53 (11), 51 (32), 50 (16), 41 (34); IR (ν~ [cm−1]) 2942m, 2869w, 2851w, 2360w, 2228m, 
1723w, 1643s, 1597s, 1581s, 1449s, 1390w, 1344m, 1313s, 1260s, 1202s, 1175m, 1120s, 
1099m, 1027s, 901s; Rf = 0.15 (silica gel, cyclohexane:EtOAc, 10:1). The NMR spectra 
were consistent with the literature data.[78] 
4-Hydroxy-1-phenylbut-2-yn-1-one (78) 
Following a modified procedure of OBRECHT et al.,[37] in a 100 mL 
three-necked flask equipped with a reflux condenser, 1-phenyl-4-
((tetrahydro-2H-pyran-2-yl)oxy)but-2-yn-1-one (1.54 g, 6.31 mmol, 
1.00 eq.) was dissolved in EtOH (30 mL) and PPTS[79] (323 mg, 
1.29 mol, 20.4 mol%) was added. The reaction mixture was stirred at 60 °C for two 
hours and then quenched with water (60 mL). After separation of the phases, the 
aqueous phase was extracted with EtOAc (2×60 mL) and the combined organic phases 
were washed with brine (2×60 mL). The organic phase was dried over MgSO4, filtered 
and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (silica gel, cyclohexane:EtOAc, 10:1) to give the product as a 
brown oil (827 mg, 5.16 mmol, 82%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 8.14 (d, 3JHH = 7.1 Hz, 2H, HCar), 7.62 (tt, 
2,3JHH = 7.4, 1.5 Hz, 1H, HCar), 7.49 (t, 3JHH = 7.7 Hz, 2H, HCar), 4.57 (sbr, 2H, CH2), 2.19 (sbr, 
1H, OH); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 177.8 (C=O), 136.4 (Car), 
134.5 (HCar), 129.8 (2 HCar), 128.8 (2 HCar), 92.2 (Cq), 83.5 (Cq), 51.2 (CH2); GC-MS (EI, 
70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 11.9 min), m/z (%) 160 (M+, 
45), 131 (74), 104 (38), 77 (100), 51 (83), 50 (50); IR (ν~ [cm−1]) 3403w, 3061w, 2908w, 
2857w, 2464w, 2230w, 1775w, 1639s, 1595s, 1579s, 1448s, 1312s, 1260s, 1175m, 1102m, 
1095m, 1069m, 1023s, 1000m, 900m, 796w, 762w, 732m; Rf = 0.39 (silica gel, 
cyclohexane:EtOAc, 1:1). The NMR spectra were consistent with the literature data.[37] 
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4-Bromo-2-phenylfuran (75) 
Following a modified procedure of OBRECHT et al.,[37] in a 100 mL three-
necked flask equipped with a thermometer and a reflux condenser, 
4-hydroxy-1-phenylbut-2-yn-1-one (827 mg, 5.16 mmol, 1.00 eq.) was 
dissolved in dry toluene (60 mL) and 48% aqueous HBr solution 
(10.0 mL, 88.4 mmol, 17.1 eq.) was added dropwise. The reaction mixture was heated 
to 50 °C and stirred for three hours. After cooling to room temperature, it was diluted 
with EtOAc (200 mL) and poured onto ice. After separation of the phases, the aqueous 
phase was extracted with EtOAc (2×100 mL) and the combined organic phases were 
washed with brine (100 mL). The organic phase was dried over MgSO4, filtered and 
the solvent was removed under reduced pressure. The crude product was purified by 
flash chromatography (silica gel, 40×4 cm, npentane) to give the product as colorless 
crystals (417 mg, 1.87 mmol, 36%). 
m.p. 43–44 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.64–7.61 (m, 2H, HCar), 
7.47 (d, 4JHH = 0.8 Hz, 1H, OCH), 7.42–7.37 (m, 2H, HCar), 7.30 (tt, 3,4JHH = 7.4, 1.5 Hz, 1H, 
HCar), 6.69 (d, 4JHH = 0.8 Hz, 1H, OCCH); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 154.9 (OC(C6H5)), 140.3 (OCH), 129.9 (Car), 128.9 (2 HCar), 128.3 (HCar), 124.0 
(2 HCar), 108.4 (OCCH), 101.6 (CBr); GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 
270 °C, 10 min, tR = 10.0 min), m/z (%) 224, 222 (M+, 61), 143 (16), 116 (11), 115 (100), 114 
(22), 113 (12), 89 (12), 77 (14), 63 (16), 62 (10), 51 (16), 50 (11); IR (ν~ [cm−1]) 3146w, 3114w, 
3075w, 3035w, 2360w, 2344w, 1971w, 1895w, 1773w, 1709w, 1608w, 1585m, 1568m, 
1515m, 1476m, 1445m, 1350m, 1309w, 1284w, 1275m, 1202m, 1179w, 1145m, 1121m, 
1070m, 1034m, 1015m, 1000w, 979w, 924s, 907s, 799m, 757s; Rf = 0.25 (silica gel, 
npentane). The NMR spectra were consistent with the literature data.[37] 
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2,4-Diphenylfuran (79) 
Compound 79 was synthesized following the procedure described 
for the synthesis of 3-phenylfuran (41a) using Ni(dppe)Cl2 (24.3 mg, 
0.05 mmol, 2.96 mol%), 4-bromo-2-phenylfuran (347 g, 1.55 mmol, 
1.00 eq.) and phenylmagnesium bromide (1.0 M in THF, 1.71 mL, 
1.71 mmol, 1.10 eq.). The crude crystals were purified by flash 
chromatography (silica gel, 40×4 cm, cyclohexane:EtOAc, 20:1) and subsequent bulb to 
bulb distillation (0.2 torr, 160 °C) to give the product as colorless crystals (84.2 mg, 
0.38 mmol, 25%). 
m.p. 108–109 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.76 (d, 4JHH = 0.8 Hz, 
1H, OCH), 7.74–7.72 (m, 2H, HCar), 7.56–7.53 (m, 2H, HCar), 7.44–7.39 (m, 4H, HCar), 
7.31–7.27 (m, 2H, HCar), 6.97 (d, 4JHH = 0.9 Hz, 1H, OCCH); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 155.0 (OC(C6H5)), 138.0 (OCH), 132.5 (Car), 130.8 (Car), 129.0 
(2 HCar), 128.9 (2 HCar), 128.5 (OCHC), 127.7 (HCar), 127.3 (HCar), 126.0 (2 HCar), 124.0 
(2 HCar), 104.1 (OCCH); MS (EI), m/z (%) 220 (M+, 100), 192 (20), 191 (81), 190 (14), 189 
(36), 165 (28), 63 (10); IR (ν~ [cm−1]) 3035w, 2357m, 2342m, 1962w, 1946w, 1886w, 1743w, 
1609m, 1538m, 1488m, 1452s, 1445m, 1363m, 1199m, 1185w, 1146m, 1102w, 1074m, 
1059m, 1016s, 999m, 966m, 930s, 912s, 906s, 891m, 872m, 853w; Rf = 0.41 (silica gel, 
cyclohexane:EtOAc, 20:1); GC (6-Methyl-2,3-pentyl-γ-cyclodextrin, (60% in 
polysiloxane PS086), 30 m × 0.25 mm × 0.125 μm, 60 kPa H2, 95 °C, 30 min, 5.0 K/min, 
180 °C, 30 min): tR = 65.4 min. 
2-Methyl-2-(2-phenylethynyl)oxirane (83) 
Following a modified procedure of LIGHTBURN et al.,[38b] in a 50 mL 
three-necked flask equipped with a thermometer phenyl acetylene 
(1.10 mL, 9.82 mmol, 1.00 eq.) was dissolved under argon in dry THF 
(25 mL) and cooled to −30° C. At this temperature nBuLi (1.6 M in 
hexanes, 6.60 mL, 10.6 mmol, 1.08 eq.) was added dropwise over a period of 30 min 
and the reaction mixture was then cooled to −78° C. Chloroacetone (0.85 mL, 
10.2 mmol, 1.04 eq.) was added to the yellow solution over a period of 10 min, the 
cooling bath was removed and the dark red mixture was stirred at room temperature 
for 1 d. The reaction mixture was quenched with aqueous saturated NH4Cl solution 
(50 mL) and ice, transferred to a separation funnel and rinsed with THF (25 mL). After 
the phases were separated, the aqueous phase was extracted with Et2O (3×50 mL) and 
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the combined organic phases were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. Flash chromatography (silica gel, 40×4 cm, 
cyclohexane:EtOAc, 20:1) gave the product 83 as a pale yellow oil (1.10 g, 6.97 mmol, 
71%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.45–7.41 (m, 2H, HCar), 7.35–7.28 (m, 3H, 
HCar), 3.13 (dq, 2,4JHH = 5.6, 0.8 Hz, 1H, CH2), 2.85 (d, 2JHH = 5.6 Hz, 1H, CH2), 1.66 (d, 
4JHH = 0.5 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 132.0 (2 HCar), 
128.8 (HCar), 128.4 (2 HCar), 122.3 (Car), 88.5 (Cq), 82.2 (Cq), 55.9 (CH2), 47.8 (Cq), 23.2 
(CH3); GC-MS (EI, 70 eV, Me2Si, 60 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 12.3 min), 
m/z (%) 158 (M+, 55), 130 (14), 129 (82), 128 (100), 127 (46), 115 (32), 103 (11), 102 (18), 
77 (25), 74 (11), 63 (14), 51 (23), 50 (13); IR (ν~ [cm−1]) 3058w, 2988w, 1597w, 1491m, 
1444w, 1380w, 1337m, 1292w, 1191w, 1066w, 907w, 813w, 757m, 694w; EA: calculated 
for C11H10O: C = 83.52, H = 6.37; measured: C = 83.34, H = 6.53; Rf = 0.17 (silica gel, 
cyclohexane:EtOAc, 20:1). The NMR spectra were consistent with the literature data.[80] 
2-Phenyl-4-methylfuran (85) 
Following a modified procedure of BLANC et al.,[38a] in a 250 mL three-
necked flask 2-methyl-2-(2-phenylethynyl)oxirane (83) (2.77 g, 
17.5 mmol, 1.00 eq.) was dissolved in CH2Cl2/MeOH (100 mL, 9/1 v/v). To 
this mixture successively pTsOH (169 mg, 0.88 mmol, 5.01 mol%) and 
then AgOTf (230 mg, 0.88 mmol, 5.02 mol%) were added. The resulting mixture was 
stirred at room temperature for 1 d. The reaction mixture was filtered over a pad of 
silica gel (5×5 cm) and washed with CH2Cl2 (5×50 mL). After removal of the solvent 
under reduced pressure, the residue was purified by flash chromatography (silica gel, 
30×5 cm, npentane) to give the title compound 85 as colorless oil (1.42 g, 8.98 mmol, 
51%). 
1H-NMR (400.1 MHz, DMSO, 300 K): δ (ppm) 7.65 (dd, 3,4JHH = 8.3, 1.1 Hz, 2H, HCar), 
7.50 (s, 1H, OCCH), 7.40 (t, 3JHH = 7.8 Hz, 2H, HCar), 7.27 (t, 3JHH = 7.4 Hz, 1H, HCar), 
6.81 (s, 1H, OCH), 2.03 (d, 4JHH = 1.0 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, DMSO, 
300 K): δ (ppm) 152.8 (OC(C6H5)), 139.3 (OCH), 130.4 (OCHC), 128.7 (2 HCar), 127.2 
(HCar), 123.1 (2 HCar), 121.6 (Car), 108.3 (OC(C6H5)CH), 9.48 (CH3); MS (EI), m/z (%) 158 
(M+, 100), 129 (51), 128 (25), 127 (11), 115 (23); IR (ν~ [cm−1]) 1756s, 1701m, 1597m, 1580w, 
1448m, 1351w, 1225w, 1058m, 982m, 914m, 752s, 725m, 694s; EA: calculated for 
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C11H10O: C = 83.52, H = 6.37; measured: C = 82.65, H = 6.31; Rf = 0.28 (silica gel, 
npentane); GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 
30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min): 
tR = 14.7 min; GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm 
× 0.25 μm, 40 kPa H2, 90 °C, 10 min, 0.1 °C/min, 92 °C, 10 °C/min, 180 °C, 10 min): 
tR = 36.4 min. The NMR spectra were consistent with the literature data.[81] 
2-Methyl-2-(oct-1-yn-1-yl)oxirane (84) 
Compound 84 was synthesized following the procedure described for 
the preparation of 2-methyl-2-(2-phenylethynyl)oxirane (83) using 
1-octyne (1.50 mL, 9.97 mmol, 1.00 eq.), nBuLi (1.6 M in hexanes, 
6.50 mL, 10.4 mmol, 1.04 eq.) and chloroacetone (0.85 mL, 10.2 mmol, 
1.03 eq.). The crude product was distilled (20 mbar, 120 °C) and chromatographed 
(silica gel, 40×4 cm, cyclohexane:EtOAc, 20:1) to give the pure compound 84 as a pale 
yellow oil (949 mg, 5.71 mmol, 57%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 2.96 (dd, 2,4JHH = 5.6, 0.5 Hz, 1H, CH2), 
2.72 (d, 2JHH = 5.6 Hz, 1H, CH2), 2.17 (t, 3JHH = 7.1 Hz, 2H, CH2), 1.53 (s, 3H, CH3), 1.48 
(dd, 2,3JHH = 14.9, 7.4 Hz, 2H, CH2), 1.39–1.26 (m, 6H, CH2), 0.88 (t, 3JHH = 7.0 Hz, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 83.4 (Cq), 79.5 (Cq), 55.8 (CH2), 47.7 
(Cq), 31.4 (CH2), 28.6 (CH2), 28.5 (CH2), 23.5 (CH2), 22.7 (CH2), 18.8 (CH2), 14.2 (CH3); 
GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 7.2 min), m/z (%) 
109 (13), 97 (16), 96 (29), 93 (100), 91 (11), 82 (11), 81 (31), 79 (32), 77 (27), 68 (34), 67 (85), 
66 (21), 65 (30), 55 (24), 53 (37), 52 (11), 51 (22), 43 (20), 41 (81); IR (ν~ [cm−1]) 2955m, 
2932m, 2858m, 2355m, 1684w, 1466w, 1379w, 1339w; EA: calculated for C11H18O: C = 
79.47, H = 10.91; measured: C = 79.40, H = 10.77; Rf = 0.21 (silica gel, cyclohexane:EtOAc, 
20:1). 
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2-Hexyl-4-methylfuran (86) 
Compound 86 was synthesized following the procedure described for the 
preparation of 2-phenyl-4-methylfuran (85) using 2-methyl-2-(oct-1-yn-1-
yl)oxirane (84) (830 mg, 4.99 mmol, 1.00 eq.), pTsOH (48.7 mg, 0.25 mmol, 
5.05 mol%) and AgOTf (69.6 mg, 0.27 mmol, 5.32 mol%). The crude residue was 
purified by flash chromatography (silica gel, 40×4 cm, npentane) to give the title 
compound (403 mg, 2.43 mmol, 49%) as a colorless liquid. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.05 (t, 4JHH = 0.9 Hz, 1H, OCH), 5.84 (s, 
1H, CH), 2.56 (t, 3JHH = 7.6 Hz, 2H, CH2), 1.99 (d, 4JHH = 0.9 Hz, 3H, CH3), 1.61 (mc, 2H, 
CH2), 1.36–1.26 (m, 6H, CH2), 0.89 (t, 3JHH = 6.9 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 156.8 (OC(C6H13)), 137.3 (OCH), 120.5 (OCHC), 107.5 
(OC(C6H13)CH), 31.8 (CH2), 29.1 (CH2), 28.2 (CH2), 28.1 (CH2), 22.7 (CH2), 14.2 (CH3), 
10.0 (CH3); GC-MS (EI, 70 eV, Me2Si, 60 °C, 2 min, 10 °C/min, 270 °C, 10 min, 
tR = 9.6 min), m/z (%) 166 (M+, 23), 109 (22), 95 (100), 67 (21), 41 (27); IR (ν~ [cm−1]) 2955m, 
2924m, 2858m, 2358w, 1618w, 1553w, 1458w, 1377w, 1122w, 935w, 798w, 737w; 
EA: calculated for C11H18O: C = 79.47, H = 10.91; measured: C = 79.67, H = 10.78; Rf = 0.33 
(silica gel, npentane); GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, 
Restek Rtx-1701, 30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 90 °C, 32 min, 0.1 °C/min, 92 °C, 
0 min, 10 °C/min, 250 °C, 10 min): tR = 27.2 min; GC (β-Cyclodextrin, Diethyl-
tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 40 kPa H2, 90 °C, 10 min, 0.1 °C/min, 
92 °C, 0 min, 10 °C/min, 180 °C, 10 min): tR = 21.4 min. 
2-Butylbenzofuran (91) 
Following a modified procedure of ORTEGA et al.,[33] in an 10 mL Schlenk 
tube benzofuran (0.22 mL, 2.02 mmol, 1.00 eq.) was dissolved in THF 
(4 mL) under argon and cooled to −78 °C. Then nBuLi (1.6 M in hexanes, 
1.50 mL, 2.40 mmol, 1.19 eq.) was added via syringe, the mixture was 
stirred for another two hours at this temperature and then 1-bromobutane (0.32 mL, 
2.94 mmol, 1.45 eq.) was added. The reaction was stirred at room temperature for 1 d, 
quenched with 10 mL water and transferred to a separation funnel. After extraction 
with MTBE (3×10 mL), the combined organic phases were dried over MgSO4, filtered 
and concentrated to give the crude product. Flash chromatography (silica gel, 24×4 cm, 
npentane) and subsequent bulb to bulb distillation (20 mbar, 100 °C) gave the desired 
product (106 mg, 0.61 mmol, 30%) as a colorless liquid. 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.49–7.47 (m, 1H, HCar), 7.42–7.40 (m, 1H, 
HCar), 7.23–7.15 (m, 2H, HCar), 6.38 (d, 4JHH = 0.6 Hz, 1H, OCCH), 2.78 (t, 3JHH = 7.5 Hz, 
2H, CH2), 1.74 (mc, 2H, CH2), 1.44 (mc, 2H, CH2), 0.97 (t, 3JHH = 7.4 Hz, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 159.9 (OC), 154.8 (OC), 129.2 (Car), 
123.1 (HCar), 122.5 (HCar), 120.3 (HCar), 110.8 (HCar), 101.9 (OCCH), 30.1 (CH2), 28.3 
(CH2), 22.4 (CH2), 14.0 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 
100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 10.3 min), m/z (%) 174 (M+, 24), 132 (35), 
131 (100); IR (ν~ [cm−1]) 2957m, 2930m, 2860w, 2330w, 1601m, 1587m, 1555m, 1452s, 
1252m, 1169m, 1024m, 945m, 930m, 878m, 793m, 737s, 502s; Rf = 0.27 (silica gel, 
npentane); HPLC (OD-H, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 210 and 240 nm): 
tR = 8.1 min. The NMR spectra were consistent with the literature data.[33] 
2-Decylbenzofuran (92) 
Compound 92 was synthesized following the procedure decribed for 
the preparation of 2-butylbenzofuran (91) using benzofuran (90) 
(0.22 mL, 2.02 mmol, 1.00 eq.), nBuLi (1.6 M in hexanes, 1.70 mL, 
2.72 mmol, 1.35 eq.) and 1-bromodecane (2.20 mL, 10.3 mmol, 5.11 eq.). 
Flash chromatography (silica gel, 19×2 cm, npentane) and subsequent bulb to bulb 
distillation (0.1 torr, 80 °C) gave the desired product (177 mg, 0.60 mmol, 30%) as a 
colorless liquid. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.49–7.46 (m, 1H, HCar), 7.42–7.40 (m, 1H, 
HCar), 7.22–7.15 (m, 2H, HCar), 6.37 (d, 4JHH = 0.9 Hz, 1H, OCCH), 2.76 (t, 3JHH = 7.6 Hz, 
2H, CH2), 1.74 (mc, 2H, CH2), 1.91–1.45 (m, 14H, CH2), 0.88 (t, 3JHH = 6.9 Hz, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 159.9 (OC), 154.7 (OC), 129.2 (Car), 
123.1 (HCar), 122.5 (HCar), 120.3 (HCar), 110.8 (HCar), 101.9 (OCCH), 32.1 (CH2), 29.8 
(CH2), 29.7 (CH2), 29.5 (CH2), 29.5 (CH2), 29.4 (CH2), 28.6 (CH2), 27.9 (CH2), 22.8 (CH2), 
14.3 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 
7 °C/min, 250 °C, 10 min, tR = 20.6 min), m/z (%) 258 (M+, 25), 145 (10), 132 (52), 131 
(100), 107 (10), 95 (25); IR (ν~ [cm−1]) 2922m, 2853w, 1603w, 1562s, 1556s, 1454m, 1252w, 
1024w, 932w, 880w, 791w, 748m, 737m; Rf = 0.31 (silica gel, npentane); HPLC (OD-H, 
nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 210 and 240 nm): tR = 7.8 min. The NMR 
spectra were consistent with the literature data.[33] 
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2-(Decyl-1-d)benzofuran-3-d (d-92) 
In a 2 mL vial with a stirring bar, 2-decylbenzofuran (92) 
(25 mg, 0.1 mmol) and [Ir(L2c)COD]BArF (1 mol%) were 
dissolved in dry CH2Cl2 (0.5 mL) and the vial was placed 
in an autoclave. It was stirred at 30 bar of D2 pressure 
and 60 °C for 4 h. The reaction mixture was concentrated, the residue redissolved in a 
nhexane/MTBE (4/1) mixture and filtered through a pasteur pipette filled with silica 
gel (ca. 5 cm). The filtrate was concentrated and the mixture of fully hydrogenated 
deuterated compound and d-92 (71:29, GC-MS) was separated by flash 
chromatography (silica gel, npentane). Benzofuran d-92 was obtained as a colorless oil, 
which shows deuterium incorporation at C3 (89%) and on the alkyl chain (74%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.49–7.46 (m, 1H, HCar), 7.42–7.40 (m, 1H, 
HCar), 7.22–7.15 (m, 2H, HCar), 2.76 (t, 3JHH = 7.6 Hz, 1H, CH2), 1.74 (mc, 2H, CH2), 1.91–
1.45 (m, 14H, CH2), 0.88 (t, 3JHH = 6.9 Hz, 3H, CH3); 2H-NMR (76.8 MHz, CDCl3 in CHCl3, 
300 K): δ (ppm) 6.43 (s, 1D), 2.76 (s, 0.8D); 13C{1H/2H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 159.6 (OC), 154.5 (OC), 128.9 (Car), 122.9 (HCar), 122.3 (HCar), 120.0 (HCar), 110.6 
(HCar), 101.4 (OCCD), 31.8 (CH2), 29.5 (CH2), 29.5 (CH2), 29.3 (CH2), 29.3 (CH2), 29.1 
(CH2), 28.0 (CHD), 27.5 (CH2), 22.6 (CH2), 14.1 (CH3); GC-MS (EI, 70 eV, 5% 
polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 5 min, 
tR = 10.2 min), m/z (%) 260 (M+, 22), 146 (11), 134 (48), 133 (100), 132 (44), 96 (17), 95 (16), 
81 (10), 41 (10). 
2-(Prop-1-en-2-yl)benzofuran (93) 
In a 5 mL Schlenk tube benzofuran (0.20 mL, 1.84 mmol, 1.00 eq.) was 
dissolved in 4 mL THF under argon and cooled to −78 °C. Then nBuLi 
(1.6 M in hexanes, 1.70 mL, 2.72 mmol, 1.48 eq.) was added via syringe, 
the mixture was stirred for 2.5 hours at this temperature, then acetone 
(0.68 mL, 9.20 mmol, 5.01 eq.) was added. After stirring for 22 hours at room 
temperature, the reaction was quenched with aqueous 3 M HCl solution (10 mL) and 
transferred to a separation funnel. After phase separation, the organic phase was 
extracted with MTBE (2×20 mL), dried over MgSO4, filtered and concentrated to give 
the crude product. Flash chromatography (silica gel, 21×2 cm, npentane) gave the 
desired product as a pale yellow oil (205 mg, 1.30 mmol, 71%). 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.46 (ddd, 3,4JHH = 7.6, 1.3, 0.6 Hz, 1H, 
HCar), 7.37 (dd, 3,4JHH = 8.0, 0.8 Hz, 1H, HCar), 7.21–7.17 (m, 1H, HCar), 7.12 (dt, 3JHH = 7.5, 
1.0 Hz, 1H, HCar), 6.57 (s, 1H, OCCH), 5.72 (s, 1H, CH2), 5.10 (mc, 1H, CH2), 2.06 (s, 3H, 
CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 157.0 (Car), 154.9 (Car), 133.0 
(Cq), 129.1 (Car), 124.7 (HCar), 122.8 (HCar), 121.1 (HCar), 113.4 (CH2), 111.1 (HCar), 102.9 
(OCH), 19.5 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 
2 min, 30 °C/min, 250 °C, 5 min, tR = 7.0 min), m/z (%) 159 (13), 158 (M+, 100), 157 (15), 
143 (35), 131 (10), 128 (11), 118 (12), 115 (23); IR (ν~ [cm−1]) 2946w, 2921m, 2852w, 1555m, 
1473w, 1452s, 1439w, 1379w, 1337w, 1300m, 1257s, 1171s, 1146w, 1112m, 1096m, 
1007w, 955m, 892m, 885m, 804s, 752m, 740s; Rf = 0.31 (silica gel, npentane); 
HPLC (OD-H, nheptane:iPrOH 99:1, 0.5 mL/min, 24 °C, 230 nm): tR = 8.1 min. The NMR 
spectra were consistent with the literature data.[82] 
2-Phenylbenzofuran (95a) 
Following a modified procedure of SUZUKI et al.,[83] in a 25 mL Schlenk 
tube benzofuran-2-boronic acid (200 mg, 1.21 mmol, 1.05 eq.), 
Pd(OAc)2 (24.7 mg, 0.11 mmol, 9.34 mol%), sodium carbonate 
(237 mg, 2.24 mmol, 1.94 eq.) and iodobenzene (0.13 mL, 1.15 mmol, 
1.00 eq.) were dissolved in 6.5 mL acetone and 7.5 mL water. The black mixture was 
stirred at room temperature for five hours. Water (20 mL) was added to the reaction 
mixture and transferred to a separation funnel. After extraction with CH2Cl2 (3×20 mL), 
the combined organic phases were dried over MgSO4, filtered and concentrated to give 
the crude product. Flash chromatography (silica gel, 21×3 cm, npentane) gave the 
desired product as a colorless solid (180 mg, 0.93 mmol, 77%). 
m.p. 117–118 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.88 (dd, 3,4JHH = 8.2, 
1.0 Hz, 2H, HCar), 7.60–7.58 (m, 1H, HCar), 7.53 (dd, 3,4JHH = 8.1, 0.7 Hz, 1H, HCar), 7.46 
(mc, 2H, HCar), 7.36 (mc, 1H, HCar), 7.29 (mc, 1H, HCar), 7.26–7.22 (m, 1H, HCar), 7.04 (d, 
4JHH = 0.8 Hz, 1H, OCCH); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 156.1 (OC), 
155.0 (OC), 130.6 (Car), 129.4 (Car), 128.9 (2 HCar), 128.7 (HCar), 125.1 (2 HCar), 124.1 
(HCar), 123.1 (HCar), 121.0 (HCar), 111.3 (HCar), 101.4 (OCCH); GC-MS (EI, 70 eV, 5% 
polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 5 min, 
tR = 9.2 min), m/z (%) 195 (16), 194 (M+, 100), 165 (42), 97 (12), 82 (11); IR (ν~ [cm−1]) 
3052w, 1564m, 1558m, 1471m, 1456s, 1442m, 1351m, 1305m, 1295m, 1272w, 1258m, 
1208m, 1169m, 1146w, 1105m, 1074m, 1039s, 1020s, 1005m, 932m, 919s, 882m, 865w, 
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852w, 805s, 761s, 740s, 689s, 678s, 660s; Rf = 0.26 (silica gel, npentane). The NMR spectra 
were consistent with the literature data.[33] 
2-Phenylbenzofuran-3-d (d-95a) 
In a 2 mL vial with a stirring bar, 2-phenylbenzofuran (95a) (11 mg, 
0.05 mmol) and [Ir(L2c)COD]BArF (1 mol%) were dissolved in dry 
CH2Cl2 (0.25 mL) and the vial was placed in an autoclave. It was 
stirred at 40 bar of D2 pressure and 60 °C for 24 h. The reaction 
mixture was concentrated, the residue redissolved in a nhexane/MTBE (4/1) mixture 
and filtered through a pasteur pipette filled with silica gel (ca. 5 cm). The filtrate was 
concentrated and compound d-95a was obatained as a colorless oil with deuterium 
incorporation at C3 (80%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.88 (dd, 3,4JHH = 8.2, 1.0 Hz, 2H, HCar), 
7.60–7.58 (m, 1H, HCar), 7.53 (dd, 3,4JHH = 8.1, 0.7 Hz, 1H, HCar), 7.46 (mc, 2H, HCar), 7.36 
(mc, 1H, HCar), 7.29 (mc, 1H, HCar), 7.26–7.22 (m, 1H, HCar), 7.04 (d, 4JHH = 0.8 Hz, 0.2H, 
OCCH); 2H-NMR (76.8 MHz, CDCl3 in CHCl3, 300 K): δ (ppm) 7.09 (s, 1D); 
13C{1H/2H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 156.0 (OC), 155.0 (OC), 130.6 (Car), 
129.3 (Car), 128.9 (2 HCar), 128.7 (HCar), 125.1 (2 HCar), 124.4 (HCar), 123.1 (HCar), 121.0 
(HCar), 111.3 (HCar), 101.2 (OCCD); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 
100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 5 min, tR = 9.2 min), m/z (%) 196 (18), 195 
(M+, 100), 194 (21), 166 (48), 165 (20), 98 (12), 83 (13). 
2-(4-Methoxyphenyl)benzofuran (95b) 
Compound 95b was synthesized following the procedure for the 
preparation of 2-phenylbenzofuran (95a) using benzofuran-
2-boronic acid (200 mg, 1.21 mmol, 1.08 eq.), Pd(OAc)2 (24.8 mg, 
0.11 mmol, 9.64 mol%), sodium carbonate (237 mg, 2.23 mmol, 
1.99 eq.) and 4-iodoanisole (268 mg, 1.12 mmol, 1.00 eq.). Flash chromatography (silica 
gel, 25×3 cm, npentane) gave the desired product as a colorless solid (48.3 mg, 
0.21 mmol, 19%). 
m.p. 134–135 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.80 (mc, 2H, HCar), 
7.57–7.49 (m, 2H, HCar), 7.25–7.19 (m, 2H, HCar), 6.98 (mc, 2H, HCar), 6.89 (d, 
4JHH = 0.8 Hz, 1H, OCCH), 3.87 (s, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 160.1 (Car), 156.2 (Car), 155.4 (Car), 126.6 (2 HCar), 123.9 (HCar), 123.5 (Car), 123.0 
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(HCar), 120.7 (HCar), 114.4 (2 HCar), 111.1 (HCar), 99.8 (OCCH), 55.5 (CH3); GC-MS (EI, 
70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 5 min, 
tR = 10.7 min), m/z (%) 225 (17), 224 (M+, 100), 210 (11), 209 (71), 181 (33), 152 (20), 112 
(11); IR (ν~ [cm−1]) 2959w, 2931w, 2910w, 2898w, 2854w, 2837w, 1730m, 1722m, 1653w, 
1608m, 1594m, 1587m, 1503s, 1465m, 1452s, 1440s, 1418s, 1322m, 1306m, 1297m, 1245s, 
1210m, 1170m, 1111m, 1106m, 1040m, 1022s, 1006m, 933m, 919s, 885m, 834s, 819m, 
803s, 798s, 780m, 749s, 741s, 637m, 623m, 611m, 534s, 523s, 519s, 515s, 504m; Rf = 0.30 
(silica gel, npentane:MTBE, 20:1). The NMR spectra were consistent with the literature 
data.[33] 
2-(4-(Trifluoromethyl))phenylbenzofuran (95c) 
Compound 95c was synthesized following the procedure for the 
preparation of 2-phenylbenzofuran (95a) using benzofuran-
2-boronic acid (200 mg, 1.21 mmol, 1.08 eq.), Pd(OAc)2 (25.3 mg, 
0.11 mmol, 9.74 mol%), sodium carbonate (238 mg, 2.25 mmol, 
1.98 eq.) and 4-iodobenzotrifluoride (315 mg, 1.13 mmol, 1.00 eq.). Flash 
chromatography (silica gel, 25×3 cm, npentane) gave the desired product as a colorless 
solid (246 mg, 0.94 mmol, 83%). 
m.p. 162–164 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.97 (d, 3JHH = 8.3 Hz, 
2H, HCar), 7.70 (d, 3JHH = 8.4 Hz, 2H, HCar), 7.62 (d, 3JHH = 7.5 Hz, 1H, HCar), 7.55 (d, 
3JHH = 8.2 Hz, 1H, HCar), 7.36–7.24 (m, 2H, HCar), 7.15 (s, 1H, OCCH); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 155.3 (Car), 154.4 (Car), 133.8 (Car), 130.3 (q, 
2JCF = 32.6 Hz, CCF3), 129.0 (Car), 125.9 (q, 3JCF = 3.8 Hz, 2 HCar), 125.3 (HCar), 125.1 
(2 HCar), 124.2 (q, 1JCF = 271.8 Hz, CF3), 123.4 (HCar), 121.5 (HCar), 111.5 (HCar), 103.4 
(OCCH); 19F{1H}-NMR (376.5 MHz, CDCl3, 300 K): δ (ppm) −62.7 (CF3); GC-MS (EI, 
70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 5 min, 
tR = 7.2 min), m/z (%) 263 (16), 262 (M+, 100), 165 (25), 106 (14); IR (ν~ [cm−1]) 2922w, 
2854w, 1615m, 1610w, 1566w, 1475w, 1450m, 1413m, 1320m, 1299m, 1277m, 1259m, 
1189w, 1160s, 1148m, 1129w, 1103s, 1066m, 1043m, 1031m, 1012m, 976w, 961w, 937m, 
920m, 885m, 856w, 848m, 841s, 803s, 770w, 745s, 725w, 708w, 689s, 657w, 635w, 612m, 
577s; Rf = 0.26 (silica gel, npentane). The NMR spectra were consistent with the 
literature data.[33] 
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2-(2,2-Dibromovinyl)phenol (97) 
Following a modified procedure of NEWMAN et al.,[84] in a 250 mL round 
bottom flask PPh3 (9.79 g, 37.0 mmol, 6.01 eq.) was dissolved in CH2Cl2 
(40 mL) and cooled to 0 °C. Then CBr4 (6.19 g, 18.5 mmol, 3.01 eq.) in 
CH2Cl2 (20 mL) was added. After 10 minutes NEt3 (5.50 mL, 39.3 mmol, 
6.39 eq.) was added followed by salicylaldehyde (0.60 mL, 6.15 mmol, 1.00 eq.) in 
CH2Cl2 (6 mL). The mixture was stirred for 30 min at 2 °C and then for two hours at 
room temperature. The reaction was quenched with aqueous saturated NH4Cl solution 
(70 mL) and transferred to a separation funnel. After separation of the phases, the 
aqueous phase was extracted with CH2Cl2 (2×70 mL) and the combined organic phases 
were concentrated to a total volume of 10 mL. Filtration of the crude product over a 
pad of silica gel (4×5 cm) and washing with CH2Cl2 (120 mL) and Et2O (40 mL) gave a 
yellow oil which was chromatographed (silica gel, 22×4 cm, npentane:EtOAc, 85:15) to 
give the product as a colorless solid (1.65 g, 5.94 mmol, 97%). 
m.p. 58–60 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.56 (s, 1H, CH=CBr2), 7.54 
(dd, 3,4JHH = 7.8, 0.5 Hz, 1H, HCar), 7.26–7.22 (m, 1H, HCar), 6.96 (t, 3JHH = 7.6 Hz, 1H, 
HCar), 6.83 (dd, 3,4JHH = 8.1, 0.9 Hz, 1H, HCar), 4.96–4.92 (m, 1H, OH); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 152.6 (Car), 132.5 (CH=CBr2), 130.2 (HCar), 129.4 
(HCar), 123.0 (Car), 120.8 (HCar), 115.9 (HCar), 92.2 (CH=CBr2); GC-MS (EI, 70 eV, 5% 
polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min, 
tR = 15.0 min), m/z (%) 278 (M+, 20), 118 (100), 90 (19), 89 (25), 63 (11); IR (ν~ [cm−1]) 
1556m, 1493w, 1445m, 1348w, 1339w, 1298w, 1232m, 1198w, 1178m, 1153w, 1091m, 
1042m, 1001m, 914w, 878m, 835s, 824s, 756m, 745s, 719w, 600m, 571m, 507s; Rf = 0.31 
(silica gel, npentane:EtOAc, 85:15). The NMR spectra were consistent with the 
literature data.[84] 
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2-Bromobenzofuran (98) 
Following a modified procedure of NEWMAN et al.,[84] in a 25 mL Young 
tube 2-(2,2-dibromovinyl)phenol (97) (991 mg, 3.57 mmol, 1.00 eq.), 
K3PO4 (1.55 g, 7.15 mmol, 2.00 eq.) and copper iodide (34.5 mg, 
0.18 mmol, 5.00 mol%) were dissolved in THF (15 mL) and refluxed for 
six hours. The reaction mixture was then filtered over a pad of silica gel (2×5 cm), 
washed with MTBE (120 mL) and concentrated. The crude product was 
chromatographed (silica gel, 20×2 cm, npentane) and the desired product was obtained 
as a colorless oil (660 mg, 3.35 mmol, 94%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.52–7.44 (m, 2H, HCar), 7.28–7.21 (m, 
2H, HCar), 6.73 (d, 4JHH = 0.8 Hz, 1H, OCCH); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 155.9 (Car), 128.9 (Car), 128.3 (Cq), 124.4 (HCar), 123.5 (HCar), 120.2 (HCar), 111.1 
(HCar), 108.4 (OCBrCH); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 
100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 15.0 min), m/z (%) 197 (M+, 60), 196 (60), 89 
(100), 63 (20), 62 (11); IR (ν~ [cm−1]) 2365w, 1616w, 1605w, 1537m, 1445s, 1250s, 1161s, 
1088w, 1065s, 1024m, 930m, 918s, 880s, 789s, 735s, 602s; Rf = 0.41 (silica gel, npentane). 
The NMR spectra were consistent with the literature data.[84] 
2-Benzylbenzofuran (99) 
Following a modified procedure of ORTEGA et al.,[33] in a 10 mL 
Young tube zinc (571 mg, 8.51 mmol, 2.04 eq.) was heated with a 
heatgun for 15 minutes. After the flask had cooled to room 
temperature iodine (76.1 mg, 0.30 mmol, 7.19 mol%) and THF (4 mL) 
were added. As soon as the pale yellow color of the reaction mixture disappeared 
benzylbromide (0.73 mL, 5.98 mmol, 1.44 eq.) was added under argon and the 
resulting mixture was stirred at 70 °C overnight. In a 25 mL Young tube Pd(OAc)2 
(48.1 mg, 0.21 mmol, 5.04 mol%) and P(oTol)3 (124 mg, 0.40 mmol, 9.69 mol%) were 
dissolved in THF (12 mL). After 10 minutes 2-bromobenzofuran (829 mg, 4.17 mmol, 
1.00 eq.) was added and the mixture was cooled to −10 °C. The previously prepared 
zinc compound was added over a period of 10 minutes at this temperature and the 
cooling bath was removed. The mixture was stirred for four hours, then filtered over 
a pad of silica gel (2×5 cm) and washed with EtOAc (2×50 mL). Flash chromatography 
(silica gel, 24×2 cm, npentane) gave the desired product as a colorless oil (689 mg, 
3.31 mmol, 79%). 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.49–7.40 (m, 2H, HCar), 7.36–7.26 (m, 5H, 
HCar), 7.19 (mc, 2H, HCar), 6.38 (d, 4JHH = 0.8 Hz, 1H, OCCH), 4.12 (s, 2H, CH2); 13C{1H}-
NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 157.9 (Car), 155.1 (Car), 137.4 (Car), 129.1 
(2 HCar), 129.0 (Car), 128.8 (2 HCar), 126.9 (HCar), 123.6 (HCar), 122.7 (HCar), 120.5 (HCar), 
111.1 (HCar), 103.5 (OCCH), 35.2 (CH2); GC-MS (EI, 70 eV, 5% polyphenyl-
methylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 17.3 min), m/z (%) 
209 (14), 208 (M+, 95), 207 (100), 179 (10), 178 (20),131 (52), 89 (14), 77 (10); IR (ν~ [cm−1]) 
3062w, 3029w, 2358w, 1740w, 1600w, 1584w, 1495w, 1472w, 1452s, 1420w, 1316w, 
1252m, 1191w, 1164w, 1104w, 953m, 829w, 804w, 793w, 750m, 741m, 703m, 628m, 
569m, 548m, 534s, 524s, 509m, 504s; Rf = 0.16 (silica gel, npentane). The NMR spectra 
were consistent with the literature data.[33] 
3,5-Dimethylbenzofuran (56a)[85] 
Following a modified procedure of COREY et al.,[41] a 250 mL three-necked 
round bottom flask equipped with a reflux condenser, was charged with 
sodium hydride (60% m/m; 252 mg, 6.30 mmol, 1.50 eq.), which was 
washed with npentane (3×10 mL). Trimethyloxosulfonium iodide (1.40 g, 
6.30 mmol, 1.50 eq.) was added and argon atmosphere was established in the reaction 
vessel. Absolute DMSO (50 mL) was slowly added and the resulting mixture was 
stirred for 45 min. After that a solution of 2-hydroxy-5-methylacetophenone (1.00 g, 
4.20 mmol, 1.00 eq.) in absolute DMSO (25 mL) was added and the reaction mixture 
was stirred for 18 hours at 40 °C and then for 5.5 hours at 90 °C. It was extracted with 
Et2O (3×30 mL), the combined organic layers were washed with brine (20 mL), dried 
over MgSO4, filtered and concentrated. The crude product was purified by flash 
chromatography (silica gel, 17×2 cm, npentane) to obtain the product as a colorless 
liquid (570 mg, 94% m/m, 3.90 mmol, 59%) containing traces of npentane (6% m/m). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.37–7.31 (m, 3H, HCar), 7.10 (dd, 
3,4JHH = 8.3, 1.3 Hz, 1H, OCH), 2.47 (s, 3H, CH3), 2.23 (d, 4JHH = 1.3 Hz, 3H, OCHCCH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 153.8 (OC), 141.6 (OCH), 131.8 
(OCC), 129.2 (CCH3), 125.4 (HCar), 119.4 (HCar), 115.5 (OCHCCH3), 110.9 (HCar), 21.5 
(CH3), 8.0 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 
2 min, 30 °C/min, 250 °C, 5 min, tR = 6.3 min), m/z (%) 146 (M+, 100), 145 (99), 131 (21), 
117 (23), 115 (24), 91 (11); IR (ν~ [cm−1]) 2919w, 2862w, 2356w, 1456m, 1286m, 1186s, 
1089s, 804m, 786m, 608m; HRMS (EI, 30 eV, 100 °C) calc. m/z for C10H10O: 146.0732, 
CHAPTER 7 
121 
found: 146.0731; Rf = 0.71 (silica gel, cyclohexane: EtOAc, 9:1); GC (14% Cyano-
propylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 30 m × 0.25 mm × 0.25 μm, 
60 kPa H2, 90 °C, 32 min, 0.1 °C/min, 92 °C, 0 min, 10 °C/min, 250 °C, 10 min): 
tR = 55.3 min; HPLC (OJ, nheptane:iPrOH 100:0, 0.5 mL/min, 208 and 250 nm): 
tR = 23.3 min. 
6-Bromo-3,5-dimethylbenzofuran (56b)[85] 
Compound 56b was synthesized following the procedure described for 
the preparation of 3,5-dimethylbenzofuran (56a) using sodium hydride 
(60% m/m; 250 mg, 6.30 mmol, 1.50 eq.), trimethyloxosulfonium iodide 
(1.40 g, 6.30 mmol, 1.50 eq.) and 4-bromo-2-hydroxy-5-methylaceto-
phenone (1.00 g, 4.20 mmol, 1.00 eq.). The crude product was purified by flash 
chromatography (silica gel, 11×2 cm, cyclohexane) to obtain the desired product as 
colorless crystals (428 mg, 1.90 mmol, 44%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.66 (s, 1H, HCar), 7.36 (s, 1H, HCar), 7.35 
(dd, 3,4JHH = 2.5, 1.2 Hz, 1H, OCH), 2.49 (s, 3H, CH3), 2.21 (d, 4JHH = 1.3 Hz, 3H, 
OCHCCH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 154.1 (OC), 142.1 
(OCH), 131.5 (Car), 128.7 (Car), 120.4 (HCar), 115.4 (OCHCCH3), 115.1 (HCar), 110.9 (HCar), 
21.2 (CH3), 8.0 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 
2 min, 30 °C/min, 250 °C, 5 min, tR = 7.9 min), m/z (%) 226 (85), 225 (M+, 36), 224 (89), 
223 (29), 146 (11), 145 (100), 116 (15), 115 (50), 91 (11), 72 (19); IR (ν~ [cm−1]) 3116w, 
2975w, 2925w, 2855w, 2356w, 1576w, 1448s, 1377m, 1310m, 1281m, 1198w, 1161w, 
1079s, 1036m, 1000m, 939m, 854s, 814s, 783s, 768s, 694s; EA: calculated for C10H9BrO: 
C = 53.36, H = 4.03; measured: C = 53.64, H = 4.13; Rf = 0.33 (silica gel, npentane); 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 30 m 
× 0.25 mm × 0.25 μm, 60 kPa H2, 90 °C, 32 min, 0.1 °C/min, 92 °C, 0 min, 10 °C/min, 
250 °C, 10 min): tR = 55.3 min, (hydrogenated product tR = 55.9 min); HPLC (analyzed 
as 3,5-dimethyl-2,3-dihydrobenzofuran (116)). 
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7.5 Synthesis and Characterization of Substituted Thiophenes 
2-Butyl-5-phenylthiophene (134) 
In a 25 mL Young tube 2-phenylthiophene (336 mg, 1.99 mmol, 
1.00 eq.) was dissolved under slightly positive argon flow in dry THF 
(5 mL) and cooled to −78 °C. At this temperature nBuLi (1.6 M in 
hexanes, 1.50 mL, 2.40 mmol, 1.20 eq.) was added dropwise via 
syringe. The green mixture was stirred for one hour and 1-bromobutane (0.27 mL, 
2.41 mmol, 1.21 eq.) was added. The reaction mixture was stirred for 19 h at room 
temperature, quenched with water (5 mL) and transferred to a separation funnel. After 
separation of the phases, the aqueous phase was extracted with MTBE (3×5 mL) and 
the combined organic phases were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The obtained yellow oil was purified by flash 
chromatography (silica gel, 23×4 cm, nhexane:CH2Cl2, 95:5) to give the title compound 
134 as colorless oil (431 mg, 1.99 mmol, 99%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.58–7.55 (m, 2H, HCar), 7.35 (mc, 2H, 
HCar), 7.24 (mc, 1H, HCar), 7.12 (d, 3JHH = 3.6 Hz, 1H, SC(C6H5)CH), 6.75 (d, 3JHH = 3.6 Hz, 
1H, SC(C4H9)CH), 2.83 (t, 3JHH = 7.6 Hz, 2H, CH2), 1.70 (mc, 2H, CH2), 1.43 (mc, 2H, CH2), 
0.96 (t, 3JHH = 7.6 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 145.8 
(SC(C6H5)), 141.8 (SC(C4H9)), 134.9 (Car), 128.9 (2 HCar), 127.1 (HCar), 125.6 (2 HCar), 125.1 
(SC(C4H9)CH), 122.8 (SC(C6H5)CH), 33.9 (CH2), 30.1 (CH2), 22.4 (CH2), 14.0 (CH3); 
MS (EI), m/z (%) 216 (M+, 33), 174 (13), 173 (100); IR (ν~ [cm−1]) 3067w, 3025w, 2954w, 
2927w, 2854w, 1599w, 1501m, 1466w, 1377w, 1073w, 1027w, 952w, 907m, 800w, 753s, 
689m, 637w; Rf = 0.30 (silica gel, nhexane:CH2Cl2, 95:5). The NMR spectra were 
consistent with the literature data.[32] 
2-Methyl-5-phenythiophene (135) 
Following a modified procedure of FAGNOU et al.,[58] in a 25 mL Schlenk 
flask Pd(OAc)2 (23.0 mg, 0.100 mmol, 2.20 mol%), PCy3 (60.2 mg, 
0.204 mmol, 4.48 mol%), potassium carbonate (1.04 g, 7.45 mmol, 
1.64 eq.), and pivalic acid (165 mg, 1.60 mmol, 35.0 mol%) were 
dissolved under slightly positive argon flow in N,N-dimethylacetamid (12 mL). Also 
2-methylthiophene (0.45 mL, 4.56 mmol, 1.00 eq.) and bromobenzene (0.53 mL, 
4.98 mmol, 1.00 eq.) were added and the yellow reaction mixture was heated to 100 °C 
for 16 h. The mixture was allowed to cool to room temperature, diluted with EtOAc 
SnBu
C14H16S
216.34 g/mol
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(20 mL) and transferred to a separation funnel. After the organic phase was washed 
with water (3×30 mL), the aqueous phase was extracted with EtOAc (2×20 mL) and the 
combined organic phases were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The obtained brown oil was purified by flash 
chromatography (silica gel, 23×4 cm, npentane) to give the title compound 135 as 
colorless crystals (686 mg, 3.94 mmol, 86%). 
m.p. 44–46 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.57–7.55 (m, 2H, HCar), 
7.36 (mc, 2H, HCar), 7.24 (mc, 1H, HCar), 7.11 (d, 3JHH = 3.5 Hz, 1H, SC(C6H5)CH), 6.73 
(dq, 3,4JHH = 3.5, 0.7 Hz, 1H, SC(CH3)CH), 2.52 (s, 3H, CH3); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 142.1 (SC(C6H5)), 139.7 (SC(CH3)), 134.9 (Car), 128.9 (2 HCar), 
127.1 (HCar), 126.3 (SC(CH3)CH), 125.6 (2 HCar), 123.0 (SC(C6H5)CH), 15.6 (CH3); 
MS (EI), m/z (%) 175 (16), 174 (M+, 100), 173 (93), 141 (16), 129 (10), 115 (11), 97 (10);  
IR (ν~ [cm−1]) 3058w, 2912w, 2855w, 1598w, 1498m, 1469w, 1443w, 1261w, 1211w, 
1166w, 1154w, 1072w, 1027w, 945w, 901w, 872w, 799s, 747s, 737s, 683s, 670s; Rf = 0.23 
(silica gel, npentane). The NMR spectra were consistent with the literature data.[23a] 
2-Benzylthiophene (139) 
Following a modified procedure of HENRY et al.,[53] in a 25 mL Young 
tube benzylchloride (0.17 mL, 1.47 mmol, 1.00 eq.), sodium carbonate 
(335 mg, 3.16 mmol, 2.15 eq.), 2-thiophene boronic acid (238 mg, 
1.81 mmol, 1.23 eq.) and Pd(PPh3)4 (37.0 mg, 0.03 mmol, 2.16 mol%) was 
dissolved under slightly positive argon flow in DME (6 mL) and water (3 mL). The 
mixture was heated to 100 °C for four hours, cooled to room temperature and diluted 
with water (10 mL). The mixture was extracted with CH2Cl2 (3×20 mL), the combined 
organic phases were dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The obtained yellow oil was purified by flash chromatography 
(silica gel, 22×2 cm, cyclohexane:EtOAc, 20:1) to give the title compound 139 as 
colorless oil (300 mg, 1.72 mmol, 99%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.33–7.30 (m, 2H, HCar), 7.28–7.23 (m, 3H, 
HCar), 7.15 (dd, 3,4JHH = 5.1, 1.2 Hz, 1H, SCH), 6.93 (dd, 3JHH = 5.2, 3.4 Hz, 1H, SCHCH), 
6.81 (dq, 3,4JHH = 3.4, 1.1 Hz, 1H, SC(CH2C6H5)CH), 4.16 (s, 2H, CH2); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 144.2 (Cthiophene), 140.5 (Car), 128.7 (2 HCar), 128.7 
(2 HCar), 127.0 (HCar), 126.6 (CHthiophene), 125.3 (CHthiophene), 124.1 (CHthiophene), 36.2 (CH2); 
S
C11H10S
174.26 g/mol
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MS (EI), m/z (%) 175 (16), 174 (M+, 100), 173 (81), 141 (14), 129 (20), 128 (11), 115 (11), 97 
(56); Rf = 0.54 (silica gel, cyclohexane:EtOAc, 20:1). The NMR spectra were consistent 
with the literature data.[53] 
2,5-Dibenzylthiophene (140) 
In a 25 mL Young tube 2-benzylthiophene (300 mg, 1.72 mmol, 
1.00 eq.) was dissolved under slightly positive argon flow in dry 
THF (5 mL) and cooled to −78 °C. At this temperature nBuLi 
(1.6 M in hexanes, 1.50 mL, 2.40 mmol, 1.25 eq.) was added 
dropwise via syringe. The mixture was stirred for one hour, benzylbromide (0.30 mL, 
2.48 mmol, 1.29 eq.) was added and the cooling bath was removed. The reaction 
mixture was stirred over the weekend at room temperature, quenched with water 
(10 mL) and transferred to a separation funnel. The aqueous phase was extracted with 
MTBE (3×20 mL) and the combined organic phases were dried over MgSO4, filtered 
and the solvent was removed under reduced pressure. The obtained yellow oil was 
purified by flash chromatography (silica gel, 20×2 cm, cyclohexane:EtOAc, 20:1) to give 
the title compound as colorless oil (396 mg, 1.50 mmol, 87%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.32–7.27 (m, 5H, HCar), 7.25–7.19 (m, 5H, 
HCar), 6.60 (s, 2H, S(CH2C6H5)CH), 4.07 (s, 4H, 2 CH2); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 142.8 (2 Cthiophene), 140.5 (2 Car), 128.7 (4 HCar), 128.6 (4 HCar), 
126.6 (2 HCar), 124.9 (2 CHthiophene), 36.5 (2 CH2); MS (EI), m/z (%) 265 (13), 264 (M+, 61), 
173 (100), 129 (16), 91 (11); Rf = 0.52 (silica gel, cyclohexane:EtOAc, 20:1). 
2,5-Diethylthiophene (148) 
In a 25 mL Young tube 2-ethylthiophene (1.00 mL, 8.74 mmol, 1.00 eq.) 
was dissolved under slightly positive argon flow in dry THF (10 mL) 
and cooled to −78 °C. At this temperature nBuLi (1.6 M in hexanes, 
6.60 mL, 10.6 mmol, 1.21 eq.) was added dropwise via syringe. The mixture was stirred 
for one hour, 1-bromoethane (0.80 mL, 10.5 mmol, 1.20 eq.) was added and the cooling 
bath was removed. The reaction mixture was stirred for 24 hours at room temperature, 
quenched with water (15 mL) and transferred to a separation funnel. The aqueous 
phase was extracted with MTBE (3×25 mL) and the combined organic phases were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
obtained oil was 99% pure (1H-NMR: 1% of ethylthiophene) (1.08 g, 7.54 mmol, 86%). 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.58 (s, 2H, SCCH), 2.79 (q, 3JHH = 7.5 Hz, 
4H, 2 CH2), 1.29 (t, 3JHH = 7.5 Hz, 6H, 2 CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 144.9 (2 SC(CH2CH3)), 122.8 (2 SCHCH), 23.6 (2 CH2), 16.1 (2 CH3); MS (EI), 
m/z (%) 140 (M+, 58), 126 (12), 125 (100), 111 (13), 91 (17); IR (ν~ [cm−1]) 2965m, 2930w, 
2893w, 2872w, 2852w, 1456w, 801m, 520s; Rf = 0.49 (silica gel, cyclohexane:EtOAc, 
20:1). 
2,5-Dibutylthiophene (149) 
In a 25 mL Young tube 2-butylthiophene (1.00 mL, 6.66 mmol, 1.00 eq.) 
was dissolved under slightly positive argon flow in dry THF (10 mL) 
and cooled to −78 °C. At this temperature nBuLi (1.6 M in hexanes, 
5.00 mL, 8.00 mmol, 1.20 eq.) was added dropwise via syringe. The mixture was stirred 
for one hour, 1-bromobutane (0.90 mL, 8.03 mmol, 1.21 eq.) was added and the cooling 
bath was removed. The reaction mixture was stirred for 20 hours at room temperature, 
quenched with water (15 mL) and transferred to a separation funnel. The aqueous 
phase was extracted with MTBE (3×15 mL) and the combined organic phases were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
obtained red oil was purified by flash chromatography (silica gel, 20×2 cm, 
cyclohexane:EtOAc, 20:1) to give the title compound 149 as colorless oil (1.21 g, 
6.19 mmol, 93%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.56 (s, 2H, SCCH), 2.75 (t, 3JHH = 7.6 Hz, 
4H, CH2), 1.63 (mc, 4H, CH2), 1.39 (mc, 4H, CH2), 0.93 (mc, 6H, CH3); MS (EI), m/z (%) 
196 (M+, 19), 154 (15), 153 (100), 111 (16), 97 (17); IR (ν~ [cm−1]) 2956m, 2928m, 2871w, 
2856w, 1465w, 1456w, 1436w, 1378w, 798w, 567s, 544s; Rf = 0.49 (silica gel, 
cyclohexane:EtOAc, 20:1). 
2-(4-(Methylsulfonyl)benzyl)thiophene (142) 
Compound 142 was synthesized following the procedure 
described for the synthesis of 2-benzylthiophene (139) using 
2-methylsulfonyl benzylbromide (625 mg, 1.51 mmol, 1.00 eq.), 
sodium carbonate (339 mg, 3.20 mmol, 2.12 eq.), 2-thiophene 
boronic acid (240 mg, 1.82 mmol, 1.21 eq.) and Pd(PPh3)4 (37.4 mg, 0.03 mmol, 
2.13 mol%). The obtained brown oil was purified by flash chromatography (silica gel, 
S
SO2CH3
C12H12O2S2
252.35 g/mol
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15×2 cm, cyclohexane:EtOAc, 3:1) to give the title compound as orange oil (259 mg, 
1.03 mmol, 63%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.90–7.85 (m, 2H, HCar), 7.46–7.42 (m, 2H, 
HCar), 7.19 (dd, 3,4JHH = 5.2, 1.2 Hz, 1H, SCH), 6.96 (dd, 3JHH = 5.2, 3.4 Hz, 1H, SCHCH), 
6.83 (dq, 3,4JHH = 3.3, 1.0 Hz, 1H, SCHCHCH), 4.25 (s, 2H, CH2), 3.04 (s, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 146.9 (Car), 141.9 (Cthiophene), 138.9 (Car), 
129.6 (2 HCar), 127.9 (2 HCar), 127.2 (CHthiophene), 126.0 (CHthiophene), 124.8 (CHthiophene), 44.7 
(CH3), 36.0 (CH2); MS (EI), m/z (%) 254 (10), 253 (17), 252 (M+, 100), 251 (19), 173 (77), 
172 (30), 171 (32), 129 (26) 128 (17), 97 (67), 45 (27); IR (ν~ [cm−1]) 3747w, 2357w, 1408w, 
1303m, 1149m, 1090w, 959w, 592w, 563m, 524s; Rf = 0.18 (silica gel, cyclohexane:EtOAc, 
3:1). 
(4-Nitrophenyl)(thiophene-2-yl)methanol (144) 
Following a modified procedure of GUPTA et al.,[86] in a 100 mL 
three-necked round bottom flask equipped with a thermometer, 
TMEDA (0.91 mL, 5.97 mmol, 1.20 eq.) was dissolved in dry Et2O 
(10 mL) and cooled to 0 °C. At this temperature subsequent nBuLi 
(1.6 M in hexanes, 3.80 mL, 6.08 mmol, 1.37 eq.) and thiophene 
(0.40 mL, 4.95 mmol, 1.00 eq.) were added and stirred for another one hour. In a 
separate two-necked round bottom flask 4-nitrobenzaldehyde (918 mg, 6.01 mmol, 
1.21 eq.) was dissolved in dry THF (10 mL) and cooled with water/ice bath. The 
aldehyde was then added to the lithiated thiophene in solution over a period of 16 
min, which upon addition turned brown. The cooling bath was removed and the 
mixture was stirred at room temperature for one hour. After quenching with aqueous 
saturated NH4Cl solution (20 mL) and diluting with MTBE (20 mL), the mixture was 
transferred to a separation funnel. The phases were separated and the organic phase 
was washed with water (2×30 mL) and brine (30 mL), the combined organic phases 
were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The obtained brown oil was purified by flash chromatography (silica gel, 24×4 cm, 
npentane:EtOAc, 3:1) to give the title compound 144 as yellow-brown solid (898 mg, 
3.82 mmol, 77%). 
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1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 8.26–8.13 (m, 2H, HCar), 7.68–7.58 (m, 2H, 
HCar), 7.31 (dd, 3JHH = 4.8, 1.5 Hz, 1H, SCH), 6.98–6.92 (m, 2H, Hthiophene), 6.17 (d, 
3JHH = 3.3 Hz, 1H, CH(OH)), 2.63 (s, 1H, OH); IR (ν~ [cm−1]) 3743m, 2926w, 2367w, 
2323w, 1515m, 1346m, 646w, 554m, 537s; Rf = 0.18 (silica gel, npentane:EtOAc, 20:5). 
The NMR spectra were consistent with the literature data.[87] 
3,4-Diphenylthiophene (131a) 
Following a modified procedure of YANO et al.,[60] in a 100 mL 
three-necked round bottom flask Pd(PPh3)4 (293 mg, 0.25 mmol, 
5.05 mol%) was dissolved in degased DME (12 mL) and added 
dropwise 3,4-dibromothiophene (0.56 mL, 4.96 mmol, 1.00 eq.). 
Degased aqueous 2 M solution of sodium carbonate (2.11 g, 19.9 mmol, 
4.00 eq.) was added and the mixture stirred for 5 min. Phenylboronic acid (1.57 g, 
12.5 mmol, 2.51 eq.) in degased EtOH (15 mL) was added and heated to 90 °C. After 
21 hours the mixture was cooled to room temperature, filtered over celite and washed 
with CH2Cl2 (3×40 mL). The reaction mixture was transferred to a separation funnel 
and the aqueous phase was extracted with CH2Cl2 (3×5 mL). The combined organic 
phase was dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. The obtained mixture of brown oil solid was purified by flash 
chromatography (silica gel, 24×4 cm, cyclohexane) to give a white solid (1.16 mg, 
4.92 mmol, 99%). 
m.p. 111–112 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.32 (s, 2H, SCH), 7.29–
7.18 (m, 10H, HCar); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 141.9 
(2 SCHC(C6H5)), 136.7 (2 Car), 129.2 (4 HCar), 128.8 (4 HCar), 127.0 (2 HCar), 124.2 (2 SCH); 
MS (EI), m/z (%) 237 (20), 236 (M+, 100), 235 (76), 234 (30), 221 (22), 202 (19), 189 (11), 
117 (14), 104 (12); IR (ν~ [cm−1]) 3100w, 3093w, 1437m, 1180w, 1164w, 1073w, 934w, 
920w, 866m, 849w, 804s, 777m, 756s, 735m, 725m, 694s, 679m, 654m, 616m, 609m, 550s, 
535m, 519m; Rf = 0.23 (silica gel, cyclohexane). The NMR spectra were consistent with 
the literature data.[54] 
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3,4-Dimethylthiophene (131c) 
Following a modified procedure of WÜRTHNER et al.,[59] in a 100 mL 
three-necked round bottom flask 3,4-dibromothiophene (130) (0.56 mL, 
4.96 mmol, 1.00 eq.) and Ni(dppp)Cl2 (142 mg, 0.26 mmol, 5.23 mol%) were 
dissolved in dry THF (20 mL) and cooled to 0 °C. At this temperature 
methyl magnesium bromide (3.0 M in Et2O, 4.00 mL, 12.0 mmol, 2.42 eq.) was added 
and the mixture was refluxed for 16 hours. The brown reaction mixture was quenched 
with aqueous saturated NH4Cl solution (20 mL) and transferred to a separation funnel. 
The phases were separated and the aqueous phase was extracted with MTBE 
(3×20 mL), dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. The obtained mixture was used without further purification (501 mg, 
4.46 mmol, 90%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.88 (s, 2H, SCH), 2.17 (s, 6H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 137.5 (2 SCHCCH3), 120.8 (2 SCH), 
14.7 (2 CH3); MS (EI), m/z (%) 112 (M+, 78), 111 (100), 97 (44), 77 (14), 45 (19), 43 (14);  
IR (ν~ [cm−1]) 1685w, 1653w, 1481w, 1436m, 1157m, 1119m, 1100m, 1070m, 1055w, 
1027w, 998w, 717s, 691s, 547s, 537s; Rf = 0.66 (silica gel, cyclohexane:EtOAc 1:1). The 
NMR spectra were consistent with the literature data.[54] 
3,4-Diethylthiophene (131d) 
Compound 131d was synthesized following the procedure described for 
the synthesis of 3,4-dimethylthiophene (131c) using 3,4-dibromo-
thiophene (130) (0.56 mL, 4.96 mmol, 1.00 eq.), Ni(dppp)Cl2 (140 mg, 
0.26 mmol, 5.14 mol%) and ethylmagnesium bromide (0.9 M in THF, 
14.0 mL, 12.6 mmol, 2.54 eq.). The obtained brown oil was used without further 
purification (627 mg, 4.47 mmol, 90%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.91 (s, 2H, SCH), 2.54 (q, 3JHH = 7.5 Hz, 
4H, CH2), 1.25 (t, 3JHH = 7.5 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 143.5 (2 SCHC(CH2CH3)), 119.6 (2 SCH), 22.0 (2 CH2), 13.8 (2 CH3); MS (EI), 
m/z (%) 140 (M+, 45), 125 (100), 111 (13), 97 (16), 91 (12), 45 (11); IR (ν~ [cm−1]) 3100w, 
3054w, 2963w, 2933w, 2874w, 1672w, 1436m, 1174m, 1170m, 1156m, 1120m, 1099m, 
862w, 782w, 720s, 693s, 536s; Rf = 0.63 (silica gel, cyclohexane:EtOAc, 3:1). 
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7.6 Synthesis and Characterization of Substituted Thiophene 1,1-Dioxides 
2-Butyl-5-phenylthiophene 1,1-dioxide (136) 
In a 25 mL Schlenk tube 2-butyl-5-phenylthiophene (134) (918 mg, 
4.24 mmol, 1.00 eq.) was dissolved in AcOH (4 mL) and 30% 
hydrogen peroxide (2.60 mL, 25.5 mmol, 6.00 eq.) was added 
dropwise via syringe. The cloudy mixture was heated for two hours 
and became yellow after one hour. The reaction mixture was cooled to room 
temperature and aqueous saturated NaHCO3 was added slowly until a pH of 8–9 was 
reached. It was extracted with CH2Cl2 (3×20 mL), the combined organic phases were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
obtained yellow solid was purified by flash chromatography (silica gel, 24×3 cm, 
cyclohexane:EtOAc, 75:25) to give a pale solid, which was dissolved in a minimum of 
CH2Cl2 and npentane was added. The precipitated solid was washed with npentane 
and dried (326 mg, 1.31 mmol, 31%). 
m.p. 96–97 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.73–7.70 (m, 2H, HCar), 
7.46–7.40 (m, 3H, HCar), 6.85 (d, 3JHH = 4.8 Hz, 1H, SO2C(C6H5)CH), 6.45 (dt, 3,4JHH = 4.8, 
2.1 Hz, 1H, SO2C(C4H9)CH), 2.57 (mc, 2H, CH2), 1.70 (mc, 2H, CH2), 1.46 (mc, 2H, CH2), 
0.97 (t, 3JHH = 7.4 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 145.1 
(SO2C(C6H5)), 141.3 (SO2C(C4H9)), 130.1 (Car), 129.3 (2 HCar), 127.5 (HCar), 126.4 (2 HCar), 
121.9 (SO2C(C4H9)CH), 120.6 (SO2C(C6H5)CH), 28.8 (CH2), 24.2 (CH2), 22.4 (CH2), 13.9 
(CH3); MS (EI), m/z (%) 248 (M+, 38), 158 (13), 157 (100), 155 (47), 141 (32), 128 (11), 115 
(34), 105 (14), 102 (33), 91 (22); IR (ν~ [cm−1]) 3071w, 3061w, 2963w, 2932m, 2900w, 
2890w, 2863w, 2855w, 2356w, 1496m, 1457w, 1447m, 1418m, 1286s, 1270s, 1142s, 1117s, 
1079w, 970w, 852w, 770w, 729w, 680w, 666w, 637w, 615w, 592s; EA: calculated for 
C14H16O2S: C = 67.71, H = 6.49; measured: C = 67.68, H = 6.55; Rf = 0.38 (silica gel, 
cyclohexane:EtOAc, 75:25). 
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2-Methyl-5-phenylthiophene 1,1-dioxide (137) 
In a 100 mL three-necked round bottom flask 2-methyl-5-phenyl-
thiophene (135) (202 mg, 1.15 mmol, 1.00 eq.) was dissolved in 
CH2Cl2/acetone (2/10 mL) and the freshly prepared 
dimethyldioxirane[85] (∼0.07 M in acetone, 20.0 mL, 4.60 mmol, 4.00 eq.) 
was added. The pale yellow mixture was stirred for 18 hours, evaporated under 
reduced pressure and the obtained yellow solid was purified by flash chromatography 
(silica gel, 20×2 cm, cyclohexane:EtOAc, 75:25) to give a pale solid, which was 
dissolved in a minimum of CH2Cl2 and npentane was added. The precipitated solid 
was washed with npentane and dried (112 mg, 0.54 mmol, 47%). 
m.p. 128–129 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.66–7.63 (m, 2H, HCar), 
7.39–7.33 (m, 3H, HCar), 6.77 (d, 3JHH = 4.7 Hz, 1H, SO2C(C6H5)CH), 6.40 (dq, 3,4JHH = 3.8, 
1.8 Hz, 1H, SO2C(CH3)CH), 2.13 (d, 4JHH = 1.8 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 142.4 (SO2C(C6H5)), 140.5 (SO2C(CH3)), 130.2 (Car), 129.3 (2 HCar), 
127.4 (HCar), 126.3 (2 HCar), 122.9 (SC(CH3)CH), 120.6 (SO2C(C6H5)CH), 9.6 (CH3); 
MS (EI), m/z (%) 206 (M+, 58), 159 (12), 158 (100), 157 (35), 141 (11), 129 (10), 115 (32), 
102 (94), 76 (13); IR (ν~ [cm−1]) 3067w, 2360w, 1280m, 1133m, 1115m, 761m, 694s, 572s, 
504s; EA: calculated for C11H10O2S: C = 64.05, H = 4.89; measured: C = 64.03, H = 4.96; 
Rf = 0.17 (silica gel, cyclohexane:EtOAc, 75:25). 
2,5-Dibenzylthiophene 1,1-dioxide (141) 
Compound 141 was synthesized following the procedure 
described for the synthesis of 2-butyl-5-phenylthiophene 1,1-
dioxide (136) using 2,5-dibenzylthiophene (140) (838 mg, 
3.17 mmol, 1.00 eq.), AcOH (7 mL) and 30% hydrogen peroxide 
(2.00 mL, 19.6 mmol, 6.18 eq.). The obtained yellow oil was purified by flash 
chromatography (silica gel, 22×4 cm, cyclohexane:EtOAc, 75:25) to give a pale solid, 
which was dissolved in a minimum of CH2Cl2 and npentane was added. The 
precipitated solid was washed with npentane and dried (255 mg, 0.86 mmol, 27%). 
m.p. 88–90 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.36–7.23 (m, 10H, HCar), 
5.92 (s, 2H, SO2CCH), 3.76 (s, 4H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 144.3 (2 SO2C(CH2C6H5)), 135.1 (2 Car), 129.4 (4 HCar), 129.0 (4 HCar), 127.4 
(2 HCar), 123.3 (2 SO2CCH), 30.3 (2 CH2); MS (EI), m/z (%) 233 (18), 232 (M+−SO2, 92), 
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217 (12), 215 (11), 154 (12), 153 (12), 141 (56), 128 (22), 117 (10), 115 (25), 91 (100);  
IR (ν~ [cm−1]) 3083w, 3061w, 3028w, 2360w, 1734w, 1601w, 1493m, 1454m, 1280s, 1126s, 
1026m, 852w, 695s, 543s; EA: calculated for C18H16O2S: C = 72.95, H = 5.44; measured: 
C = 72.53, H = 5.51; HRMS (ESI, 4500 V, 180 °C) calc. m/z for C18H17O2S+: 297.0941, 
found: 297.0944 [M+H]+; calc. m/z for C18H20NO2S+: 314.1207, found: 314.1209 [M+NH4]+; 
calc. m/z for C18H16NaO2S+: 319.0766, found: 319.0763 [M+Na]+; calc. m/z for 
C18H16KO2S+: 335.0502, found: 335.0503 [M+K]+; calc. m/z for C36H32NaO4S2+: 615.1638, 
found: 615.1634 [2M+Na]+; calc. m/z for C36H32KO4S2+: 631.1370, found: 631.1374 
[2M+K]+; Rf = 0.42 (silica gel, cyclohexane:EtOAc, 75:25). 
2,5-Diethylthiophene 1,1-dioxide (150) 
In a 50 mL Schlenk tube 2,5-ethylthiophene (148) (567 mg, 4.04 mmol, 
1.00 eq.), urea hydrogen peroxide (3.16 g, 32.6 mmol, 8.07 eq.) was 
dissolved in dry THF (10 mL) and trifluoroacetic acid anhydride 
(3.40 mL, 24.0 mmol, 5.93 eq.) was added dropwise via syringe over a 
period of 25 min. After one hour stirring aqueous saturated NaHCO3 was added 
slowly until a pH of 8–9 was reached. It was extracted with CH2Cl2 (3×40 mL), the 
combined organic phases were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The crude solid was purified by flash 
chromatography (silica gel, 27×3 cm, cyclohexane:EtOAc, 3:1) to give a colorless solid 
(440 mg, 2.50 mmol, 62%). 
m.p. 52–56 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.27 (t, 3JHH = 1.3 Hz, 2H, 
SO2CCH), 2.51 (q, 3JHH = 7.4 Hz, 4H, CH2), 1.26 (t, 3JHH = 7.4 Hz, 6H, CH3); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 145.5 (2 SO2C(C2H5)), 121.2 (2 SO2C), 17.7 (2 CH2), 
11.1 (2 CH3); MS (EI), m/z (%) 172 (M+, 29), 124 (24), 109 (100), 93 (47), 91 (31), 79 (27), 
77 (38), 65 (11), 43 (10), 41 (13); HRMS (ESI, 4500 V, 180 °C) calc. m/z for C8H13O2S+: 
173.0630, found: 173.0631 [M+H]+; calc. m/z for C8H12NaO2S+: 195.0448, found: 195.0450 
[M+Na]+; calc. m/z for C16H25O4S2+: 345.1184, found: 345.1189 [2M+H]+; calc. m/z for 
C16H24NaO4S2+: 367.1005, found: 367.1008 [2M+Na]+; IR (ν~ [cm−1]) 3083w, 2978, 2881w, 
2356w, 1441m, 1280s, 1257s, 1128s, 1080m, 849s, 713m, 634m, 548s; Rf = 0.27 (silica gel, 
cyclohexane:EtOAc, 75:25); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): 
tR = 51.3 min; GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-
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1701, 30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): 
tR(trans) = 42.8 min. 
2,5-Dibutylthiophene 1,1-dioxide (151) 
Compound 151 was synthesized following the procedure described for 
the synthesis of 2-butyl-5-phenylthiophene 1,1-dioxide (136) using 
2,5-dibutylthiophene (149) (1.28 g, 5.50 mmol, 1.00 eq.), AcOH (10 mL) 
and 30% hydrogen peroxide (3.40 mL, 33.3 mmol, 6.05 eq.). The 
obtained yellow oil was purified by flash chromatography (silica gel, 22×4 cm, 
cyclohexane:EtOAc, 75:25) to give a colorless oil (255 mg, 2.09 mmol, 38%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.26 (t, 4JHH = 1.1 Hz 2H, SO2CCH), 2.47 
(t, 3JHH = 7.6 Hz, 4H, CH2), 1.70–1.54 (mc, 4H, CH2), 1.46–1.31 (mc, 4H, CH2), 0.94 (t, 
3JHH = 7.4 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 144.1 
(2 SO2C(C4H9)), 121.8 (2 SO2CCH), 28.8 (2 CH2), 24.1 (2 CH2), 22.4 (2 CH2), 13.8 (2 CH3); 
MS (EI), m/z (%) 228 (M+, 19), 186 (12), 138 (14), 137 (100), 121 (11), 107 (17), 95 (21), 93 
(27), 91 (22), 85 (11), 81 (19), 80 (13), 79 (46), 77 (23), 67 (13), 55 (18), 43 (25), 41 (29);  
IR (ν~ [cm−1]) 2958w, 2931w, 2873w, 2863w, 1715w, 1465w, 1456w, 1289m, 1144m, 
1110w, 534s; HRMS (ESI, 4500 V, 180 °C) calc. m/z for C12H21O2S+: 229.1255, found: 
229.1257 [M+H]+; calc. m/z for C12H24NO2S+: 246.1520, found: 246.1522 [M+NH4]+; calc. 
m/z for C12H20NaO2S+: 251.1078, found: 251.1076 [M+Na]+; calc. m/z for C12H20KO2S+: 
267.0822, found: 267.0816 [M+K]+; calc. m/z for C24H40NaO4S2+: 479.2259, found: 
479.2260 [2M+Na]+; Rf = 0.37 (silica gel, cyclohexane:EtOAc, 75:25). 
3,4-Diphenylthiophene 1,1-dioxide (152) 
Compound 152 was synthesized following the procedure described for 
the synthesis of 2,5-diethylthiophene 1,1-dioxide (150) using 
3,4-diphenylthiophene (131a) (445 mg, 1.88 mmol, 1.00 eq.), urea 
hydrogen peroxide (1.48 g, 15.4 mmol, 8.20 eq.) and trifluoroacetic acid 
anhydride (1.60 mL, 11.3 mmol, 5.99 eq.). The crude solid was purified 
by flash chromatography (silica gel, 23×2 cm, cyclohexane:EtOAc, 4:1) to give a white 
solid (244 mg, 0.91 mmol, 48%). 
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m.p. 172–173 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.38 (mc, 2H, HCar), 7.29 
(mc, 4H, HCar), 7.07–7.04 (m, 4H, HCar), 6.63 (s, 2H, SO2CH); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 145.2 (2 SO2CHC), 131.5 (2 Car), 130.2 (2 SO2CH C), 128.6 
(4 HCar), 128.6 (4 HCar), 127.6 (2 HCar); MS (EI), m/z (%) 268 (M+, 45), 240 (11), 239 (62), 
221 (16), 220 (59), 202 (15), 192 (21), 191 (60), 189 (20), 165 (14), 161 (15), 105 (100), 102 
(62), 77 (33), 76 (26), 63 (10), 51 (12); HRMS (ESI, 4500 V, 180 °C) calc. m/z for 
C16H12NaO2S+: 291.0450, found: 291.0452 [M+Na]+; calc. m/z for C32H24NaO4S+: 559.1008, 
found: 559.1010 [2M+Na]+; IR (ν~ [cm−1]) 3064w, 2370w, 1748m, 1489w, 1444w, 1302w, 
1215w, 1117m, 908w, 904w, 755m, 734m, 727m, 694m, 691m, 689m, 682m, 645w, 555s, 
543s; Rf = 0.38 (silica gel, cyclohexane:EtOAc, 4:1). 
3,4-Dimethylthiophene 1,1-dioxide (153) 
Compound 153 was synthesized following the procedure described for the 
synthesis of 2,5-diethylthiophene 1,1-dioxide (150) using 3,4-dimethyl-
thiophene (131c) (677 mg, 6.03 mmol, 1.00 eq.), urea hydrogen peroxide 
(4.79 g, 49.4 mmol, 8.19 eq.) and trifluoroacetic acid anhydride (5.20 mL, 
36.6 mmol, 6.07 eq.). The crude solid was purified by flash chromatography (silica gel, 
27×4 cm, cyclohexane:EtOAc, 1:1) to give a pale yellow solid (361 mg, 2.50 mmol, 42%). 
m.p. 104–105 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.28 (d, 4JHH = 1.2 Hz, 
2H, SO2CH), 2.04 (d, 4JHH = 1.2 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 142.9 (2 SO2CHC), 126.2 (2 SO2CH), 14.5 (2 CH3); MS (EI), m/z (%) 144 (M+, 60), 
115 (54), 97 (13), 96 (100), 95 (46), 81 (16), 79 (10), 77 (19), 68 (34), 67 (84), 65 (19), 53 (33), 
51 (16), 45 (26), 43 (61), 41 (37), 40 (19); HRMS (ESI, 4500 V, 180 °C) calc. m/z for 
C6H9O2S+: 145.0318, found: 145.0318 [M+H]+; calc. m/z for C6H8NaO2S+: 167.0137, found: 
167.0137 [M+Na]+; IR (ν~ [cm−1]) 3100w, 3076m, 1636w, 1565w, 1452w, 1437m, 1388m, 
1374m, 1308m, 1276s, 1187m, 1175s, 1154m, 1092s, 1089s, 1031m, 1015w, 998m, 867s, 
786s, 677m, 581s, 577s, 570s, 567s; Rf = 0.29 (silica gel, cyclohexane:EtOAc, 1:1); 
GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa 
H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): tR = 68.6 min; GC (14% 
Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 30 m × 0.25 mm 
× 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): tR = 67.4 min. 
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3,4-Diethylthiophene 1,1-dioxide (154) 
Compound 154 was synthesized following the procedure described for 
the synthesis of 2,5-diethylthiophene 1,1-dioxide (150) using 3,4-diethyl-
thiophene (131d) (721 mg, 5.14 mmol, 1.00 eq.), urea hydrogen peroxide 
(4.01 g, 41.4 mmol, 8.04 eq.) and trifluoroacetic acid anhydride (4.40 mL, 
31.0 mmol, 6.03 eq.). The crude solid was purified by flash chromatography (silica gel, 
25×4 cm, cyclohexane:EtOAc, 4:1 then 2:1) to give a colorless solid (513 mg, 2.98 mmol, 
58%). 
m.p. 120–121 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.25 (t, 4JHH = 1.6 Hz, 2H, 
SO2CH), 2.35 (dq, 3,4JHH = 7.2, 1.6 Hz, 4H, CH2), 1.19 (t, 3JHH = 7.2 Hz, 6H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 149.0 (2 SO2CHC(C2H5)), 124.7 
(2 SO2CH), 21.4 (2 CH2), 11.3 (2 CH3); MS (EI), m/z (%) 172 (M+, 23), 143 (41), 124 (35), 
109 (100), 91 (11), 81 (22), 79 (16), 77 (19), 67 (11), 65 (11), 57 (25), 53 (14), 51 (10), 41 (16); 
HRMS (ESI, 4500 V, 180 °C) calc. m/z for C8H13O2S+: 173.0630, found: 173.0631 [M+H]+; 
calc. m/z for C8H12NaO2S+: 195.0449, found: 195.0450 [M+Na]+; IR (ν~ [cm−1]) 3096w, 
3078m, 2974m, 2940w, 1569w, 1448m, 1423m, 1386m, 1382m, 1300w, 1277s, 1264m, 
1248s, 1172m, 1157m, 1120w, 1092s, 1055m, 1043w, 996w, 970m, 859m, 819s, 807m, 
760m, 580s, 575s, 555s, 531m, 517m, 512m, 508m; Rf = 0.19 (silica gel, 
cyclohexane:EtOAc, 75:25); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): 
tR = 72.2 min; GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-
1701, 30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): 
tR = 75.3 min. 
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7.7 Characterization of Substituted Tetrahydrofurans and 
Dihydrobenzofurans 
Hydrogenation products 4-methyl-2-phenyl-tetrahydrofuran (113)[46, 88], 2-phenyl-
tetrahydrofuran (105)[89] and 2-(4-(trifluoromethyl)phenyl)tetrahydrofuran (107)[90] are 
known compounds. Hydrogenation product, 6-bromo-3,5-dimethyl-2,3-dihydro-
benzofuran (117), was analyzed after lithiation with subsequent aqueous workup as 
the unhalogenated product, 3,5-dimethyl-2,3-dihydrobenzofuran (116). 
3-Phenyltetrahydrofuran (100) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.27–7.14 (m, 5H, HCar), 4.08 
(dd, 3JHH = 7.7, 7.6 Hz, 1H, CH2), 4.01 (dt, 3JHH = 8.3, 8.3, 4.5 Hz, 1H, CH2), 
3.86 (dd, 3JHH = 8.1, 8.0 Hz, 1H, CH2), 3.67 (dd, 3JHH = 8.2, 7.8 Hz, 1H, CH2), 
3.34 (quint, 3JHH = 7.9, 7.9, 7.9, 7.9 Hz, 1H, CH), 2.30 (mc, 1H, CH2), 1.95 (qd, 3JHH = 12.3, 
8.1, 8.1, 8.1 Hz, 1H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 142.8 (Car), 
128.7 (2 HCar), 127.4 (2 HCar), 126.6 (HCar), 74.8 (CH2), 68.7 (CH2), 45.2 (CH), 34.8 (CH2); 
GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 6.8 min), m/z 
(%) 148 (M+, 42), 118 (56), 117 (100), 115 (21), 91 (33), 77 (10), 51 (11); IR (ν~ [cm−1]) 3062w, 
3028w, 2968w, 2929w, 2854w, 1603w, 1493m, 1454w, 1356w, 1208w, 1183w, 1067m, 
1053m, 1030w, 968w, 904w, 819w, 757s, 699s, 667w, 624w; EA: calculated for C10H12O: 
C = 81.04, H = 8.16; measured: C = 80.78, H = 8.29; Rf = 0.47 (silica gel, 
cyclohexane:EtOAc, 2:1); GC (γ-Cyclodextrin-trifluoroacetyl, Chiraldex, 30 m 
× 0.25 mm, 60 kPa H2, 95 °C, 60 min, 5.0 K/min, 160 °C, 5 min): tR(major) = 24.9 min, 
tR(minor) = 25.7 min; [α]D20 −17.3 (c 1.16, CH2Cl2, 98% ee). The NMR spectra were consistent 
with the literature data.[91] 
3-(4-Methoxyphenyl)tetrahydrofuran (101) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.17 (mc, 2H, HCar), 6.86 
(mc, 2H, HCar), 4.12 (t, 3JHH = 7.9 Hz, 1H, CH2), 4.06 (dt, 3JHH = 8.4, 8.3, 
4.5 Hz, 1H, CH2), 3.91 (dd, 2,3JHH = 15.5, 8.1 Hz, 1H, CH2), 3.80 (s, 3H, CH3), 
3.68 (t, 3JHH = 8.1 Hz, 1H, CH2), 3.31–3.40 (m, 1H, CH), 2.34 (dtd, 2,3JHH = 12.2, 7.6, 7.6, 
4.5 Hz, 1H, CH2), 1.97 (qd, 2,3JHH = 12.3, 8.2, 8.2, 8.2 Hz, 1H, CH2); 
O
C10H12O
148.20 g/mol
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3C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 158.4 (Car), 134.7 (Car), 128.3 (2 HCar), 
114.1 (2 HCar), 74.9 (CH2), 68.6 (CH2), 55.4 (CH3), 44.4 (CH), 34.9 (CH2); GC-MS (EI, 
70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 10.3 min), m/z (%) 178 (M+, 
64), 149 (14), 148 (100), 133 (35), 121 (50), 105 (36), 91 (25), 77 (56), 65 (25), 51 (26);  
IR (ν~ [cm−1]) 2932w, 2908w, 2854w, 2835w, 1611w, 1583w, 1513s, 1463m, 1454w, 
1442w, 1354w, 1305w, 1243s, 1178s, 1117w, 1053s, 1033s, 969w, 901w, 828s, 811m, 
773w, 602m; EA: calculated for C11H14O2: C = 74.13, H = 7.92; measured: C = 74.15; H = 
8.21; Rf = 0.17 (silica gel, cyclohexane:EtOAc, 10:1); GC (γ-Cyclodextrin-trifluoroacetyl, 
Chiraldex, 30 m × 0.25 mm, 60 kPa H2, 50 °C, 50 min, 5.0 K/min, 160 °C, 10 min): 
tR = 74.4 min; HPLC (IC, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 225 nm): 
tR(major) = 32.8 min, tR(minor) = 34.2 min; [α]D20 +16.2 (c 1.17, CH2Cl2, 95% ee) from 
hydrogenation with (R)-enantiomer of catalyst. 
3-(4-(Trifluoromethyl)phenyl)tetrahydrofuran (102) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.57 (d, 3JHH = 8.1 Hz, 2H, 
HCar), 7.37 (d, 3JHH = 8.2 Hz, 2H, HCar), 4.14 (dd, 3JHH = 8.4, 7.6 Hz, 1H, CH2), 
4.09 (dt, 3JHH = 8.4, 8.3, 4.7 Hz, 1H, CH2), 3.93 (dd, 2,3JHH = 16.0, 7.7 Hz, 1H, 
CH2), 3.76 (dd, 3JHH = 8.5, 6.9 Hz, 1H, CH2), 3.46 (quint, 3JHH = 7.5, 7.5, 7.4, 7.4 Hz, 1H, 
CH), 2.41 (dtd, 2,3JHH = 12.5, 8.0, 7.8, 4.7 Hz, 1H, CH2), 2.00 (mc, 1H, CH2); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 147.3 (Car), 129.0 (q, 2JCF = 32.4 Hz, 
Car), 127.7 (2 HCar), 125.7 (q, 3JCF = 3.8 Hz, 2 Car), 124.1 (q, 1JCF = 261.1 Hz, CF3), 74.6 
(OCH2), 68.6 (OCH2CH2), 45.0 (OCH2CH), 34.8 (OCH2CH2); 19F{1H}-NMR (376.5 MHz, 
CDCl3, 300 K): δ (ppm) −62.7 (CF3); GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 
270 °C, 10 min, tR = 7.1 min), m/z (%) 216 (M+, 16), 197 (10), 186 (69), 159 (15), 118 (11), 
117 (100), 115 (27); IR (ν~ [cm−1]) 2973w, 2936w, 2866w, 2861w, 1700w, 1619m, 1452w, 
1422w, 1322s, 1161s, 1112s, 1088m, 1067s, 1016s, 970w, 907w, 836s, 764w; 
EA: calculated for C11H11F3O: C = 61.11, H = 5.13; measured: C = 61.19, H = 5.37; Rf = 0.37 
(silica gel, cyclohexane:EtOAc, 2:1); GC (γ-Cyclodextrin-trifluoroacetyl, Chiraldex, 
30 m × 0.25 mm, 60 kPa H2, 95 °C, 32 min, 5.0 K/min, 160 °C, 5 min): tR(major) = 32.3 min, 
tR(minor) = 33.1 min; [α]D20 −9.2 (c 1.18, CH2Cl2, >97% ee). 
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3-Cyclohexyltetrahydrofuran (103) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.92 (t, 3JHH = 7.8 Hz, 1H, 
CH2), 3.85 (dt, 3JHH = 8.4, 3.3 Hz, 1H, CH2), 3.72 (dt, 3JHH = 8.5, 6.6 Hz, 1H, 
CH2), 3.36 (t, 3JHH = 8.4 Hz, 1H, CH2), 1.95 (m, 2H, CH2), 1.67 (m, 5H, CH2), 
1.51 (m, 1H, CH), 1.19 (m, 4H, CH2), 0.97 (m, 2H, CH2); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 72.2 (CH2), 68.5 (CH2), 46.0 (CH), 41.7 (CH), 32.5 (CH2), 32.2 
(CH2), 30.8 (CH2), 26.6 (CH2), 26.4 (CH2), 26.3 (CH2); GC-MS (EI, 70 eV, Me2Si, 100 °C, 
2 min, 10 °C/min, 270 °C, 10 min, tR = 6.8 min), m/z (%) 154 (M+, 10), 136 (18), 121 (13), 
108 (15), 107 (16), 95 (14), 94 (20), 93 (14), 83 (32), 82 (92), 81 (62), 80 (16), 79 (31), 77 (13), 
69 (11), 68 (27), 67 (100), 65 (10), 55 (80), 54 (24), 53 (31); IR (ν~ [cm−1]) 2919s, 2849s, 
2668w, 2361w, 2337w, 1781w, 1700w, 1448s, 1348w, 1260w, 1187w, 1118w, 1086s, 
1070m, 1050m, 1038m, 966w, 907m, 890m; EA: caclulated for C10H18O: C = 77.87, H = 
11.76; measured: C = 77.92, H = 11.65; Rf = 0.11 (silica gel, npentane:EtOAc, 50:1); 
GC (6-Methyl-2,3-pentyl-γ-cyclodextrin (60% in polysiloxane PS086), 
30 m × 0.25 mm × 0.125 μm, 60 kPa H2, 60 °C, 30 min, 1.0 K/min, 100 °C, 5 min, 
10.0 K/min, 180 °C, 5 min): tR(minor) = 51.8 min, tR(major) = 52.6 min; [α]D20 −6.6 (c 1.28, 
CH2Cl2, >98% ee). The NMR spectra were consistent with the literature data.[91] 
3-Octyltetrahydrofuran (104) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.89 (t, 3JHH = 7.7 Hz, 1H, 
CH2), 3.83 (dt, 3JHH = 8.2, 4.1 Hz, 1H, CH2), 3.73 (dd, 2,3JHH = 15.4, 7.9 Hz, 1H, 
CH2), 3.31 (t, 3JHH = 7.8 Hz, 1H, CH2), 2.15 (dt, 2,3JHH = 14.7, 7.4 Hz, 1H, CH2), 2.02 (dtd, 
2,3JHH = 12.1, 7.5, 4.6 Hz, 1H, CH2), 1.48 (dq, 2,3JHH = 12.0, 7.9 Hz, 1H, CH), 1.41–1.21 (m, 
14H, CH2), 0.88 (t, 3JHH = 6.9 Hz, 3H, CH3); 13C{1H-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 73.7 (CH2), 68.1 (CH2), 39.6 (CH), 33.5 (CH2), 32.7 (CH2), 32.0 (CH2), 29.9 (CH2), 
29.7 (CH2), 29.4 (CH2), 28.8 (CH2), 22.8 (CH2), 14.3 (CH3); GC-MS (EI, 70 eV, Me2Si, 
60 °C, 2 min, 10 °C/min, 270 °C, 10 min, tR = 13.0 min), m/z (%) 138 (20), 137 (59), 112 
(12), 110 (15), 109 (24), 97 (18), 96 (31), 95 (77), 84 (21), 83 (47), 82 (42), 81 (37), 71 (23), 
70 (47), 69 (56), 68 (36), 67 (37), 57 (34), 56 (47), 55 (86), 54 (20), 53 (12), 43 (63), 42 (32), 
41 (100); IR (ν~ [cm−1]) 2957m, 2922s, 2853s, 1466w, 1099w, 1059w, 909m, 660m;  
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EA: calculated for C12H24O: C = 78.20, H = 13.12; measured: C = 78.02, H = 12.91; Rf = 0.48 
(silica gel, cyclohexane:EtOAc, 4:1); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 95 °C, 50 min, 0.1 °C/min, 96 °C, 0 min, 10 °C/min, 
180 °C, 10 min): tR(minor) = 55.3 min, tR(major) = 57.3 min; [α]D20 −2.0 (c 0.21, CH2Cl2, 95% ee). 
2-Phenyl-4-methyltetrahydrofuran (113) 
Synthesized following the general working procedure for 
hydrogenations with iridium catalysts. The mixture of cis:trans (92:8) 
isomers could not be separated on semipreparative HPLC (OD, 
nhexane:iPrOH, 95:5, 6 mL/min). 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 30 m 
× 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min): diastereomers: 
tR = 13.8 min; GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm 
× 0.25 μm, 40 kPa H2, 90 °C, 10 min, 0.1 °C/min, 92 °C, 10 °C/min, 180 °C, 10 min): 
tR1 = 34.4 min, tR2 = 34.6 min, tR3 = 35.2 min, tR4 = 35.4 min. 
2-Hexyl-4-methyltetrahydrofuran (114) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. The mixture of cis:trans (90:10) isomers could 
not be separated. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.99–3.98 (m, 2H, CH2 trans), 
3.88–3.80 (m, 2H, CH2 cis), 3.34 (t, 3JHH = 7.9 Hz, 1H, CH cis), 3.24 (mc, 1H, CH trans), 
3.37–2.24 (m, 1H, CH2 cis), 2.15–2.09 (m, 1H, CH2 cis), 1.67–1.54 (m, 1H, CH cis), 1.49–
1.21 (m, 10H, 5 CH2 cis), 1.03 (d, 3JHH = 6.6 Hz, 3H, CH3 cis), 0.87 (t, 3JHH = 6.7 Hz, 3H, CH3 
cis); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 80.5 (Cq cis), 79.0 (Cq trans), 75.0 
(CH trans), 74.5 (CH cis), 41.1 (CH2 cis), 39.8 (CH2 trans), 36.3 (CH2 cis), 34.5 (CH2 cis), 
33.3 (CH2 trans), 32.0 (CH2 cis), 29.6 (CH2 cis), 26.5 (CH2 cis), 26.4 (CH2 trans), 22.8 (CH2 
cis), 18.1 (CH3 cis), 18.3 (CH3 trans), 14.2 (CH3 cis); GC-MS (EI, 70 eV, Me2Si, 60 °C, 
2 min, 10 °C/min, 270 °C, 10 min, tR = 10.2 min), m/z (%) 86 (10), 85 (100), 67 (17), 57 
(27), 55 (14), 43 (21), 41 (36); IR (ν~ [cm−1]) 2956m, 2925s, 2871m, 2855m, 1457w, 1378w, 
1106w, 1041w, 1015w, 646w; EA: calculated for C12H24O: C = 77.58, H = 13.02; measured: 
C = 77.49, H = 12.86; Rf = 0.15 (silica gel, cyclohexane:EtOAc, 20:1); GC (14% Cyano-
propylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 30 m × 0.25 mm × 0.25 μm, 
60 kPa H2, 90 °C, 32 min, 0.1 °C/min, 92 °C, 0 min, 10 °C/min, 250 °C, 10 min): 
tR(cis) = 33.4 min, tR(trans) = 33.8 min; GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
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25 m × 0.25 mm × 0.25 μm, 40 kPa H2, 90 °C, 10 min, 0.1 °C/min, 92 °C, 0 min, 10 °C/min, 
180 °C, 10 min): tR(major) = 24.0 min, tR(minor) = 24.7 min. The NMR spectra were consistent 
with the literature data.[92] 
2,4-Diphenyltetrahydrofuran (112) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. The mixture of cis:trans 
isomers was separated by flash chromatography (silica gel, 
cyclohexane:EtOAc, 20:1). 
trans-2,4-Diphenyltetrahydrofuran (trans-2a) – calyxolane A 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.40–7.23 (m, 10H, HCar), 5.24 (dd, 
3JHH = 7.8, 5.8 Hz, 1H, CH), 4.48 (dd, 3JHH = 8.5, 7.4 Hz, 1H, CH2), 3.96 (t, 3JHH = 8.2 Hz, 
1H, CH2), 3.55 (quint, 3JHH = 7.8, 7.8, 7.8, 7.8 Hz, 1H, CH), 2.49 (dt, 2,3JHH = 12.6, 7.7 Hz, 
1H, CH2), 2.34 (ddd, 2,3JHH = 12.6, 8.3, 5.8 Hz, 1H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 
300 K): δ (ppm) 143.7 (Car), 142.2 (Car), 128.8 (2 Car), 128.5 (2 Car), 127.5 (2 Car), 127.3 (Car), 
126.8 (Car), 125.6 (2 Car), 80.7 (CH), 75.3 (CH2), 44.6 (CH), 42.9 (CH2); cis-2,4-Diphenyl-
tetrahydrofuran (cis-2b) – calyxolane B sample contains 6% calyxolane A 1H-NMR 
(400.1 MHz, CDCl3, 300 K): δ (ppm) 7.45–7.22 (m, 10H, HCar), 5.07 (dd, 3JHH = 10.1, 
5.7 Hz, 1H, CH), 4.36 (t, 3JHH = 8.2 Hz, 1H, CH2), 4.03 (t, 3JHH = 8.5 Hz, 1H, CH2), 3.64 (dq, 
3JHH = 10.6, 8.2, 8.1 Hz, 1H, CH), 2.76 (ddd, 2,3JHH = 12.8, 7.2, 5.8 Hz, 1H, CH2), 2.02 (m, 
1H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 142.8 (Car), 141.8 (Car), 128.7 
(2 Car), 128.6 (2 Car), 127.5 (Car), 127.4 (2 Car), 126.8 (Car), 125.8 (2 Car), 82.0 (CH), 75.2 
(CH2), 46.2 (CH), 43.9 (CH2); GC-MS (EI, 70 eV, Me2Si, 100 °C, 2 min, 10 °C/min, 270 °C, 
10 min, tR(cis) = 15.0 min, tR(trans) = 15.1 min), m/z (%) 224 (M+, 39), 195 (13), 194 (81), 193 
(93), 179 (61), 178 (35), 165 (21), 146 (25), 133 (27), 120 (21), 118 (23), 117 (100); Rf = 0.16 
(cis), 0.24 (trans) (silica gel, cyclohexane:EtOAc, 20:1); GC (6-Methyl 2,3-pentyl-γ-cyclo-
dextrin (60% in polysiloxane PS086), 30 m × 0.25 mm × 0.125 μm, 60 kPa H2, 95 °C, 
30 min, 5.0 K/min, 180 °C, 30 min): tR(cis) = 55.8 min, tR(trans) = 56.2 min. The NMR spectra 
were consistent with the literature data.[93] 
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2-Cyclohexyltetrahydrofuran (108) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.84–3.79 (m, 1H, OCH2), 
3.74–3.68 (m, 1H, OCH2), 3.51–3.46 (m, 1H, CH), 1.94–0.92 (m, 15H, CH2); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 84.1 (OCH), 67.8 (OCH2), 43.2 (CH), 
30.1 (CH2), 29.4 (CH2), 29.3 (CH2), 26.7 (CH2), 26.3 (CH2), 26.1 (CH2), 26.0 (CH2);  
GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 
250 °C, 10 min, tR = 6.8 min), m/z (%) 71 (100), 70 (26), 43 (16); IR (ν~ [cm−1]) 2923m, 
2850m, 1707m, 1696m, 1669w, 1660w, 1448m, 1437w, 1259w, 1064w, 1030w, 1016w, 
807w, 545w, 533s, 502s; Rf = 0.21 (silica gel, cyclohexane:EtOAc, 20:1); GC (β-
Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 60 °C, 
1 °C/min, 120 °C, 10 °C/min, 180 °C, 10 min): tR(major) = 31.6 min, tR(minor) = 32.9 min; 
[α]D20 +0.97 (c 0.47, CH2Cl2, 82% ee). The NMR spectra were consistent with the 
literature data.[94] 
2-Octyltetrahydrofuran (109) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.85 (dd, 2,3JHH = 14.5, 7.3 Hz, 
1H, OCH2), 3.77 (mc, 1H, OCHC8H17), 3.70 (dd, 3JHH = 14.3, 7.9 Hz, 1H, OCH2), 2.00–1.80 
(m, 3H, OCH2CH2CH2), 1.61–1.52 (m, 1H, OCH2CH2CH2), 1.47–1.38 (m, 3H, CH2), 1.27 
(mc, 11H, CH2), 0.88 (t, 3JHH = 6.9 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 79.6 (OCH2), 67.8 (OCH), 35.9 (CH2), 32.1 (CH2), 31.5 (CH2), 29.9 (CH2), 29.7 
(CH2), 29.4 (CH2), 26.6 (CH2), 25.9 (CH2), 22.8 (CH2), 14.3 (CH3); GC-MS (EI, 70 eV, 5% 
polyphenylmethylsiloxane, 100 kPa, 60 °C, 3 min, 3 °C/min, 140 °C, 40 min, 250 °C, 
5 min, tR = 24.5 min), m/z (%) 71 (100), 43 (13); IR (ν~ [cm−1]) 2954m, 2921s, 2853s, 1461w, 
1378w, 1061m, 921w, 816w, 723w, 668m; EA: calculated for C12H24O: C = 78.20, H = 
13.12; measured: C = 78.25, H = 12.96; Rf = 0.16 (silica gel, cyclohexane:EtOAc, 20:1); 
GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa 
H2, 95 °C, 45 min, 10 °C/min, 180 °C, 10 min): tR(major) = 36.4 min, tR(minor) = 37.6 min. 
[α]D20 +0.4 (c 0.75, CHCl3, 46% ee). The NMR spectra were consistent with the literature 
data.[89] 
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2-(4-Trifluoromethyl)phenyltetrahydrofuran (107) 
Synthesized following the general working procedure for 
hydrogenations with iridium catalysts. When palladium on charcoal 
was used, the tetrahydrofuran ring was opened to give the 
corresponding alcohol. 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 
30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 2 min, 7 °C/min, 250 °C, 10 min): 
tR = 13.0 min; HPLC (IC, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 220 nm): 
tR1 = 10.0 min, tR2 = 11.4 min; [α]D20 +0.7 (c 0.50, CH2Cl2, 69% ee). The NMR spectra were 
consistent with the literature data.[89] 
3,5-Dimethyl-2,3-dihydrobenzofuran (116) 
Synthesized following the general working procedure for hydrogenations 
with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.96 (s, 1H, HCar), 6.92 (d, 
3JHH = 8.1 Hz, 1H, HCar), 6.68 (d, 3JHH = 8.1 Hz, 1H, HCar), 4.66 (t, 3JHH = 8.8 Hz, 
1H, OCH2), 4.06–4.02 (m, 1H, OCH2), 3.50 (mc, 1H, OCH2CH), 2.29 (s, 3H, aryl-CH3), 
1.31 (d, 3JHH = 6.9 Hz, 3H, CH3); 13C{1H}NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 157.7 
(Car), 132.4 (Car), 129.8 (Car), 128.4 (HCar), 124.5 (HCar), 109.1 (HCar), 78.7 (CH2), 36.7 (CH), 
20.9 (CH3), 19.4 (CH3); GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 
100 °C, 2 min, 7 °C/min, 250 °C, 10 min, tR = 6.9 min), m/z (%) 148 (M+, 62), 133 (100), 
105 (68), 77 (11); IR (ν~ [cm−1]) 2961w, 2923w, 2915w, 2009w, 2866w, 1490s, 1469m, 
1456m, 1452m, 1436w, 1375w, 1242m, 1215m, 1205m, 1192m, 1138w, 1121w, 1109m, 
1036w, 967s, 939w, 879w, 807s, 790m, 644w, 626w, 610w, 582w, 518m, 507s, 502w; 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxan, Restek Rtx-1701, 
30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 90 °C, 32 min, 0.1 °C/min, 92 °C, 0 min, 10 °C/min, 
250 °C, 10 min): tR = 55.8 min; Rf = 0.20 (silica gel, nheptane:EtOAc, 20:1); HPLC (OJ, 
nheptane:iPrOH 100:0, 0.5 mL/min, 25 °C, 200 nm): tR(major) = 16.4 min, tR(minor) = 20.9 min; 
[α]D20 +3.0 (c 0.10, CH2Cl2, 92% ee). 
O
C10H12O
148.20 g/mol
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2-Butyl-2,3-dihydrobenzofuran (119) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.14 (dd, 3,4JHH = 7.3, 
0.7 Hz, 1H, HCar), 7.10 (mc, 1H, HCar), 6.81 (dt, 3,4JHH = 7.4, 0.8 Hz, 1H, 
HCar), 6.75 (d, 3JHH = 8.0 Hz, 1H, HCar), 4.76 (mc, 1H, OCH), 3.29–3.21 (m, 1H, OCHCH2), 
2.85 (dd, 2,3JHH = 15.4, 7.9 Hz, 1H, OCHCH2), 1.88–1.80 (m, 1H, CH2), 1.72–1.63 (m, 1H, 
CH2), 1.51–1.36 (m, 4H, CH2), 0.93 (t, 3JHH = 7.1 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 159.8 (Car), 128.0 (HCar), 127.1 (OCar), 125.0 (HCar), 120.2 (HCar), 
109.4 (HCar), 83.5 (OCH), 36.0 (CH2), 35.6 (CH2), 27.8 (CH2), 22.8 (CH2), 14.3 (CH3); 
GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 60 kPa, 100 °C, 2 min, 7 °C/min, 
250 °C, 10 min, tR = 33.4 min), m/z (%) 174 (M+, 55), 134 (10), 133 (76), 120 (43), 119 (29), 
108 (13), 107 (100), 105 (18), 91 (35), 77 (11); IR (ν~ [cm−1]) 2956m, 2929m, 2871w, 2859w, 
1706w, 1610w, 1597m, 1494w, 1480s, 1461m, 1448w, 1436w, 1230s, 1207w, 1175w, 
1097w, 1057w, 1015w, 970w, 867m, 804w, 747s, 710w; Rf = 0.38 (silica gel, 
cyclohexane:EtOAc, 20:1); HPLC (OD-H, nheptane:iPrOH 99:1, 0.5 mL/min, 25 °C, 
230 nm): tR(major) = 8.6 min, tR(minor) = 11.8 min; [α]D20 +63.7 (c 0.33, CH2Cl2, 95% ee). The 
NMR spectra were consistent with the literature data.[33] 
2-Decyl-2,3-dihydrobenzofuran (120) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.14 (d, 3JHH = 7.3 Hz, 1H, 
HCar), 7.09 (t, 3JHH = 7.7 Hz, 1H, HCar), 6.81 (dt, 3,4JHH = 7.5, 0.7 Hz, 1H, 
HCar), 6.76 (d, 3JHH = 8.0 Hz, 1H, HCar), 4.76 (mc, 1H, OCH), 3.26 (dd, 2,3JHH = 15.4, 8.9 Hz, 
1H, OCHCH2), 2.85 (dd, 2,3JHH = 15.4, 7.9 Hz, 1H, OCHCH2), 1.88–1.79 (m, 1H, CH2), 
1.71–1.62 (m, 1H, CH2), 1.53–1.20 (m, 16H, CH2), 0.89 (t, 3JHH = 6.8 Hz, 3H, CH3); 13C{1H}-
NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 159.8 (Car), 128.0 (HCar), 127.1 (Car), 125.0 
(HCar), 120.2 (HCar), 109.4 (HCar), 83.6 (OCH), 36.3 (CH2), 35.6 (CH2), 32.1 (CH2), 29.8 
(CH2), 29.8 (CH2), 29.7 (CH2), 29.7 (CH2), 29.5 (CH2), 25.6 (CH2), 22.9 (CH2), 14.3 (CH3); 
GC-MS (EI, 70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 
250 °C, 5 min, tR = 10.3 min), m/z (%) 260 (M+, 50), 133 (47), 120 (72), 119 (25), 108 (16), 
107 (100), 91 (19), 77 (11); IR (ν~ [cm−1]) 2922m, 2829m, 1723w, 1707w, 1695w, 1599w, 
1480m, 1462w, 1448w, 1232m, 1170w, 870w, 862w, 809w, 747m, 721w, 710w, 680w; 
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Rf = 0.50 (silica gel, npentane:EtOAc, 20:1); HPLC (OD-H, nheptane:iPrOH 99:1, 
0.5 mL/min, 25 °C, 230 nm): tR(major) = 8.1 min, tR(minor) = 8.9 min; [α]D20 +24.7 (c 0.55, 
CH2Cl2, 99% ee). The NMR spectra were consistent with the literature data.[33] 
2-Isopropyl-2,3-dihydrobenzofuran (121) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.21–7.07 (m, 2H, HCar), 
6.83 (ddd, 3,4JHH = 7.5, 7.5, 0.8 Hz, 1H, HCar), 6.76 (d, 3JHH = 8.0 Hz, 1H, 
HCar), 4.58–4.47 (m, 1H, OCH), 3.24–3.14 (m, 1H, OCHCH2), 2.95 (dd, 2,3JHH = 15.6, 
8.6 Hz, 1H, OCHCH2), 1.97 (dq, 3JHH = 13.5, 6.7 Hz, 1H, OCHC(CH3)2H) 1.04 (d, 
3JHH = 6.7 Hz, 1H, CH3), 0.97 (d, 3JHH = 6.8 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 160.1 (Car), 128.0 (HCar), 127.3 (Car), 125.0 (HCar), 120.1 (HCar), 
109.2 (HCar), 88.5 (OCH), 33.4 (CH(CH3)2), 33.0 (CH2), 18.4 (CH3), 17.9 (CH3); GC-MS 
(EI, 70 eV, 5% polyphenylmethylsiloxane, 100 kPa, 50 °C, 2 min, 30 °C/min, 250 °C, 
5 min, tR = 6.6 min), m/z (%) 162 (M+, 59), 147 (50), 133 (18), 119 (40), 118 (11), 107 (100), 
91 (46); IR (ν~ [cm−1]) 2958w, 2931w, 2872w, 1610w, 1597w, 1505w, 1480s, 1461s, 1436w, 
1388w, 1367w, 1361w, 1323w, 1319w, 1230s, 1196w, 1179w, 1166w, 1097w, 1016w, 
984m, 1001w, 887w, 860m, 804w, 745s, 714w, 705w, 658w; Rf = 0.47 (silica gel, 
npentane:EtOAc, 20:1); HPLC (OD-H, nheptane:iPrOH 99:1, 0.5 mL/min, 24 °C, 
230 nm): tR(major) = 8.3 min, tR(minor) = 9.4 min; [α]D20 +11.8 (c 0.39, CH2Cl2, 97% ee). The 
NMR spectra were consistent with the literature data.[33] 
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7.8 Characterization of Substituted Dihydro- and Tetrahydrothiophene 
1,1-Dioxides 
2-Benzyltetrahydrothiophene 1,1-dioxide (165a) 
In a 25 mL Young tube tetrahydrothiophene 1,1-dioxide (0.20 mL, 
2.08 mmol, 1.00 eq.) was dissolved under slightly positive argon flow in 
dry THF (5 mL) and cooled to −78 °C. At this temperature nBuLi (1.6 M 
in hexanes, 1.50 mL, 2.40 mmol, 1.16 eq.) was added dropwise via 
syringe. The mixture was stirred for one hour, benzylbromide (0.55 mL, 4.54 mmol, 
2.18 eq.) was added and the cooling bath was removed. The reaction mixture was 
stirred for 15 h at room temperature, quenched with water (10 mL) and transferred to 
a separation funnel. The aqueous phase was extracted with MTBE (2×20 mL) and the 
combined organic phases were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The obtained oil was purified by flash 
chromatography (silica gel, 20×2 cm, cyclohexane:EtOAc, 20:1 then 3:1) to give the 
product 165a as a colorless oil (301 mg, 1.43 mmol, 69%). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.34–7.21 (m, 5H, HCar), 3.34 (dd, 
2,3JHH = 14.0, 4.9 Hz, 1H, SO2CH(CH2C6H5)), 3.18 (mc, 2H, CH2), 3.05 (mc, 1H, CH2), 2.73 
(dd, 2,3JHH = 14.0, 10.0 Hz, 1H, CH2), 2.23–2.14 (m, 2H, CH2), 2.09–1.95 (m, 1H, CH2), 1.89–
1.76 (m, 1H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 137.3 (Car), 129.0 
(2 HCar), 128.9 (2 HCar), 127.1 (HCar), 62.4 (SO2CH(CH2C6H5)), 51.5 (CH2), 33.7 (CH2), 
29.1 (CH2), 20.1 (CH2); MS (EI), m/z (%) 210 (M+ 16), 146 (39), 145 (19), 144 (20), 143 (25), 
129 (37), 118 (25), 117 (100), 115 (28), 104 (24), 92 (11), 91 (97), 67 (15), 65 (14);  
IR (ν~ [cm−1]) 2976w, 2881w, 2878w, 2364w, 2247w, 1715m, 1311w, 1289m, 1144m, 539s; 
Rf = 0.10 (silica gel, cyclohexane:EtOAc, 75:25). 
2,5-Dibenzyltetrahydrothiophene 1,1-dioxide (163) 
In a 25 mL Young tube 2-benzyltetrahydrothiophene 1,1-dioxide 
(300 mg, 1.43 mmol, 1.00 eq.) was dissolved under slightly 
positive argon flow in dry THF (5 mL) and cooled to −78 °C. At 
this temperature nBuLi (1.6 M in hexanes, 1.10 mL, 1.76 mmol, 
1.23 eq.) was added dropwise via syringe. The mixture was stirred for one hour, 
benzylbromide (0.21 mL, 1.71 mmol, 1.20 eq.) was added and the cooling bath was 
removed. The reaction mixture was stirred for 21 hours at room temperature, 
quenched with water (10 mL) and transferred to a separation funnel. The aqueous 
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phase was extracted with MTBE (3×20 mL) and the combined organic phases were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
obtained oil was purified by flash chromatography (silica gel, 21×2 cm, 
cyclohexane:EtOAc, 4:1). The product 163 was obtained as a mixture of both isomers 
(60:40, cis:trans). The colorless oil (176 mg, 0.06 mmol, 41%) solidifies upon standing. 
Reduction of 2,5-dibenzylthiophene 1,1-dioxide (141) with palladium on charcoal gave 
the fully reduced compound 163 in a ratio of 82:18 (cis:trans). 
m.p. 68–69 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.33–7.30 (m, 5H, HCar 
both diastereomers), 7.28–7.21 (m, 7H, HCar both diastereomers), 3.40–3.36 (m, 2H, 
CH2(C6H5) both diastereomers), 3.35–3.30 (m, 2H, SO2CH cis), 3.26–3.20 (m, 2H, SO2CH 
trans), 2.74 (dd, 2,3JHH = 14.0, 10.7 Hz, 2H, CH2(C6H5) both diastereomers), 2.13–2.06 (m, 
2H, SO2CHCH2 trans), 2.06–1.99 (m, 2H, SO2CHCH2 cis), 1.89–1.83 (m, 2H, SO2CHCH2 
cis), 1.68–1.61 (m, 2H, SO2CHCH2 trans); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 137.3 (2 Car cis), 137.2 (2 Car trans), 129.1 (4 HCar cis), 129.0 (4 HCar trans), 128.9 
(4 HCar cis), 128.9 (4 HCar trans), 127.1 (2 HCar cis), 127.1 (2 HCar trans), 63.2 
(2 SO2CH(CH2C6H5) trans), 62.0 (2 SO2CH(CH2C6H5) cis), 34.6 (2 CH2 trans), 33.8 (2 CH2 
cis), 27.4 (2 CH2 trans), 25.6 (2 CH2 cis); IR (ν~ [cm−1]) 3027w, 2858w, 2362w, 1490w, 
1458w, 1292m, 1250m, 1120m, 758m, 694s, 615m, 555s, 498s; HRMS (ESI, 4500 V, 
180 °C) calc. m/z for C18H21O2S+: 301.1259, found: 301.1257 [M+H]+; calc. m/z for 
C18H24NO2S+: 318.1523, found: 318.1522 [M+NH4]+; calc. m/z for C18H20NaO2S+: 323.1079, 
found: 323.1076 [M+Na]+; calc. m/z for C18H20KO2S+: 339.0815, found: 339.0816 [M+K]+; 
calc. m/z for C36H40NaO4S2+: 623.2262, found: 623.2260 [2M+Na]+; Rf = 0.29 (silica gel, 
cyclohexane:EtOAc, 4:1). 
2-(cis)-Dibenzyltetrahydrothiophene 1-oxide (166) 
In a 25 mL Young tube tetrahydrothiophene 1-oxide (0.18 mL, 
1.97 mmol, 1.00 eq.) was dissolved under slightly positive argon 
flow in dry THF (5 mL) and cooled to −78 °C. At this temperature 
nBuLi (1.6 M in hexanes, 1.50 mL, 2.40 mmol, 1.22 eq.) was added 
dropwise via syringe. The mixture was stirred for one hour, benzylbromide (0.29 mL, 
2.39 mmol, 1.22 eq.) was added and the cooling bath was removed. The reaction 
mixture was stirred at room temperature for 22 hours, quenched with water (15 mL) 
and transferred to a separation funnel. The aqueous phase was extracted with CH2Cl2 
(3×30 mL) and the combined organic phases were dried over MgSO4, filtered and the 
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solvent was removed under reduced pressure. Only 20 mg from the obtained oil 
(414 mg) were submitted to semipreparative HPLC (Reprospher 100 Si 5 μm, 
250 × 20 mm, nhexane:iPrOH 90:10) and the pure product cis-166 was obtained as a 
white solid (3 mg). 
m.p. 87–88 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.34–7.19 (m, 10H, HCar), 
3.31–3.24 (m, 2H, CH), 3.17 (dd, 2,3JHH = 14.1, 5.7 Hz, 2H, CH2), 2.74 (dd, 2,3JHH = 13.9, 
9.3 Hz, 2H, CH2), 2.35–2.26 (m, 2H, CH2), 1.81–1.72 (m, 2H, CH2); 13C{1H}-NMR 
(100.6 MHz, CDCl3, 300 K): δ (ppm) 138.0 (2 Car), 129.1 (4 HCar), 128.9 (4 HCar), 127.1 
(2 HCar), 70.9 (2 HC), 36.2 (2 CH2), 29.2 (2 CH2); IR (ν~ [cm−1]) 3075w, 2922m, 2370w, 
1496m, 1455m, 1445m, 1143m, 1030m, 1015s, 1002m, 988m, 973m, 947m, 921m, 758m, 
747m, 710s, 704s, 695s, 689m, 621m, 533m; HRMS (ESI, 4500 V, 180 °C) calc. m/z for 
C18H21OS+: 285.1308, found: 285.1307 [M+H]+; calc. m/z for C18H20NaOS+: 307.1127, 
found: 307.1129 [M+Na]+; calc. m/z for C18H20KOS+: 323.0866, found: 323.0864 [M+K]+; 
calc. m/z for C36H41O2S2+: 569.2542, found: 569.2542 [2M+H]+; calc. m/z for C36H40NaO2S2+: 
591.2362, found: 591.2365 [2M+Na]+; Rf = 0.13 (silica gel, cyclohexane:EtOAc, 1:3). 
2,3b,5,6b-Tetrabenzyl-3a,3b,6a,6b-tetrahydrocyclobuta[1,2-b:3,4-b']dithiophene-
1,1,4,4-tetraoxide (167) 
The dimer 167 was formed from 2,5-dibenzylthiophene 
1,1-dioxide (141) after letting the monomer standing on air 
and light for about three months. 
m.p. 239–240 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): 
δ (ppm) 7.25–7.16 (m, 12H, HCar), 7.15–7.14 (m, 4H, HCar), 
7.04–7.00 (m, 4H, HCar), 5.51 (dt, 3,4JHH = 4.8, 1.7 Hz, 2H, 
SO2CCH), 4.11–4.09 (m, 2H, SO2CCHCH), 3.68 (dd, 3JHH = 8.7, 3.4 Hz, 4H, CH2), 3.37 (d, 
2JHH = 16.8 Hz, 2H, CH2), 3.25 (d, 2JHH = 16.8 Hz, 2H, CH2); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 149.0 (4 Car), 135.2 (2 SO2C), 129.3 (2 SO2CCH), 129.1 (4 HCar), 
129.0 (4 HCar), 128.9 (4 HCar), 128.8 (4 HCar), 127.4 (2 HCar), 127.0 (2 HCar), 63.1 (2 SO2C), 
47.3 (2 SO2CCH), 35.9 (2 CH2), 30.6 (2 CH2); IR (ν~ [cm−1]) 2925w, 2360w, 1419m, 1292s, 
1202w, 1124m, 1079m, 1058w, 1028w, 941w, 907w, 873m, 852m, 805w, 774w, 731m, 
709m, 694m, 691m, 639m, 620w, 596m, 569m; HRMS (ESI, 4500 V, 180 °C) calc. m/z for 
C36H32NaO4S2+: 615.1634, found: 615.1639 [M+Na]+; calc. m/z for C72H64NaO8S4+: 
1207.3376, found: 1207.3382 [2M+Na]+; Rf = 0.38 (silica gel, cyclohexane:EtOAc, 3:1). 
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2-Butyl-5-phenyltetrahydrothiophene 1,1-dioxide (156) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. The mixture of cis:trans 
(84:16) isomers could not be separated. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.41–7.37 (m, 5H, HCar), 
4.22 (mc, 1H, SO2CH), 3.17 (mc, 1H, SO2CH), 2.47–2.32 (m, 2H, CH2), 2.08–1.93 (m, 2H, 
CH2), 1.66–1.57 (m, 2H, CH2), 1.54–1.34 (m, 4H, CH2), 0.93 (t, 3JHH = 7.2 Hz, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 130.8 (Car), 129.3 (2 HCar), 129.0 
(HCar), 128.9 (2 HCar), 66.0 (SO2CH), 59.8 (SO2CH), 29.5 (CH2), 28.0 (CH2), 26.2 (CH2), 
26.0 (CH2), 22.7 (CH2), 14.0 (CH3); MS (EI), m/z (%) 104 (100); IR (ν~ [cm−1]) 2956m, 
2946m, 2934m, 2871w, 2860w, 2367w, 2358w, 1497w, 1454w, 1305m, 1244w, 1129m, 
698w, 646w, 603w, 594w, 534s; HRMS (ESI, 4500 V, 180 °C) calc. m/z for C14H21O2S+: 
253.1255, found: 253.1257 [M+H]+; calc. m/z for C14H24NO2S+: 270.1520, found: 270.1522 
[M+NH4]+; calc. m/z for C14H20NaO2S+: 275.1077, found: 275.1076 [M+Na]+; calc. m/z for 
C14H20KO2S+: 291.0813, found: 291.0816 [M+K]+; calc. m/z for C28H40NaO4S2+: 527.2258, 
found: 527.2260 [2M+Na]+; Rf = 0.30 (silica gel, cyclohexane:EtOAc, 3:1); HPLC (AD-H, 
nheptane:iPrOH 90:10, 0.5 mL/min, 25 °C, 220 nm): tR(trans) = 27.5 min, tR2(cis) = 34.1 min, 
tR3(trans) = 38.6 min, tR4(cis) = 47.1 min. 
2-Butyl-5-phenyl-4,5-dihydrothiophene 1,1-dioxide (155) 
Synthesized following the general working procedure for 
hydrogenations with iridium catalysts. The mixture of 155, 156 and 
157 (51:18:31, GC-MS) was separated by semi-preparative HPLC 
(AD, nHex:iPrOH, 95:5, 8.0 mL/min, 25 °C). Compound 155 was 
obtained in its pure form, while dihydrothiophene 157 was obtained as a mixture with 
tetrahydrothiophene 156 (1.0:0.5, 1H-NMR). 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.44–7.37 (m, 5H, HCar), 6.39 (ddt, 
3,4JHH = 4.1, 2.8, 1.6 Hz, 1H, CH), 4.42 (dd, 3JHH = 8.3, 7.1 Hz, 1H, CH), 3.16 (dddt, 
2,3,4JHH = 18, 8.1, 4.0, 1.9 Hz, 1H, CH2), 2.98 (ddq, 2,3JHH = 18, 7.3, 2.5 Hz, 1H, CH2), 2.47 
(mc, 2H, CH2), 1.66 (mc, 2H, CH2), 1.47–1.39 (m, 2H, CH2), 0.95 (t, 3JHH = 7.4 Hz, 3H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 144.6 (SO2Car), 131.2 (Car), 130.1 
(SO2CCH), 129.3 (2 HCar), 129.3 (HCar), 129.1 (2 HCar), 64.8 (SO2CH), 32.4 (CH2), 29.6 
(CH2), 24.3 (CH2), 22.4 (CH2), 13.9 (CH3); MS (EI), m/z (%) 129 (39), 128 (11), 105 (11), 
104 (100). 
nBu S
OO
C14H20O2S
252.37 g/mol
nBu S
OO
C14H18O2S
250.36 g/mol
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2-Butyl-5-phenyl-2,3-dihydrothiophene 1,1-dioxide (157) 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.43–7.37 (m, 5H, HCar), 
6.71 (dd, 3JHH = 4.3, 2.8 Hz, 1H, CH), 3.35 (mc, 1H, CH), 3.16 (ddd, 
2,3JHH = 18, 8.1, 4.3 Hz, 1H, CH2), 2.98 (ddd, 2,3JHH = 18, 6.8, 2.8 Hz, 1H, 
CH2), 2.46–2.32 (m, 2H, CH2), 2.17–1.93 (m, 2H, CH2), 1.74–1.64 (m, 
2H, CH2), 0.95 (t, 3JHH = 7.2 Hz, 3H, CH3); MS (EI), m/z (%) 250 (29), 143 (45), 130 (25), 
129 (36), 128 (24), 115 (24), 105 (30), 103 (12), 102 (100), 91 (14). 
2-Methyl-5-phenyltetrahydrothiophene 1,1-dioxide (159) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. The mixture of cis:trans 
(84:16) isomers could not be separated. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.41–7.37 (m, 5H, HCar), 
4.23 (mc, 1H, SO2CH cis), 4.14–4.09 (m, 1H, SO2CH trans), 3.35–3.26 (m, 1H, SO2CH cis), 
3.24–3.14 (m, 1H, SO2CH trans), 2.48–2.36 (m, 3H, CH2 cis), 2.01–1.91 (m, 1H, CH2 cis), 
1.44 (d, 3JHH = 7.0 Hz, 3H, CH3 cis); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 
130.9 (Car), 129.3 (2 HCar), 129.1 (HCar), 128.9 (2 HCar), 65.8 (SO2CH), 55.0 (SO2CH), 27.7 
(CH2), 26.2 (CH2), 13.0 (CH3); MS (EI), m/z (%) 104 (100); IR (ν~ [cm−1]) 3030w, 2933w, 
2873w, 1601w, 1496m, 1452m, 1307s, 1278m, 1252m, 1123s, 766w, 718w, 699w, 592w, 
586w; HRMS (ESI, 4500 V, 180 °C) calc. m/z for C11H15O2S+: 211.0784, found: 211.0787 
[M+H]+; calc. m/z for C11H18NO2S+: 228.1050, found: 228.1053 [M+NH4]+; calc. m/z for 
C11H14NaO2S+: 233.0608, found: 233.0607 [M+Na]+; calc. m/z for C11H14KO2S+: 249.0341, 
found: 249.0346 [M+K]+; calc. m/z for C22H28NaO4S2+: 443.1318, found: 443.1321 
[2M+Na]+; Rf = 0.13 (silica gel, cyclohexane:EtOAc, 3:1); HPLC (OD-H, nheptane:iPrOH 
95:5, 0.5 mL/min, 25 °C, 220 nm): tR(cis1) = 54.5 min, tR(trans1) = 60.2 min, tR(cis2) = 67.2 min, 
tR(trans2) = 75.4 min. 
nBu S
OO
C14H18O2S
250.36 g/mol
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2-Methyl-5-phenyl-4,5-dihydrothiophene 1,1-dioxide (158) 
Synthesized following the general working procedure for 
hydrogenations with iridium catalysts. The mixture of 158 and 160 
(71:29, GC-MS) was separated by semi-preparative HPLC (OD, 
nHex:iPrOH, 90:10, 8.0 mL/min). Both mono-reduced compounds were 
obtained in their pure form. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.45–7.37 (m, 5H, HCar), 6.41 (mc, 1H, 
CH), 4.42 (dd, 3JHH = 8.1, 7.3 Hz, 1H, CH), 3.16 (dddt, 2,3,4JHH = 18, 8.0, 3.9, 2.0 Hz, 1H, 
CH2), 2.97 (ddd, 2,3JHH = 18, 7.2, 2.5 Hz, 1H, CH2), 2.12 (dt, 3JHH = 2.5, 1.8 Hz, 3H, CH3); 
MS (EI), m/z (%) 208 (15), 129 (33), 128 (15), 104 (100), 103 (11), 78 (14). 
2-Methyl-5-phenyl-2,3-dihydrothiophene 1,1-dioxide (160) 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.69–7.67 (m, 2H, HCar), 
7.42–7.41 (m, 3H, HCar), 6.72 (dd, 3JHH = 3.8, 3.2 Hz, 1H, CH), 3.46 (dq, 
3JHH = 14, 7.0 Hz, 1H, CH), 3.11 (ddd, 2,3JHH = 18, 8.1, 4.1 Hz, 1H, CH2), 
2.50 (ddd, 2,3JHH = 18, 6.1, 3.0 Hz, 1H, CH2), 1.52 (d, 3JHH = 7.0 Hz, 3H, 
CH3); MS (EI), m/z (%) 208 (23), 129 (50), 128 (13), 115 (11), 105 (21), 103 (10), 102 (100). 
2,5-Dibutyltetrahydrothiophene 1,1-dioxide (168) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. The mixture of cis:trans 
(90:10) isomers could not be separated. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.01–2.93 (m, 2H, 
SO2CH), 2.24–2.15 (m, 2H, CH2), 2.00–1.89 (m, 2H, CH2), 1.80–1.71 (m, 2H, CH2), 1.53–
1.31 (m, 10H, CH2), 0.93 (t, 3JHH = 7.1 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 
300 K): δ (ppm) 60.6 (2 SO2CH), 29.5 (2 CH2), 27.8 (2 CH2), 26.3 (2 CH2), 22.7 (2 CH2), 
14.0 (2 CH3); MS (EI), m/z (%) 111 (46), 97 (68), 85 (14), 84 (14), 83 (64), 69 (100), 67 (12), 
57 (25), 56 (43), 55 (72), 43 (33), 42 (21), 41 (44); IR (ν~ [cm−1]) 3735w, 2956w, 2933w, 
2860w, 1457w, 1294w, 1111w, 604w, 564m, 542s; HRMS (ESI, 4500 V, 180 °C) calc. m/z 
for C12H25O2S+: 233.1568, found: 233.1570 [M+H]+; calc. m/z for C12H28NO2S+: 250.1834, 
found: 250.1835 [M+NH4]+; calc. m/z for C12H24NaO2S+: 255.1392, found: 255.1389 
[M+Na]+; calc. m/z for C24H48NaO4S2+: 487.2885, found: 487.2886 [2M+Na]+; Rf = 0.37 
(silica gel, cyclohexane:EtOAc, 3:1). 
nBu S nBu
OO
C12H24O2S
232.38 g/mol
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2,5-Diethyltetrahydrothiophene 1,1-dioxide (170) 
Synthesized following the general working procedure for 
hydrogenations with palladium on charcoal. The mixture of cis:trans 
(95:5) isomers could not be separated. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 2.96–2.88 (m, 2H, SO2CH), 
2.24–2.16 (m, 2H, CH2), 2.04–1.93 (m, 2H, CH2), 1.80–1.71 (m, 2H, CH2), 1.61–1.49 (m, 
2H, CH2), 1.07 (t, 3JHH = 7.4 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 62.3 (2 SO2CH), 26.0 (2 CH2), 21.6 (2 CH2), 12.0 (2 CH3); MS (EI), m/z (%) 111 
(19), 70 (23), 69 (100), 57 (10), 56 (36), 55 (53), 42 (16), 41 (48); IR (ν~ [cm−1]) 2964w, 2938w, 
2915w, 2878w, 2854w, 1461w, 1456w, 1448w, 1383w, 1286m, 1273m, 1243w, 1152w, 
1108m, 1076w, 1016w, 749w, 710w, 515s; HRMS (ESI, 4500 V, 180 °C) calc. m/z for 
C8H16O2S+: 177.0942, found: 177.0944 [M+H]+; calc. m/z for C8H20NO2S+: 194.1207, found: 
194.1209 [M+NH4]+; calc. m/z for C8H16NaO2S+: 199.0765, found: 199.0763 [M+Na]+; calc. 
m/z for C16H32NaO4S2+: 375.1630, found: 375.1634 [2M+Na]+; Rf = 0.21 (silica gel, 
cyclohexane:EtOAc, 3:1); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): 
tR(trans1) = 53.0 min, tR(trans2) = 56.2 min, tR(cis) = 61.0 min; GC (14% Cyanopropylphenyl/86% 
Dimethylpolysiloxane, Restek Rtx-1701, 30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 
60 min, 7 °C/min, 250 °C, 10 min): tR(trans) = 57.8 min; tR(cis) = 60.5 min. 
2,5-Diethyl-2,3-dihydrothiophene 1,1-dioxide (171) 
Synthesized following the general working procedure for 
hydrogenations with iridium catalysts. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.19 (dq, 3,4JHH = 4.1, 2.0 Hz, 
1H, SO2CCH), 3.11 (quint, 3JHH = 7.5 Hz, 1H, SO2CH), 2.94–2.84 (m, 1H, 
CH2), 2.35 (mc, 1H, CH2), 2.11–2.00 (m, 2H, CH2), 1.71–1.60 (m, 2H, CH2), 1.22 (t, 
3JHH = 7.4 Hz, 3H, CH3), 1.13 (t, 3JHH = 7.4 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 
300 K): δ (ppm) 146.4 (SO2C), 129.4 (SO2CCH), 60.2 (SO2CH), 31.2 (CH2), 22.1 (CH2), 17.4 
(CH2), 11.9 (CH3), 11.8 (CH3); MS (EI), m/z (%) 174 (36), 157 (18), 126 (14), 107 (12), 95 
(12), 81 (59), 79 (29), 77 (10), 68 (25), 67 (100), 57 (33), 56 (13), 55 (39), 53 (22), 43 (16), 41 
(52); IR (ν~ [cm−1]) 2971m, 2938m, 2880w, 2848w, 1718w, 1653w, 1460m, 1439m, 1384w, 
1345w, 1282s, 1220m, 1137s, 1118s, 1072m, 1025m, 1007m, 967m, 891m, 838m, 734m, 
709m, 643m, 621m, 590m, 574m, 548m, 527m, 511m, 484m; Rf = 0.18 (silica gel, 
cyclohexane:EtOAc, 3:1); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 
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25 m × 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): 
tR1 = 63.5 min; tR2 = 65.1 min; GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, 
Restek Rtx-1701, 30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 
10 min): tR = 63.2 min; [α]D20 +8.7 (c 0.95, CH2Cl2, 1% cis, >99% ee). The NMR spectra 
were consistent with the literature data.[95] 
3,4-Diethyltetrahydrothiophene 1,1-dioxide (154a), 3,4-diethyl-2,5-dihydrothio-
phene 1,1-dioxide (154b) and 3,4-diethyl-2,3-dihydrothiophene 1,1-dioxide (154c) 
Synthesized following the general working procedure for hydrogenations with 
palladium on charcoal. The product mixture of fully reduced (70%) (dr = 5:1, cis:trans) 
and rearranged product (27%) and mono reduced product (4%) could not be 
separated. 
3,4-Diethyltetrahydrothiophene 1,1-dioxide (154a) and 3,4-diethyl-2,5-dihydro-
thiophene 1,1-dioxide (154b) (72:28) 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.76 (s, 4H, 
SO2CH2 rearranged product), 3.31 (dd, 2,3JHH = 13.3, 7.2 Hz, 
2H, SO2CH2, cis), 3.13 (dd, 2,3JHH = 13.2, 7.2 Hz, 2H, SO2CH2 
trans), 2.97 (dd, 2,3JHH = 13.1, 6.6 Hz, 2H, SO2CH2 trans), 2.76 
(dd, 2,3JHH = 13.2, 10.7 Hz, 2H, SO2CH2 cis), 2.40–2.35 (m, 2H, CH trans), 2.20 (q, 
3JHH = 7.5 Hz, 4H, CH2 rearranged product), 2.11–2.04 (m, 2H, CH cis), 1.86–1.76 (m, 2H, 
CH2 cis), 1.57–1.47 (m, 4H, CH2 trans), 1.36–1.27 (m, 2H, CH2 cis), 1.01 (t, 3JHH = 7.6 Hz, 
6H, CH3 rearranged product), 0.96 (t, 3JHH = 7.3 Hz, 6H, CH3 trans), 0.93 (t, 3JHH = 7.5 Hz, 
6H, CH3 cis); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 131.0 (2 SO2CH2C 
rearranged product), 58.9 (2 SO2CH2 rearranged product), 57.3 (2 SO2CH2 cis), 55.9 
(2 SO2CH2 trans), 43.3 (2 SO2CH2CH cis), 42.0 (2 SO2CH2CH trans), 25.2 (2 CH2CH3 cis), 
22.0 (2 CH2CH3 rearranged product), 21.1 (2 CH2CH3 trans), 12.6 (2 CH3 rearranged 
product), 12.2 (2 CH3 trans), 11.9 (2 CH3 cis); Rf = 0.26 (silica gel, cyclohexane:EtOAc, 
3:1). 
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3,4-Diethyl-2,3-dihydrothiophene 1,1-dioxide (154c) 
Synthesized following the general working procedure for hydrogenations 
with iridium catalysts. 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.31 (q, 4JHH = 1.7 Hz, 1H, 
SO2CH), 3.42 (dd, 2,3JHH = 13.4, 8.3 Hz, 1H, CH2), 3.04 (dd, 2,3JHH = 13.5, 
4.0 Hz, 1H, CH2), 2.42–2.32 (m, 5H, CH), 2.18–2.11 (m, 2H, CH2), 1.85–1.80 (m, 2H, CH2), 
1.16 (t, 3JHH = 7.3 Hz, 6H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 138.5 
(Cq), 125.4 (SO2CH), 54.3 (CH2), 43.3 (CH), 29.9 (2 CH2), 11.1 (2 CH3); MS (EI), m/z (%) 
174 (76), 157 (44), 146 (68), 145 (14), 131 (11), 129 (30), 115 (16), 113 (12), 108 (11), 107 
(19), 99 (11), 98 (36), 97 (17), 96 (14), 95 (30), 93 (30), 91 (13), 85 (28), 83 (13), 82 (19), 81 
(52), 80 (17), 79 (80), 77 (28), 69 (20), 68 (14), 67 (82), 66 (11), 65 (21), 57 (20), 56 (16), 55 
(72), 54 (12), 53 (58), 52 (10), 51 (17), 45 (13), 44 (11), 43 (39), 41 (100), 40 (15); IR (ν~
[cm−1]) 3077w, 2961m, 2927m, 2874w, 2857w, 1727m, 1629w, 1460m, 1412w, 1382w, 
1288m, 1258s, 1228m, 1140m, 1122m, 1091s, 1073m, 1013m, 950w, 923w, 892w, 862m, 
791s, 744m, 705m, 661w, 576m, 524m, 489m; Rf = 0.11 (silica gel, cyclohexane:EtOAc, 
3:1); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 
60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): tR1 = 71.3 min, tR2 = 72.2 min; 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 30 m 
× 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): tR = 74.3 min. 
3,4-Dimethyl-2,3-dihydrothiophene 1,1-dioxide (153c) and 3,4-dimethyl-2,5-
dihydrothiophene 1,1-dioxide (153b) 
Synthesized following the general working procedure for hydrogenations with 
palladium on charcoal. The product mixture of mono reduced product (59%) and 
rearranged product (41%) was separated by flash chromatography (silica gel, 10×1 cm, 
cyclohexane:EtOAc, 3:1). 
3,4-Dimethyl-2,3-dihydrothiophene 1,1-dioxide (153c) 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 6.29 (q, 4JHH = 1.5 Hz, 1H, 
SO2CH), 3.49 (ddd, 2,3JHH = 13.4, 8.1 Hz, 1H, CH2), 3.07–3.00 (m, 1H, CH), 
2.95 (dd, 2,3JHH = 13.4, 4.1 Hz, 1H, CH2), 1.78 (t, 4JHH = 1.2 Hz, 3H, CH3), 1.32 
(d, 3JHH = 7.1 Hz, 3H, CH3); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): 
δ (ppm) 155.7 (SO2CHC), 126.4 (SO2CH), 57.1 (CH2), 37.6 (CH), 18.6 (CH3), 16.6 (CH3); 
MS (EI), m/z (%) 146 (34), 129 (15), 117 (44), 98 (16), 83 (10), 82 (23), 81 (16), 80 (11), 79 
(23), 69 (26), 67 (80), 65 (20), 55 (16), 54 (12), 53 (23), 43 (49), 42 (44), 41 (100), 40 (15); 
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IR (ν~ [cm−1]) 3074w, 2974w, 2879w, 1738w, 1631w, 1439w, 1416w, 1378w, 1281s, 
1226m, 1175m, 1140s, 1108m, 1089s, 1000w, 918w, 875m, 779m, 721w, 607m, 595m, 
569m, 537m, 499w, 479m, 464m; Rf = 0.10 (silica gel, cyclohexane:EtOAc, 3:1); 
GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m × 0.25 mm × 0.25 μm, 60 kPa 
H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): tR1 = 68.3 min, tR2 = 69.2 min; GC (14% 
Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 30 m × 0.25 mm 
× 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): tR = 64.6 min. 
3,4-Dimethyl-2,5-dihydrothiophene 1,1-dioxide (153b) 
m.p. 124–128 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 3.72 (d, 
4JHH = 1.2 Hz, 4H, CH2), 1.78 (t, 4JHH = 1.2 Hz, 6H, CH3); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 125.8 (2 SO2CH2C), 60.9 
(2 SO2CH2), 14.8 (2 CH3); MS (EI), m/z (%) 83 (12), 82 (40), 69 (22), 67 (61), 
65 (12), 64 (31), 56 (20), 55 (22), 54 (15), 53 (10), 48 (17), 43 (16), 42 (100), 41 (70), 40 (13); 
IR (ν~ [cm−1]) 2955w, 2922w, 2856w, 1739w, 1443w, 1403w, 1386w, 1289m, 1262m, 
1198w, 1176m, 1134w, 1108s, 822m, 726w, 563s, 483s; Rf = 0.15 (silica gel, 
cyclohexane:EtOAc, 3:1); GC (β-Cyclodextrin, Diethyl-tBuSilyl-086, MEGA, 25 m 
× 0.25 mm × 0.25 μm, 60 kPa H2, 100 °C, 60 min, 10 °C/min, 180 °C, 10 min): tR = 64.3 min; 
GC (14% Cyanopropylphenyl/86% Dimethylpolysiloxane, Restek Rtx-1701, 
30 m × 0.25 mm × 0.25 μm, 60 kPa H2, 130 °C, 60 min, 7 °C/min, 250 °C, 10 min): 
tR = 81.2 min. The NMR spectra were consistent with the literature data.[96] 
3,4-(cis)-Diphenyltetrahydrothiophene 1,1-dioxide (152a) 
m.p. 180–181 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.21–
7.13 (m, 6H, HCar), 6.83 (dd, 3,4JHH = 8.0, 1.6 Hz, 4H, HCar), 4.05 (td, 
3JHH = 5.7, 2.9 Hz, 2H, CH), 3.67 (dd, 2,3JHH = 13.6, 7.7 Hz, 2H, SO2CH2), 
3.53 (dd, 2,3JHH = 13.5, 7.8 Hz, 2H, SO2CH2); 13C{1H}-NMR (100.6 MHz, 
CDCl3, 300 K): δ (ppm) 136.7 (2 Car), 126.5 (4 HCar), 128.3 (4 HCar), 127.7 
(2 HCar), 55.9 (2 CH2), 47.4 (2 CH); MS (EI), m/z (%) 104 (100), 103 (10), 78 (11);  
IR (ν~ [cm−1]) 3027w, 3005w, 2365w, 1491m, 1455m, 1424w, 1416w, 1297s, 1282m, 
1267m, 1255w, 1225m, 1202m, 1184w, 1132m, 1121s, 1115s, 1083m, 1075m, 1033w, 
927w, 911m, 859m, 853m, 766s, 760s, 733w, 695m, 674m, 652m, 623m, 617m, 590m, 
557m; Rf = 0.25 (silica gel, cyclohexane:EtOAc, 3:1). 
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3,4-Diphenyl-2,5-dihydrothiophene 1,1-dioxide (152b) and 3,4-diphenyl-2,3-
dihydrothiophene 1,1-dioxide (152c) 
Synthesized following the general working procedure for hydrogenations with 
iridium catalysts (CRABTREE catalyst with BArF as counterion was used). The product 
mixture of rearranged product (89%) and mono reduced product (11%) was purified 
by flash chromatography (silica gel, 8×1 cm, cyclohexane:EtOAc, 5:1). 
3,4-Diphenyl-2,5-dihydrothiophene 1,1-dioxide (152b) 
m.p. 176–177 °C; 1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.28–
7.21 (m, 6H, HCar), 7.11–7.08 (m, 4H, HCar), 4.31 (s, 4H, 2 SO2CH2); 
13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 139.4 (2 Car), 134.8 
(2 Car), 131.1 (2 HCar), 128.8 (4 HCar), 128.6 (4 HCar), 61.3 (2 CH2); MS (EI), 
m/z (%) 207 (39), 206 (100), 205 (70), 204 (19), 203 (22), 202 (18), 191 (40), 
190 (18), 189 (14), 178 (16), 165 (15), 129 (17), 128 (35), 127 (11), 115 (22), 103 (11), 102 
(15), 101 (16), 91 (71), 89 (18), 77 (31), 76 (12), 51 (15), 44 (10); IR (ν~ [cm−1]) 2965w, 2923w, 
1741w, 1599w, 1490w, 1443w, 1391m, 1298s, 1250m, 1204m, 1189w, 1133m, 1121s, 
1067m, 1031w, 1003w, 977w, 933m, 913w, 898w, 885w, 789m, 759s, 729w, 694s, 637w, 
623w, 598m, 502m, 482m, 465m; Rf = 0.20 (silica gel, cyclohexane:EtOAc, 5:1); 
HPLC (AD-H, nheptane:iPrOH 80:20, 0.5 mL/min, 25 °C, 258 nm): tR = 17.2 min. 
3,4-Diphenyl-2,3-dihydrothiophene 1,1-dioxide (152c) 
1H-NMR (400.1 MHz, CDCl3, 300 K): δ (ppm) 7.39–7.27 (m, 10H, HCar), 
7.03 (d, 4JHH = 1.5 Hz, 1H, SO2CH), 4.80 (ddd, 3,4JHH = 9.2, 3.0, 1.5 Hz, 1H, 
CH), 3.93 (dd, 2,3JHH = 13.8, 9.1 Hz, 1H, CH2), 3.39 (dd, 2,3JHH = 13.8, 3.0 Hz, 
1H, CH2); 13C{1H}-NMR (100.6 MHz, CDCl3, 300 K): δ (ppm) 152.3 
(SO2CHC), 139.5 (Car), 132.0 (Car), 130.7 (HCar), 129.5 (2 HCar), 129.0 
(2 HCar), 127.7 (2 HCar), 127.6 (2 HCar), 126.7 (HCar), 99.0 (CH), 57.3 (CH), 43.3 (CH2); 
MS (EI), m/z (%) 270 (34), 207 (26), 206 (14), 205 (14), 105 (13), 104 (100), 103 (13), 102 
(17), 91 (27), 78 (13), 77 (12); IR (ν~ [cm−1]) 2952w, 2923m, 2853m, 1736w, 1603w, 1494w, 
1456w, 1377w, 1295m, 1260m, 1218w, 1122m, 1073m, 1029m, 932w, 804m, 754m, 700m, 
606w, 519m, 495m; Rf = 0.11 (silica gel, cyclohexane:EtOAc, 5:1); HPLC (AD-H, 
nheptane:iPrOH 80:20, 0.5 mL/min, 25 °C, 258 nm): tR1 = 26.1 min, tR2 = 44.4 min. 
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7.9 Crystallographic Data 
 152a 166 167 
molecular formula C36H32O4S2 C18H20OS C16H16O2S 
molecular weight [g/mol] 272.37 284.42 592.78 
calculated density [mg/m-3] 1.367 1.276 1.356 
description colorless needle colorless block colorless block 
crystal size [mm3] 0.03×0.08×0.21 0.04×0.11×0.23 0.03×0.16×0.19 
absorption coefficient 
[mm-1] 
2.123 1.866 1.986 
transmission min/max 0.84/0.94 0.81/0.93 0.73/0.94 
temperature [K] 123 123 123 
radiation (wavelength) Cu Kα 
(λ = 1.54178 Å) 
Cu Kα 
(λ = 1.54178 Å) 
Cu Kα 
(λ = 1.54178 Å) 
crystal system  monoclinic monoclinic monoclinic 
space group P 21/c C /c C 2/c 
a [Å] 14.1058(9) 24.7153(16) 18.6087(7) 
b [Å] 5.8637(3) 11.2473(7) 9.2478(4) 
c [Å] 16.6087(10) 22.1394(14) 18.2691(11) 
α [°] 90 90 90 
β [°] 105.510(4) 105.788(3) 112.5780(10) 
γ [°] 90 90 90 
V [Å3] 1323.72(14) 5922.1(7) 2903.0(2) 
Z 4 16 4 
F (000)  576 2432 1248 
Θ-range of data collection 
[°] 
3.251/68.294 4.150/68.338 5.148/68.288 
measured reflections 10564 23164 10339 
independent reflections 2361 
(merging r = 0.031) 
7636 
(merging r = 0.032) 
2617 
(merging r = 0.024 
observed reflections 2102 (I>2.0σ(I)) 7386 (I>2.0σ(I)) 2570 (I>2.0σ(I)) 
refined parameters 172 722 190 
R 0.0311 0.0291 0.0350 
RW 0.0400 0.0386 0.0403 
goodness of fit 1.0722 1.0471 1.0855 
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7.10 List of Abbreviations 
acac acetylacetone 
Ac acetate 
aq. aqueous 
BArF tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
Bn benzyl, phenylmethyl 
Bu butyl 
°C Celsius  
calc. calculated 
CAN ceric ammonium nitrate 
cat. catalyst 
COD 1,5-cyclooctadien 
conv. conversion 
Cy cyclohexane 
d (NMR) doublet 
DIAD diisopropyl azodicarboxylate 
DMA dimethylacetamide 
DME dimethylether 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
dppe 1,2-bis(diphenylphosphino)ethane 
dppp 1,2-bis(diphenylphosphino)propane 
de diastereomeric excess 
dr diastereomeric ratio 
δ (NMR) chemical shift in ppm 
EI (MS) electron ionization 
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ee enantiomeric excess 
eq. stoichiometric equivalent 
ESI (MS) electrospray ionization 
Et ethyl 
Hal halogen 
Hex hexane 
HPLC high performance liquid chromatography 
Hz hertz 
IR Infrared spectroscopy 
iPr isopropyl 
Jxy coupling constant between nuclei x and y 
L ligand 
M molar (Molarity) 
m (IR) medium (signal intensity) 
m (NMR) multiplet 
mc (NMR) center-symmetrical multiplet 
Me methyl 
m.p. melting point 
ms molecular sieves 
MS mass spectrometry 
MTBE methyl-tbutylether 
NHC N-heterocyclic carbene 
NMR nuclear magnetic resonance 
n.d. not detected 
Np neopentyl 
oTol ortho-tolyl 
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Pd/C palladium on charcoal 
Ph phenyl 
ppm parts per million, 10−6 
PPTS pyridinium ptoluenesulfonate 
Pr propyl 
q (NMR) quartet 
rac racemic 
Rf retention factor 
RT room temperature 
s (IR) strong (signal intensity) 
s (NMR) singlet 
t (NMR) triplet 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
tR retention time 
ν~  vawenumber in cm─1 
w (IR) weak (signal intensity) 
Xyl xylyl 
9-BBN 9-borabicyclo[3.3.1]nonane
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